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Abstract  
 
Functional recovery following spinal cord injury (SCI) depends on the remodeling of 
the preserved neuronal circuits. Injury-induced remodeling can be studied using the 
corticospinal tract (CST), an important descending motor tract that is involved in fine-skilled 
limb movements, as a model system. Previously it has been shown that the CST responds 
to a thoracic lesion by the formation of an intraspinal detour circuit that contributes to 
functional recovery. However the underlying principles that govern this CST remodeling are 
not fully understood. By reconstructing single CST collaterals after lesion, we reveal that 
CST remodeling occurs in three distinct phases. Initially following lesion, newly formed 
collaterals undergo a growth phase that is then followed by a collateral formation phase 
where newly formed collaterals develop a more mature and complex structure. Finally there 
is a maturation phase during which there are small scale refinements of the contact pattern.  
While such endogenous remodeling processes can lead to some degree of functional 
recovery, in many cases severe deficits persist. To this date there is no effective therapeutic 
treatment that restores sensorimotor function following SCI. In the injured peripheral nervous 
system (PNS), the activation of the intrinsic growth response can support axonal 
regeneration and functional recovery. In this thesis we investigated whether and how the 
initiation of the intrinsic neuronal growth program can improve axonal remodeling and 
functional recovery after injury. To initiate the intrinsic neuronal growth response we targeted 
the transcription factor STAT3, the expression of which had been shown to be associated 
with axonal regeneration. In a collaborative study, we used conditional genetics, viral gene 
transfer and in vivo timelapse imaging to show that sustained STAT3 expression is essential 
for the timely initiation of axonal regeneration in the PNS. In contrast to the PNS, STAT3 
expression is only transiently induced following a central nervous system (CNS) lesion. 
Therefore we next investigated whether and how intrinsic growth initiation by STAT3 
expression can be used to support the regeneration and remodeling of corticospinal fibers 
after spinal cord injury. Sustained expression of STAT3 induced by viral gene transfer was 
found to cause an increase in CST axonal sprouting and regeneration following a thoracic 
lesion. Interestingly, STAT overexpression could also stimulate axonal growth in the 
absence of any lesion. This led us to utilize a unilateral lesion pyramidotomy model to 
investigate whether sustained STAT3 expression can recruit the unlesioned tract to 
compensate for the loss of innervation in the lesioned side. Indeed STAT3 overexpression 
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was found to induce compensatory sprouting and remodeling of the unlesioned tract. Fibers 
from the unlesioned tract exited the unlesioned CST in the cervical spinal cord and grew 
across the midline into the denervated side of the cord. In addition these crossing collaterals 
were found to form contacts onto the interneurons and motorneurons responsible for 
forelimb movement. Behavioral and electrophysiological assessment validated that a new 
intraspinal circuit that was formed enabled functional recovery. 
 
 Taken together, our results show that axonal remodeling occurs in defined stages. 
Targeting the initial growth phase by viral gene transfer of STAT3, a transcription factor that 
can initiate the intrinsic neuronal growth program, is an effective strategy to enhance axonal 
remodeling and thereby promote functional recovery following injury. In this thesis, we were 
able to contribute to the further understanding of the mechanisms that underlie axonal 
remodeling. In addition we have identified a promising strategy to improve axonal 
remodeling following injury. 
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Zusammenfassung 
 
Die Wiederherstellung motorischer und sensibler Funktionen (oder die funktionelle 
Erholung) nach Rückenmarksverletzung (SCI) ist abhängig von der Reorganisationsfähigkeit 
der noch unversehrten neuronalen Schaltkreise. Die auf eine Verletzung folgende neuronale 
Umstrukturierung kann modellhaft am kortikospinalen Trakt (CST) untersucht werden. Es 
handelt sich hierbei um eine wichtige absteigende motorische Bahn, die vor allem an der 
Ausführung feinmotorischer Bewegungen beteiligt ist. Unsere Arbeitsgruppe konnte in 
vorangegangenen Studien zeigen, dass der CST nach einer thorakalen Rückenmarksläsion 
einen intraspinalen Umgehungsschaltkreis ausbildet, der maßgeblich zur funktionellen 
Erholung beiträgt. Jedoch hat man bislang die Prinzipien, auf denen diese Fähigkeit zur 
Reorganisation beruht, noch nicht vollständig verstanden.  
Durch Rekonstruktion einzelner axonaler Kollateralen des CST nach Läsion konnte 
ich  nun zeigen, dass der Umbau des CST in drei Phasen erfolgt. Initial durchlaufen 
neugebildete Kollateralen eine Wachstumsphase. Diese wird dann von einer Phase gefolgt, 
in der Kollateralen ausgebildet werden, welche zunehmend eine reife komplexe Struktur 
einnehmen. Die letzte Phase ist charakterisiert durch Verfeinerungen auf Ebene der 
interneuronalen Kontaktmuster.  
Während diese endogenen Reorganisationsprozesse zu einem gewissen Grad  
funktionelle Erholung herbeiführen, bleiben in vielen Fällen schwerwiegende Defizite zurück. 
Bislang gibt es keine effizienten Therapien, die nach einer Querschnittslähmung sensible 
und motorische Funktionen wiederherstellen.  Im peripheren Nervensystems (PNS) 
hingegen kann durch die Aktivierung des intrinsischen neuronalen Wachstumgsprogrammes 
axonale Regeneration und funktionelle Erholung erfolgreich induziert werden. In einem 
weiteren Abschnitt meiner Arbeit untersuchte ich, ob und in wie weit die Induktion des 
neuronalen Wachstumsprogramms auch im zentralen Nervensystem (ZNS)  axonales 
Remodeling und die Wiederherstellung von Funktionen verbessern würde. Um das 
intrinische neuronale Wachstumsprogramm zu initiieren, konzentrierte ich mich auf den 
Transkriptionsfaktor STAT3, dessen Expression während der axonaler Regeneration im 
peripheren Nervensystem induziert wird. Mithilfe konditioneller knock-out Mäuse,  viralen 
Gentransfers und in vivo timelapse Mikroskopie konnten wir zeigen, dass die anhaltende 
Expression von STAT3 essentiell für den zeitgemässen Beginn axonaler Regeneration im 
PNS ist. Im Gegensatz zum PNS wird die STAT3 Expression nach einer Läsion im ZNS nur 
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transient gesteigert.  Daher untersuchte ich im letzten Abschnitt meiner Arbeit, ob und wie 
die Initiierung des intrinischen neuronalen Wachstumsprograms durch STAT3 genützt 
werden könnte, um die Regeneration und Reorganisation kortikospinaler Fasern nach 
Rückenmarksläsion anzukurbeln. Ich konnte zeigen, dass die Überexpression von STAT3 
mittels viralen Gentransfers eine Zunahme des axonalen  Aussprossens und der 
Regeneration des CSTs nach einer thorakalen Läsionen bewirkte. Interessanterweise 
konnte die Überexpression von STAT 3 dabei auch das axonale Aussprossen in 
Abwesenheit einer Läsion fördern. Infolge führte ich dann eine einseitige Verletzung des 
CST auf der Höhe der Medulla oblongata (Pyramidotomie) durch und untersuchte, ob  die 
Überexpression von STAT3 in kortikalen Neuronen in der Lage ist, die unverletzte Seite des 
CST dazu zu stimulieren, den Innervationsverlust der lädierten Seite auszugleichen. 
Tatsächlich konnte ich zeigen, dass STAT3-Überexpression eine kompensatorische 
Reorganisation des unverletzten CST bewirkte. Der unverletzten CST bildete zunächst neue 
Kollateralen im zervikalen Rückenmark aus. Diese wuchsen dann über die Mittellinie auf die 
denervierte Seite des Rückenmarks, wo sie Kontakte mit kurzen propriospinalen Neuronen 
und ventralen Motoneuronen – welche die Bewegung der oberen Extremitäten kontrollieren 
– ausbildeten. Verhaltensexperimente und elektrophysiologische Messungen konnten 
bestätigen, dass diese neuen intraspinale Verschaltungen die funktionelle Erholung 
verbesserten. 
 
In der Gesamtschau meiner Ergebnisse kann man schlussfolgern, dass axonales 
Remodeling nach einer Rückenmarksverletzung in distinkten sukzessiven Phasen abläuft. 
Ich konnte weiterhin zeigen, dass der virale Gentransfer von STAT3 – einem 
Transkriptionsfaktor, der das intrinsiche neuronale Wachstumsprogramm aktiviert – eine 
effektive Strategie ist, diesen axonalen Umbau weiter zu verbessern und auf diese Weise 
die funktionelle Erholung nach Verletzung zu fördern. Ich hoffe, dass diese Arbeit dazu 
beitragen konnte, das Verständnis der Mechanismen, die axonale Umbauprozesse 
regulieren, zu erweitern. Aufbauend auf diesen Befunden konnten wir weiterhin eine 
vielversprechende Strategie identifizieren, welche axonalen Umbau und funktionelle 
Erholung nach ZNS-Verletzungen weiter verbessern kann.  
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General Introduction  
 
The worldwide incidence of spinal cord injury (SCI) is estimated to be 22 
people/million population in the western and developing world (source: International 
Campaign for Cures of Spinal Cord Injury Paralysis [ICCP]). In Germany, an estimated 18.5 
cases/million of the population suffer from SCI, with 1500  new cases reported per year 
(ICCP). SCI results from either direct or indirect trauma to the cord. Spinal cord lesions are 
commonly due to acute contusion caused by the displacement of bone fragments into the 
spinal cord (Schwab and Bartholdi 1996; Kraus 1996; Schwartz and Flanders 2006). A 
majority of injuries are caused by motor vehicle and sport accidents, while other causes 
include falls, acts of violence from stabbings or gunshot wounds, and sport-related injuries 
(Figure 1). SCI patients are commonly young males, therefore SCI presents an economical 
burden for society. Due to the organization of the spinal cord and the poor capacity of the 
central nervous system (CNS) to repair following injury, SCI disrupts descending and 
ascending motor pathways, causing a transient or permanent loss of sensorimotor and/or 
autonomic function below the level of the injury.  
 
Figure 1. Spinal Cord Injury facts and figures for the North American and European populations. (A) 
The economical impact of traumatic spinal cord injury. Data compiled from the National Spinal Cord Injury 
Statistical Center 2005 and 2011, Birmingham, Alabama, USA. (B) Etiology of traumatic spinal cord injuries 
for the European population (including Germany) by WHO 1959–2008 (Cripps et al., 2011)  
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Over 130,000 people worldwide are affected by a traumatic spinal cord injury 
resulting in paralysis and loss of sensory-motor function below the level of injury (source: 
ICCP).  Depending on the severity of the injury, the ability to control a majority of 
autonomous bodily functions that includes bowel, bladder and sexual function can be lost to 
various degrees (Figure 2; Ditunno et al., 1994; American Spinal Injury Association 2000; 
Rhee et al., 2006). Human spinal cord injury is classified clinically by the segmental level of 
injury, the completeness of the injury, and the mechanism of injury (Figure 2). An injury 
above the C4 cervical level leads to tetraplegia where there is paralysis in both the arms and 
legs. Conversely, patients with an injury at the lower thoracic to lumbar level can experience 
paralysis or reduced movement of their legs. In such cases of severe traumatic injury, the 
SCI patient will require long term care with elevated lifetime cost (Figure 1; The University of 
Alabama National Spinal Cord Injury Statistical Center 2002). In addition, the quality of life of 
many SCI patients is severely affected as they are both paralyzed and bound for life to a 
wheelchair (Westgren and Levi 1998; Krause 2003; Budh and Osteråker 2007).   
 
Figure 2. Spinal cord injury severity classification using the American Spinal Injury Association 
(ASIA) Impairment Scale (Modified from Thuret et al., 2006, Copyright © Nature Publishing Group 2006). 
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1.1. The pathophysiological response of the cord to injury 
Information regarding the pathology of human SCI is limited, though the available 
data indicates there are strong similarities between humans and rodent spinal contusion 
injuries (Kakulas 1984; Bunge et al., 1993; Kalb and Strittmatter 2010). In response to injury, 
the spinal cord undergoes three time-dependent phases (Tator 1995; Schwab and Bartholdi 
1996; Tartor 1998; Bareyre and Schwab 2003; Schwartz and Flanders 2006): The acute, 
sub-acute and chronic phase. 
 
1.1.1. The acute phase: 3-6hrs post injury 
The acute phase happens immediately to a few hours after injury. Injury to the cord 
can be caused by the displacement of bone fragments or direct compression of the cord. 
During this phase the cord undergoes biochemical and structural changes. Interneuronal 
tracts are damaged, blood flow is reduced, intracellular calcium levels rise, and there is 
cellular death and degeneration of axons (Tartor 1995; Martirosyan et al., 2011). The edema 
develops and there is a change in electrolyte levels, with an increase of extracellular 
potassium (Schwab and Bartholdi 1996). The biochemical changes lead to a state of spinal 
shock, where there is temporary flaccid paralysis and loss of tendon reflexes below the level 
of the lesion (Hiersemenzel et al., 2000; Ditunno et al., 2004).  
 
1.1.2. The sub-acute phase 6-72 hrs post injury 
During this phase there is an increase in free radical production and the release of 
excitatory neurotransmitters, such as glutamate and aspartate, up to cytotoxic levels (Park et 
al., 2004). Within hours and lasting for several days following injury, an inflammatory 
response develops (Balentine 1978; Dusart and Schwab 1994), with endothelial damage, 
release of inflammatory mediators, invasion of peripheral inflammatory cells and activation of 
microglia. Secondary damage is caused by immune cells such as neutrophils (appearing 6-
24h post-injury) macrophages (appearing 24h-2wks post-injury), and T-cells (Blight 1992; 
Schnell et al., 1999; Bethea and Dietrich, 2002; David and Kroner 2011).  
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At the lesion site a cavity and scar tissue are formed, consisting of extracellular 
matrix (ECM) proteins, mainly collagen and chondroitin sulphate proteoglycans (CSPGs), 
which secrete inhibitors hindering axonal regrowth (Fitch and Silver 2008; Fehlings and 
Hawryluk 2010). Fibroblast, Schwann cells and macrophages form the scar tissue by the 
deposit of ECM laminin, fibronectin and collagen. The sealing of the scar is dependent on 
pericytes, perivascular cells that associate with the endothelial cells of capillaries and are the 
source of scar-forming cells (Göritz et al., 2011). The glial/fibrotic scar is a hindrance to 
regeneration as it is an inhibitory environment that is made up of fibroblast-like cells, 
collagen surrounded by reactive astrocytes and microglial cells (Silver and Miller 2004; Xu et 
al., 2011; Leal-Filho 2011).  The reactive astrocytes are responsible for the upregulation, at 
the site of injury, of molecules such as semaphorin 3 (Pasterkamp et al., 2001), ephrin-B2 
(Bundesen et al., 2003), slit proteins (Hagino et al., 2003), and chondroitin sulfate 
proteoglycans (McKeon et al., 1995; Jones et al., 2003; Rhodes and Fawcett 2004). The 
scar however does serve a function as it separates the damaged tissue from healthy, hence 
protecting viable tissue from necrosis (Lindsay 1986; Reier and Houlse 1988; Schwab and 
Bartholdi 1996; Fitch and Silver 2001; Leal-Filho 2011). 
 
1.1.3. The late phase: weeks to months post injury  
In the late phase, there is the disappearance of phagocytic macrophages from the 
lesion area and what remains is a fluid-filled cyst (Figure 3). There is also the formation of 
cavities, which are filled with cerebrospinal fluid (Balentine 1978; Zhang et al., 1997). 
Examination of damaged human tissue found that necrosis is similar to animal models, 
including the cavities formed (Hughes 1974; Bunge et al., 1993). The dense network of 
reactive astrocytes makes up the major component of the scar, another albeit minor 
component is the reactive microglial cell and macrophages. At 3 weeks there is Wallerian 
degeneration (Blight and Descrecito 1986; Zhang et al., 1997), and to some extent, 
particularly in smaller lesions, remyelination by oligodendrocytes (Gledhill and McDonald 
1977; Harrison and McDonald 1977; Schwartz and Flanders 2006). There is some attempt of 
CNS axons to sprout after injury but the newly formed growth become dystrophic (Li and 
Raisman 1995; Kerschensteiner et al., 2005; Misgeld et al., 2007) after exposure to a 
gradient of inhibitory extracellular matrix molecules (Fitch and Silver 2008). Growth-
associated inhibitors such as myelin associated glycoproteins (MAGs), Nogo and 
oligodendrocyte myelin glycoprotein (OMgp) are expressed in the vicinity of the lesion area 
hindering any attempt of growth (Schwab and Bartholdi 1996; Sekhon and Fehlings 2001; 
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Filbin 2003). Near the vicinity of the lesion site, chronic demyelination occurs in both humans 
(Bunge et al., 1993; Guest et al., 2005) and experimental animals (Blight, 1983; Blight 1993; 
Cao et al., 2005; Totoiu and Keirstead 2005). Overall there is loss of myelin in the white 
matter and conduction deficits due to the biochemical and molecular changes that occur, 
interruption of tracts and demyelination (Waxman 1989; Waxman 1992; Taoka and Okajima 
1998; Sekhon and Fehlings 2001). 
 
 
 
Figure 3. Response of the spinal cord following injury.  (A) Dissected mouse spinal cord highlighting 
the thoracic spinal cord (red box). The events mentioned occur in the acute and subacute phase following a 
lesion. Scale bar represents 1mm (B) Sagittal section of a thoracic spinal cord 3 weeks following a dorsal 
T8 hemisection (neurons in blue and the corticospinal tract (CST) in red). Scale bar represents 100µm. (C) 
After spinal cord injury there is damage of ascending and descending tracts, upregulation of growth and 
inhibitory factors, accumulation of immune cells in the lesion site and the formation of the glial scar. The 
damaged axonal tracts can respond by sprouting new collaterals and by the formation of new circuits 
(Image C is modified from Thuret et al., 2006, Copyright © Nature Publishing Group 2006). 
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1.2. Clinical care and perspectives  
At present, in humans there is no treatment that is able to fully restore sensorimotor 
function following injury. Patients admitted with injury undergo surgery to remove bone 
fragments and have their spine stabilized. After surgery care involves the prevention of 
secondary damages and rehabilitation in the form of physiotherapy (Dietz 2002; Edgerton et 
al., 2006; Mehrholz et al., 2008; Markandaya et al., 2012). The acute standard of care 
involves the administration of corticosteroids such as methylprednisolone, which works by 
decreasing inflammation thereby limiting secondary damage (Bracken et al., 1985; Bracken 
et al., 1997; Bracken 2002; Hurlbert and Hamilton 2008). The use of this drug is somewhat 
controversial with some studies highlighting the benefits (Bracken et al., 1985; Bracken et 
al., 1997; Bracken and Holford 2002) and others finding the effects modest in light of 
associated side effects that can include glaucoma, hyperglycemia, depression, psychosis 
and the cessation of the natural production of cortisol (Nesathurai 1998; Sayer et al., 2006).  
 
Strategies for future treatment and management of spinal cord injury in humans are 
based on the pathophysiological changes that occur in the acute, sub-acute and late phases 
following injury. Research aims at understanding the different pathophysiological 
mechanisms that arise following injury in experimental models and that could be potentially 
targeted for therapeutic treatments. For example neuroprotective strategies have been 
developed by preventing excitotoxicity (Feldblum et al., 2000; Abdelkarim et al., 2001; 
Mazzone and Nistri 2011), by controlling the inflammatory response (Popovich et al., 1999; 
Fitch et al., 1999; Alexander and Popovich 2009; Pajoohesh-Ganji and Byrnes 2011), or by 
preventing apoptosis (Nicholson 2000; Nesic et al., 2001; Demjen et al, 2004). Other lines of 
work aim at promoting axonal growth or regeneration through the use of cell grafts and 
scaffolds that can act as bridges, through the application of growth promoting factors (Xu et 
al., 1995; Li et al., 1997; Li et al., 1998; Menei et al., 1998; Ramon-Cueto et al., 2000; 
Bamber et al., 2001;, Takami et al., 2002; Li et al., 2003; Bradbury and McMahon 2006) or 
through the manipulation of the intrinsic growth program of neurons (Qiu et al., 2002; Yip et 
al., 2010; Liu et al., 2010, Bareyre et al., 2011; Sun et al., 2011). Laboratory research has 
provided useful information in expanding the knowledge and contributing to the treatment of 
spinal cord injury. 
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1.3. Experimental models for SCI research  
In SCI research the use of appropriate animal models is important. In humans, spinal 
cord injuries can be diverse and it can be difficult to reproduce the same sort of injury in an 
experimental setting. The two main commonly used models of spinal cord injury employed 
by most laboratories are (Figure 4A):  
 
(1) The contusion injury performed using a NYU-MASCIS (New York University - 
Multicenter Animal Spinal Cord Injury Study) impactor device, which drops a weight from 
specific heights, can perform standardized grades of spinal cord injuries (Gruner 1992; 
Agrawal et al., 2010). This injury model is based on the Allen technique, developed in 1911, 
whereby a weight dropped through a tube onto the exposed thoracic cord of a dog resulting 
in a reproducible model. The contusion model is the most similar to the histological 
mechanics of human spinal cord injury (Schwab and Bartholdi 1996), however in this type of 
injury there is haemorrhage and variable tissue damage making the comparison of neuronal 
damage between different animals more challenging (David and Kroner 2011).  
 
(2) The dorsal hemisection injury involves transection of the dorsal half of the spinal 
cord at the thoracic level with fine iridectomy scissors. This model produces a smaller 
inflammatory response, is highly reproducible and allows for defined parts of the cord to be 
spared. This model is thus best suited for the precise investigation of axonal remodeling and 
was used in our studies on CST regeneration and remodeling.  
 
In addition to spinal lesion models that focus on the analysis of the corticospinal tract, 
we also used the dorsal root ganglia (DRG) model system to study the growth initiation of 
axons (Figure 4B). The DRG model system is often employed in outgrowth studies as it 
provides access to both the PNS, (known for its regenerative capabilities), and to the CNS, 
(where there is no successful regeneration) (Richardson and Issa 1984; Richardson and 
Verge 1987; Sjoberg and Kanje 1990; Chong et al., 1994; Neumann and Woolf 1999).  
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Figure 4. Localization of the Corticospinal tract (CST) and Dorsal root ganglia (DRG) neuron with its 
peripheral and central branch.  (A) The corticospinal tract (red) can be labeled or manipulated via 
stereotaxic injection of a compound (either a tracer or virus) of interest into defined coordinates in the 
cortex. In a dorsal T8 hemisection, only half of the cord is transected (dashed line) sparing fiber tracts and 
interneuronal pools located in the ventral grey and white matter. For a contusion injury, an impactor drops a 
weight from a fixed distance onto the cord enabling standardized grades of injuries. (B) The DRG can be 
exposed through surgery and also injected with a finely pulled micropipette. The neuronal cell body of the 
DRG, located in the ganglia, sends one branch into the periphery (peripheral branch) and another branch 
into the spinal cord (central branch). The peripheral branch is known for its regenerative capabilities.  
Regeneration of the central branch can occur only if the peripheral branch is first injured, an effect known 
as a conditioning lesion.  The DRG injection image is courtesy of Fabian Laage-Gaupp. Scale bar equals 
1mm in A and B. 
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1.4. Spontaneous corticospinal outgrowth and remodeling 
after SCI  
The corticospinal tract (CST), as one of the most important descending motor tract 
for skilled movements in all mammalian species (Nudo and Masterton 1988, 1990; Maier et 
al., 2008), has been a frequent model used to investigate axonal growth, regeneration and 
remodeling within the adult CNS (Schnell et al., 1994; Weidner et al., 2001; Zhou and Shine 
2003; Bareyre et al., 2004; Liu et al., 2010; Rosenzweig et al., 2010). In the mammalian 
system the CST is responsible for fine skilled movements, for example grasping and 
handling (Whishaw et al., 1998) and locomotor functions such as stride length (Bregman et 
al., 1995). In humans the CST has an even more important role and controls locomotion, 
posture as well as voluntary skilled movements (Ferguson et al., 2001; Hutson et al., 2011). 
The pyramidal neurons of the corticospinal tract originate in lamina V of the cortex. The 
fibers of this tract descend from the cerebral cortex sending axons via the internal capsule to 
the spinal cord (Dottori et al., 1998). The CST is composed of two components: a main 
component also known as the main CST which comprises of 95% of all CST axons; and a 
minor component constituted of the ventral and dorsolateral CST (Vahlsing and Feringa 
1980; Joosten et al., 1992; Brösamle and Schwab 1997; Weidner et al., 2001; Steward et al., 
2004). The tract in rodents decussates at the spinomedullary junction with the main 
component crossing over in the dorsal funiculus. In humans the CST fibers descend 
contralaterally in the lateral funiculus (Harel and Strittmatter 2006; Hutson et al., 2011). The 
remaining minor components of the CST do not decussate and the fibers run in the white 
matter of the ipsilateral dorsolateral side (Hutson et al., 2011).  At 4 weeks of age the rodent 
CST is matured and establishes contacts with the appropriate interneurons and with a 
subset of motorneurons (Ghosh et al., 2009). The topological organization of the CST is 
such that the forelimb CST (fCST) projects its collaterals in the cervical cord, while hindlimb 
CST (hCST) axons innervate the appropriate target in the lumbar cord (Akintunde and 
Buxton 1992; Ghosh et al., 2009).   
 
The CNS for a long time has had the reputation for being a “static” system in 
adulthood, where successful axonal growth, sprouting and regeneration does not occur. As 
research progresses, we are beginning to now realize that in the adult mammal the CNS has 
the capability for some spontaneous recovery of function in rodents and to some extent in 
humans (Schwab and Bartholdi 1996; Burns et al., 1997; Dietz et al., 1998; Rossignol et al., 
1999)  Many examples of injury-induced plasticity stem from the study of lesioned CST 
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connections (Bernstein and Stelzner 1983; Kuang and Kalil 1990; Schnell et al., 1994; 
Terashima 1995; Bregman et al., 1995; Li et al., 1997; Weidner et al., 2001; Bareyre et al., 
2002; Bareyre et al., 2005; Demjen et al., 2004). Prominent findings have found that the 
reorganization of neural circuits plays a key role in spontaneous recovery of function 
(Bareyre et al., 2004; Courtine et al., 2008; Ghosh et al., 2009; Alilain et al., 2011). In 2001, 
Fouad et al., (2001) observed that following an incomplete thoracic lesion in rats there were 
rearrangements in the cortical motor map. Stimulation of what was previously an area 
responsible for hindlimb muscle response instead invoked forelimb responses.  The shift in 
the cortical map was accompanied by spontaneous growth of hindlimb corticospinal axons in 
the cervical cord. However it was unknown what the neuronal targets of these newly formed 
collaterals were. 
 
Bareyre et al., (2004), then made a seminal discovery whereby functional recovery 
after SCI was attained via the formation of an intraspinal detour circuit (Figure 4). This study 
revealed that neural circuits are able to undergo spontaneous functional reorganization that 
lead to the reconnection of lesioned CST fibers with their original targets. Following a partial 
lesion of the CST, lesioned hindlimb CST axons sprouted newly formed collaterals in the 
cervical cord rostral to the lesion site. These collaterals were found to form contacts with a 
pool of excitatory interneurons known as propriospinal neurons. Propriospinal neurons were 
first described in 1902, as a network of axons extending from the proximal to distal spinal 
cord (Sherrington and Laslett 1902, 1903). These neurons are an important part of an 
intraspinal network of interneurons involved in motor reflexes, voluntary movement and 
sensory processing (Kostyuk and Vasilenko 1979; Jankowska 1992; Foreman 2000; Pierrot-
Deseilligny and Burke 2005; Alstermark et al., 2007; Conta and Stelzner, 2009; Cowley et 
al., 2010; Flynn et al., 2011). There are two main populations of propriospinal neurons. Short 
prospriospinal neurons (SPSNs), involved in the fine tuning of forelimb movement, have their 
cell bodies in C4 and their axons terminate at T2. Long propriospinal neurons (LPSNS) are 
known to coordinate forelimb and hindlimb movement. This population of PSNs has their cell 
bodies in C5/6 and their axons extend till T12/T13 (Nicolas et al., 2001; Dietz 2002).  In this 
study, it was found that initially, hCST collaterals contacted both long and short PSNs 
equally (Bareyre et al., 2004). Overtime, contacts onto SPSNs were removed while contacts 
onto LPSNs were maintained (Figure 5). Long PSNs are an ideal target as they are able to 
bypass the lesion site and contact motorneurons in the lumbar cord. Further examination 
revealed that the LPSNs had increased their contacts onto lumbar motorneurons, hence 
forming a new intraspinal circuit (Bareyre et al., 2004).  Behavioral and electrophysiological 
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experiments further proved that this circuit was functional and responsible for the 
spontaneous functional recovery seen following SCI.  
 
Figure 5. Reorganization of hindlimb CST collaterals following injury.  Timeline of the formation of a 
new intraspinal detour circuit following a dorsal T8 hemisection. (A) Normal connectivity, in absence of a 
lesion, in which the hindlimb CST (hCST) sprouts its collaterals into the lumbar cord to contact interneurons 
or motorneurons. (B) Three weeks post lesion, hCST collaterals are induced to sprout in the cervical cord 
where they were seen to form equal contacts onto both short and long propriospinal spinal relay neurons.  
(C) By 12 weeks post lesion contacts onto long propriospinal neurons (LPSNs) that bypass the lesion site 
and are involved in coordinating hindlimb and forelimb movement are strengthened and maintained. While 
contacts onto short propriospinal neurons that do not directly aid in functional recovery are pruned. LPSNs 
were seen to form contacts with lumbar motorneurons, thereby creating a new intraspinal circuit that can 
enable functional recovery. (D-F) Confocal photomicrographs showing contacts of hCST collaterals to (D) 
interneurons at 3 weeks following injury, (E) to short propriospinal neurons 3 weeks following injury, and to 
(F) LPSNs 3 weeks following injury. (D) is taken  from Lang et al., 2012. 
 
Further examining the importance of this newly formed intraspinal circuit for 
functional recovery after incomplete injuries, Courtine et al., (2008) performed a series of 
elegant experiments to examine the effects of eliminating the propriospinal relay connection. 
They demonstrated that severing the newly formed propriospinal relay connections whether 
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by a staggered hemisection or a high dose of N-methyl-D-asparate (NMDA), which in high 
doses can act as an excitotoxin, abolishes recovery. By severing the supraspinal axon 
connection, kinematic and physiological analyses showed that this results in permanent 
paralysis of the hindlimbs. The various lesion paradigms performed in this study, where 
lesions were separated both temporally and spatially, in combination with refined kinematic 
analysis, illustrated that the propriospinal relay circuit is responsible for the restoration of full, 
weight-bearing hindlimb locomotor function seen following even a severe injury. In summary, 
these studies revealed upon electrophysiological, behavioral and anatomical examination 
that a new detour circuit involving LPSNs can be formed and that this axonal remodeling 
contributed to functional recovery (Fouad et al., 2001; Bareyre et al., 2004; Courtine et al., 
2008).  
 
After injury, intraspinal circuits are spontaneously created and able to transmit 
descending supraspinal input to the lumbar motor circuits (Bareyre et al., 2004; 
Kerschensteiner et al., 2004; Ballermann and Fouad 2006; Courtine et al., 2008). These 
studies not only highlight the positive impacts that injury can induce in the form of 
remodeling, they can also help to identify the mechanisms that govern spontaneous 
remodeling and functional recovery. Exploiting this innate phenomenon by reinforcing 
beneficial axonal remodeling would be an advantageous strategy in facilitating functional 
recovery.   
 
 
1.5. Therapy-induced modulation of corticospinal 
remodeling  
 About half of SCI patients, approximately 54%, suffer from an incomplete injury 
where at an anatomical level there is some sparing of tissue and descending fibers 
(Raineteau and Schwab 2001; Spinal injury network 2011). In such cases, under the right 
conditions extensive remodeling can occur due to the preservation of the cortical, subcortical 
and remaining intact fibers and spinal circuitry. Molecular interventions to take advantage of 
spared fibers and circuits are one of the main types of therapies that are researched in the 
field of SCI (Thuret et al., 2006). In the search for successful therapeutic strategies one 
needs to consider the extrinsic and the intrinsic barriers that limit this process in the CNS.  
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Extrinsic cues that limit axonal remodeling appear to accumulate over time in the 
CNS. For example, in young animals the CST displays great plasticity and if injured the CST 
axons are able to pass the lesion site to innervate the appropriate area (Bregman et al., 
1989; Liu et al., 2011). As the animal matures the regenerative and plastic capability of the 
CNS is reduced, coinciding with the production of myelin and of inhibitory proteins such as 
associated neurite growth inhibitory proteins (Kapfhammer and Schwab 1994a,b; Steeves et 
al., 1994; Harel and Strittmatter 2006).  The glial scar forms an inhibitory environment and 
acts as a barrier to axonal regeneration. Injured axons when faced with such a barrier are 
unable to grow further and instead form retraction bulbs (Fitch and Silver 1997; Silver and 
Miller 2004; Leal-Filho 2011).  Neutralization of the inhibitory environment that is formed 
following injury is one strategy that has been used to enhance regeneration of lesioned 
axons. For example, the removal or neutralization of oligodendrocytes or myelin can improve 
regeneration (Bregman et al., 1995). When an antibody aimed against neutralizing inhibitory 
factors like Nogo-A (IN-1 antigen) is used, regenerative sprouts and long distance elongation 
is seen (Schnell and Schwab, 1990; Brosamle et al., 2000; Chen et al., 2000). Likewise 
treatment with the bacterial enzyme chondroitinase ABC (chABC), which has the ability to 
digest CSPG in the scar, also has beneficial effects in spinal cord injury models from 
contusion (Caggiano et al., 2005) hemisections (Bradbury et al., 2002; Yick et al., 2003; 
Barritt et al., 2006; Houle et al., 2006) and transections (Fouad et al., 2005). While some 
beneficial effects on axonal remodeling have been reported as well (Thallmair et al., 1998; 
Z’Graggen et al., 1998; Z'Graggen et al., 2000; Bradbury et al., 2002; Bareyre et al., 2002), 
the removal of extracellular inhibitory molecules has so far proven to be insufficient for 
extensive axonal remodeling and complete functional recovery. This might at least partially 
be due to the fact that this approach targets growth inhibitors at the lesion site, whereas 
axonal remodeling commonly occurs remote from this area.  
 
The intrinsic barrier, attributed to the decline in the intrinsic growth competence of a 
CNS neuron as it matures, affects the capabilities of injured CNS neurons to both regenerate 
and remodel. To promote axonal growth and remodeling, one commonly used strategy is the 
application of factors such as neurotrophins. When a unilateral lesion of the CST is 
performed at the pyramidal decussation (pyramidotomy lesion) in the medulla oblongata, the 
unlesioned CST tract can be recruited to compensate for the loss of the original input and 
enable functional recovery. This model system can be used to evaluate the effectiveness of 
potential molecules to promote remodeling. Following a pyramidotomy lesion, when 
motorneurons were transduced to express NT3, unlesioned CST axons were found to sprout 
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across the midline towards the transduced motorneurons (Zhou et al., 2003). Sustained 
concomitant expression of neurotrophic factors BDNF and NT3 in the cortex and spinal cord, 
respectively, further enhanced the axonal sprouting effect from the intact tract (Zhou and 
Shine 2003). An alternative and more direct approach is the manipulation of key regulatory 
genes involved in the intrinsic growth program and known to be activated in regenerating 
PNS neurons. The forced upregulation of molecules that contribute to axonal growth and 
that are normally downregulated in the CNS after injury can induce compensatory sprouting 
from the unlesioned tract. Genetically overexpressing factors such as neuronal calcium 
sensor-1 (NCS1) (Yip et al., 2010) and mTOR (Liu et al., 2010) has been reported to 
stimulate spared fibers to send their axons into to the denervated side leading to functional 
recovery of the injured limb. Remodeling requires axonal growth, as it has been shown that 
manipulation of the PI3K-Akt (of which NCS1 is a member) and PTEN/mTOR pathways can 
induce growth and lead to recovery following CNS injuries (Park et al., 2010; Yip et al., 2010; 
Liu et al., 2010). Hence the approach to induce growth through exploiting the intrinsic growth 
potential of a neuron would be an effective strategy to promote axonal remodeling.  
 
 
1.6. The Jak/STAT Pathway: A component of the intrinsic 
growth program  
In the adult mammalian system, it is well known that only in the peripheral nervous 
system (PNS) there is successful regeneration of lesioned axons. Following injury, even 
though successful regeneration does not occur in the CNS, CNS neurons are capable of 
mounting a transient regenerative response as evidenced by the expression of regeneration 
associated proteins and genes (RAGs) (Mikucki and Oblinger 1991; Tetzlaff et al., 1994; 
Fournier and McKerracher 1997; Neumann and Woolf 1999; Bulsara et al., 2002; Storer et 
al., 2003; Kruse et al., 2011). This indicates that the intrinsic growth program inherent to 
neurons is activated in response to injury, however it is not sustained. This is in contrast to 
what has been observed in the PNS, where following injury there is regeneration and a high 
expression of transcription factors and proteins associated with regeneration and growth. In 
the classical ‘conditioning lesion’ paradigm, regeneration of both the peripheral and central 
branch of the DRG neuron can occur, although regeneration of the central branch is 
dependent on prior injury of the peripheral branch (Richardson and Issa 1984; Richardson 
and Verge 1987; Sjoberg and Kanje 1990; Chong et al., 1994; Neumann and Woolf 1999; 
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Cai et al., 2002). Injury of the peripheral branch activates the intrinsic growth program and is 
thus the key for regeneration in both branches (Cai et al., 2002; Yang and Yang 2011) as 
this program is not activated in the mature CNS following an injury (Stam et al., 2007). 
Targeting factors involved in the intrinsic growth program would therefore be an effective 
strategy to promote axonal growth and regeneration following CNS injuries. Most commonly 
upregulated genes and transcription factors after injury that are found to be associated with 
regeneration are: c-Jun, Atf-3, Hspb1, HSP-27, Adcyap1, Gadd45a, Gap43, Actb, Tubb3 
and in particular the Signal transducer and activator of transcription 3 (STAT3) (Broude et 
al., 1997; Qiu et al., 2005; MacGillavry et al., 2009; Sun and He 2010; Smith et al., 2011).  
 
STAT3 has dual roles as a signal transducer and a transcription factor. The STAT3 
protein is essential during development as a complete knockout results in embryonic lethality 
(Takeda et al., 1997; Aaronson and Horvath 2002). In adulthood it is known to participate in 
various functions including neuronal cell survival, axonal growth, protection and remodeling 
(Levy and Darnell 2002). In the immune system, STAT3 plays a key role in the signal 
transduction of anti-inflammatory responses mediated via macrophages and neutrophils, in 
turn regulating the inflammation process (Kühn et al., 1993; Akira 2000; Shuai and Liu 
2003). The Janus kinase (Jak/STAT) pathway has also been implicated to be involved in 
synaptic plasticity, with pharmacological inhibition or knockdown of STAT3 blocking the 
induction of NMDAR (N-methyl-D-aspartate receptor)-LTD (long-term depression) (Nicolas 
et al., 2012). In normal conditions, STAT3 exists in the cytoplasm of a cell in an inactive form 
where it is associated with the glycoprotein 130 (gp130). The Jak/STAT3 signaling pathway 
is activated by cytokines interleukin 6 (Il6) (Zhong et al., 1994), ciliary neurotrophic factor 
(CNTF) (Rajan et al., 1996) and the leukemia inhibitory factor (LIF) (Kunisada et al., 1996). 
While the intensity and duration that the Jak/STAT pathway is activated for is tightly 
regulated and controlled by members of the suppressor of cytokine signaling (SOCS) family 
(Croker et al., 2008). Once activated by cytokines, JAK kinases phosphorylates the tyrosine 
residue (Tyr-705) of STAT3, leading to homodimerization or STAT1/3 heterodimerization 
(Figure 5). In its activated phosphorylated form, the dimerized complex is translocated to the 
nucleus where it binds to specific DNA-response elements activating the transcription of 
specific genes (Zhong et al., 1994; Akira 2000; Ng et al., 2006).  STAT3 can also be 
phosphorylated at serine 727 (Ser-727), and it has been suggested that Ser-727 
phosphorylation enables STAT3 to achieve its maximal transcriptional activity (Ceresa and 
Pessin 1996; Lim and Cao 1999; Ng et al., 2006). 
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Figure 6. Signal transducer and activator of transcription 3 (STAT3) is part of the Janus-family 
kinases (JAKs)/STAT3 pathway. This pathway can be activated in response to autocrine or paracrine 
signals, including cytokines. Upon activation, JAKs and SRC tyrosine kinases are able to phosphorylate 
STAT3 at its tyrosine residue. Following phosphorylation, STAT3 is able to dimerize and translocates to the 
nucleus where it will transcribe target genes. STAT3 signaling is tightly regulated by inhibitory molecules 
that include suppressor of cytokine signaling (SOCS) proteins, protein inhibitor of activated STAT (PIAS) 
proteins and protein tyrosine phosphatases (PTPases). 
 
 
 
                                                                     Introduction 
 
 
    21 
The following findings suggest that STAT3 signaling could be a key event in the 
regulation of axonal outgrowth:   
(i) The expression levels of phosphorylated STAT3 is increased in regenerating 
axons (Schwaiger et al., 2000; Sheu et al., 2000; Xia et al., 2002) and is associated with 
axonal remodeling (Bareyre et al., 2002).   
(ii) Molecules that have an influence on axonal regeneration and are expressed 
following a peripheral nerve injury, for example cytokines IL-6, ciliary neurotrophic factor, 
and leukemia inhibitory factor have an effect on STAT3 signaling (Curtis et al., 1994; Zhong 
et al., 1999; Cafferty et al., 2001; Cafferty et al., 2004).  
(iii) In cultured CNS neurons, STAT3 has been found to promote neuronal outgrowth 
(Smith et al., 2011) and in the DRG ‘conditioning lesion’ paradigm STAT3 is activated in the 
cell bodies of the DRG neurons only when the peripheral branch is injured (Schwaiger et al., 
2000; Qiu et al., 2005).  Taken together these findings suggest that STAT3 is an interesting 
candidate regulator of the intrinsic neuronal growth program. 
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Aims of the Thesis 
 
The overall goals of this thesis were to contribute to a better understanding of the 
structural principles underlying axonal remodeling following spinal cord injury and to 
determine whether we could enhance axonal growth, regeneration and remodeling of the 
corticospinal tract through the genetic manipulation of intrinsic neuronal growth pathways. 
Therefore the following questions were investigated within this thesis: 
 
 
1. What are the processes that underlie the maturation and remodeling of newly 
formed collaterals following injury? 
 
In aim I of this thesis we examined the manner in which the corticospinal tract 
remodels its axons following spinal cord injury. Our laboratory has previously shown that in 
response to injury, the CST can spontaneously sprout collaterals rostrally to the lesion site. 
In turn these collaterals contact interneuronal populations in the cervical cord creating a 
“detour circuit” to mediate functional recovery. Through the use of transgenic mice, genetic 
tracing methods and dye tracers, we selectively labeled the CST as well as different 
interneuronal populations in the spinal cord. Using bulk analysis and reconstructions of 
single CST collaterals we were able to follow the formation, maturation and refinement of 
CST collaterals over several months following lesion. 
 
 
2. How does the regenerative-associated transcription factor STAT3 regulate 
axonal regeneration in the PNS and CNS? 
 
In aim II of this thesis, we wanted to investigate whether the transcription factor 
STAT3 is a suitable tool to manipulate the intrinsic neuronal growth response. To reveal the 
role of STAT3 during PNS and CNS regeneration we focused on the DRG system which 
provides access to both the CNS and the PNS branches of the same neuron. The 
expression levels of STAT3 were manipulated in both the PNS (where STAT3 was ablated) 
and CNS (where STAT3 was overexpressed) through the combined use of transgenic mice 
and adeno-associated viral (AAV) viruses. With confocal and repetitive in vivo timelapse 
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microscopy, we were able to identify sustained STAT3 expression is a key requirement for 
the timely initiation of PNS axon regeneration.  
 
 
3. Can the sustained expression of STAT3 enhance axonal regeneration, 
remodeling and functional recovery following a CNS injury?  
 
In aim III of the thesis, we expanded on our previous studies in order to elucidate 
whether the initiation of an intrinsic neuronal growth response by STAT3 expression could 
also promote outgrowth of CNS axons following spinal cord injury. To address this question 
we performed two sets of experiments. First we deleted endogenous STAT3 expression in 
cortical projection neurons and analyzed the effects on endogenous CST axonal outgrowth. 
Second, through gene therapy we overexpressed STAT3 in upper corticospinal 
motorneurons and used several CST-lesion paradigms, along with behavioral and 
electrophysiological assessments to reveal the role of STAT3 in axonal remodeling, 
regeneration and functional recovery after spinal cord injury. 
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Results 
 
 
The work during this doctoral thesis has resulted in two peer-reviewed publications and one 
submitted manuscript. They are included in the thesis and constitute Chapter 3.  
 
• Lang C*, Guo, X*, Kerschensteiner, M., and Bareyre, F.M. (2012). Single Collateral 
Reconstructions Reveal Distinct Phases of Corticospinal Remodeling after Spinal 
Cord Injury. PLoS ONE. 7:e30461. 
 
• Bareyre FM, Garzorz N, Lang C, Misgeld T, Büning H, Kerschensteiner M. (2011). In 
vivo imaging reveals a phase-specific role of STAT3 during central and peripheral 
nervous system axon regeneration. Proc Natl Acad Sci U S A.108(15):6282-7. 
 
 
• Lang C, Bradley P, Kerschensteiner M, Bareyre FM. (2012). STAT3 promotes 
corticospinal remodeling, regeneration and functional recovery after spinal cord 
injury. An article submitted to the Journal of Neuroscience 
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Abstract
Background: Injuries to the spinal cord often result in severe functional deficits that, in case of incomplete injuries, can be
partially compensated by axonal remodeling. The corticospinal tract (CST), for example, responds to a thoracic transection
with the formation of an intraspinal detour circuit. The key step for the formation of the detour circuit is the sprouting of
new CST collaterals in the cervical spinal cord that contact local interneurons. How individual collaterals are formed and
refined over time is incompletely understood.
Methodology/Principal Findings: We traced the hindlimb corticospinal tract at different timepoints after lesion to show
that cervical collateral formation is initiated in the first 10 days. These collaterals can then persist for at least 24 weeks.
Interestingly, both major and minor CST components contribute to the formation of persistent CST collaterals. We then
developed an approach to label single CST collaterals based on viral gene transfer of the Cre recombinase to a small number
of cortical projection neurons in Thy1-STP-YFP or Thy1-Brainbowmice. Reconstruction and analysis of single collaterals for up
to 12 weeks after lesion revealed that CST remodeling evolves in 3 phases. Collateral growth is initiated in the first 10 days
after lesion. Between 10 days and 3–4 weeks after lesion elongated and highly branched collaterals form in the gray matter,
the complexity of which depends on the CST component they originate from. Finally, between 3–4 weeks and 12 weeks
after lesion the size of CST collaterals remains largely unchanged, while the pattern of their contacts onto interneurons
matures.
Conclusions/Significance: This study provides a comprehensive anatomical analysis of CST reorganization after injury and
reveals that CST remodeling occurs in distinct phases. Our results and techniques should facilitate future efforts to unravel
the mechanisms that govern CST remodeling and to promote functional recovery after spinal cord injury.
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Introduction
Injury to the spinal cord leads to a disruption of ascending and
descending fiber tracts followed by loss of sensation and voluntary
movements below the level of the lesion [1]. Whereas a complete
transection of the spinal cord often leads to permanent disabilities,
incomplete injuries can be followed by spontaneous functional
recovery [2–4]. An important anatomical feature underlying this
functional recovery is the remodeling of damaged axonal
connections [5–8]. Many insights into how axons remodel after
lesion stems from the study of the corticospinal tract (CST). The
CST is a major descending motor pathway that mediates skilled
movements in all mammalian species [9], [10]. The CST in
rodents consists of a main component that runs at the base of the
dorsal funiculus and minor components in the dorso-lateral and
ventral funiculus [11–13]. In recent years we and others have
studied how the hindlimb portion of the CST responds to a
thoracic dorsal hemisection. Using a combination of anterograde,
retrograde and trans-synaptic tracing techniques we have
previously shown that the formation of intraspinal detour circuits
are a key component of CST remodeling after injury [6], [14].
Detour circuits are formed in the following steps: First, the
lesioned CST fibers sprout new collaterals in the cervical spinal
cord above the level of lesion. These collaterals then extend to the
intermediate layers of the cervical gray matter. There they form
contacts with different populations of spinal interneurons,
including long propriospinal neurons, a population of interneurons
that are involved in coupling of forelimb and hindlimb movement
[15–18]. These long propriospinal neurons, the axons of which
bypass the lesion in the ventral funiculus, in return increase their
projections to hindlimb motoneurons in the lumbar spinal cord.
Electrophysiological and detailed behavioral and kinematic
analysis show that this and similar detour circuits play a key role
for the recovery of CST function [6], [7].
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30461
While it is thus established that the formation of CST collaterals
is a key step of axonal remodeling after injury, we still know very
little about how long these collaterals persist, from which CST
components they originate and how their complexity and
projection pattern evolves over time. Analysis of mice traced by
injection with the anterograde tracer BDA (Biotin Dextran Amine)
in the hindlimb motor cortex and perfused at 10 days to 24 weeks
after a dorsal hemisection of the mid-thoracic spinal cord now
revealed the following findings: CST collaterals primarily started
to grow in the first 10 days after injury. Both major and minor
CST components contributed to this emergence of collaterals.
Once emerged, the majority of CST collaterals persisted at least
for up to 24 weeks after lesion. To study how these collaterals
evolve over a long period of time (for up to 12 weeks after lesion),
we labeled single CST collaterals by viral gene transfer of Cre
recombinase to a small number of cortical projection neurons in
Thy1-Stp-YFP [13] and Thy1-Brainbow mice [19]. The reconstruc-
tion of single collaterals emerging from main and minor CST
components showed that dramatic changes in collateral length and
complexity occur between 10 days and 4 weeks after injury. These
parameters remain largely stable between 4 weeks and 12 weeks
after lesion. Analysis of the CST contacts onto interneurons
however indicated that while the morphology of the collaterals
remained largely unchanged during the late stage of the
remodeling process, their synaptic projections were still refined.
We can further show that while the overall timing of the
remodeling is similar in main and minor CST collaterals their
individual complexity differed depending on their origin. Taken
together our result suggest that CST remodeling after SCI occurs
in 3 subsequent phases: a growth initiation phase (within the first
10 days after injury), which is followed by a collateral formation
phase (between 10 days and 3–4 weeks after injury) and a later
maturation phase (between 3–4 weeks and 12 weeks after injury).
Results
Cervical CST collaterals primarily emerge in the first 10
days after lesion and persist over time
Injection of BDA 10,000 into the hindlimb motor cortex
revealed three components of the hindlimb CST in the spinal cord
(Fig. 1A). The main CST component runs at the base of the
dorsal funiculus and contains 97.660.27% (n = 8 mice) of labeled
CST fibers. The minor CST components run in the dorso-lateral
and ventral funiculus and contain 2.160.23% (n = 8 mice) and
0.360.04% (n = 8 mice) of labeled CST fibers, respectively.
In unlesioned adult mice, axons arising from all hindlimb CST
components sent only very few collaterals into the gray matter of
the cervical spinal cord (level C3–C5, Fig. 1 A, D). However, as
early as 10 days following a mid-thoracic lesion, the number of
CST collaterals in the cervical cord gray matter increased more
than 4-fold (Fig. 1 B, D). Over the following weeks the number of
cervical collaterals slowly decreased. Still the majority of the
collaterals persisted long-term and was still detected as late as 24
weeks after injury (Fig. 1 C, D). Over this timeframe the
collaterals, which in most cases have just started to enter the spinal
gray matter at 10 days after lesion (Fig. 1 B), extended further and
mainly projected to the intermediate layers of the spinal cord
(Fig. 1 C). When we analyzed the contribution of different CST
components to the formation of cervical collaterals, we found that,
while in absolute number most of the collaterals arose from the
main CST, the relative number of new collaterals that emerge per
labeled fiber was several-fold higher for the minor dorso-lateral
and ventral CST components (Fig. 1 E–P). Notably, while the
number of newly formed CST collaterals emerging from the main
CST significantly declined over time (Fig. 1 H), the number of
collaterals derived from the minor CST components remained
stable for the entire observation period (Fig. 1 L, P).
Complex CST collaterals form between 10 days and 4
weeks after lesion
To label single CST collaterals, we took advantage of Thy1-Stp-
YFP [13] and Thy1-Brainbow [19] mice. In these mouse lines the
presence of Cre recombinase either starts (in the case of Thy1-Stp-YFP)
or changes (in the case of Thy1-Brainbow mice) the expression of
fluorescent proteins in the affected neurons. Expression of Cre
recombinase was restricted to a small number of cortical projection
neurons by stereotactically injecting small amounts of a recombi-
nant Adeno-Associated Virus expressing Cre recombinase (rAAV-
Cre) into the hindlimb motor cortex (Fig. 2 A, B). Single
collaterals emerging from the axons of transduced cortical
projection neurons could than be identified based on their unique
labeling in the cervical spinal cord and reconstructed from serial
cross-sections (Fig. 2 C–G).
We used this approach to analyze the structure of cervical
collaterals emerging from main and minor CST components at 10
days, 4 weeks and 12 weeks after a mid-thoracic hemisection of the
spinal cord (Fig. 3). At 10 days following the injury, CST
collaterals emerging from all CST components were fairly short
(Fig. 3 A–C, J), had a simple, mostly unbranched structure (Fig. 3
K) and showed very few, if any, boutons (Fig. 3 L). At 4 weeks
after lesion, the collaterals were substantially longer (Fig. 3 D–F,
J), had a complex often highly branched structure (Fig. 3 K) and a
higher number of boutons (Fig. 3 L). At this time, the anatomical
structure of a collateral depended on its white matter origin.
Compared to main CST collaterals, collaterals emerging from the
ventral CST were long but showed a relatively simple structure
with few branch points and boutons (Fig. 3 E, J–L). In contrast,
collaterals emerging from the dorso-lateral CST component had a
highly complex structure and significantly more branchpoints and
boutons compared to both ventral and main CST collaterals
(Fig. 3 J–L). While the structure of CST collaterals thus evolved
substantially between 10 days and 4 weeks after lesion, collaterals
emerging from all CST components remain largely unchanged
between 4 weeks and 12 weeks after injury (Fig. 3 G–L).
Consequently, at 12 weeks after lesion dorso-lateral CST
collaterals still had significantly more branchpoints than main
CST collaterals and more branchpoints and boutons than ventral
CST collaterals (Fig. 3 J–L).
Synaptic differentiation of newly formed CST boutons
To determine the synaptic differentiation of the newly formed
CST boutons we traced the hindlimb CST and then stained
cervical and lumbar spinal cord sections with antibodies against
two synaptic markers: bassoon, a marker of the presynaptic active
zone and synapsin I, a protein that regulates neurotransmitter
release at the synapse (Fig. 4). We first determined the percentage
of boutons that are immunoreactive for the synaptic markers in the
lumbar spinal cord of unlesioned mice (n = 2 mice). Of these
‘‘control’’ boutons 51% were immunoreactive for synapsin I and
52% were immunoreactive for bassoon. As these values likely
represent the mature expression pattern, this value was set as
100% and the immunoreactivity in newly formed boutons was
expressed as a percentage of the mature expression pattern. The
analysis of CST boutons in the cervical spinal cord at 10 days and
3 weeks after lesion then showed that the expression of both
bassoon (Fig 4 A–C) and synapsin I (Fig. 4 D–F) is low at 10 days
after lesion but is comparable to the expression pattern observed in
the lumbar spinal cord of unlesioned mice by 3 weeks. Double-
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immunostaining experiments further showed that 3 weeks after
lesion 80.564.5% of the immunoreactive CST boutons are double
positive for synapsin I and bassoon while comparably few of them
showed the expression of only one marker (862% are only
immunoreactive for synapsin I and 11.566.5% are only
immunoreactive for bassoon, Fig. 4 G).
Figure 1. Population analysis of hindlimb CST collateral formation at different timepoints after SCI. (A–C) Reconstruction of hindlimb
CST collaterals (black) from 5 consecutive sections in the cervical spinal cord of control mice (A) and of mice perfused 10 days (B) and 24 weeks (C)
following SCI. (D) Quantification of the total numbers of collaterals emerging from all CST components in the cervical gray matter of control mice and
of mice at different timepoints following SCI. (E–G) Confocal images of main CST (BDA, yellow) and the adjacent gray matter (Neurotrace, blue; border
shown by dashed white line) in control mice (E) and in mice perfused 10 days (F, arrow indicates CST collateral emerging from main CST) and 24
weeks (G, arrow indicates CST collateral emerging from main CST) following SCI. (H) Quantification of the number of collaterals emerging from the
main CST component at different timepoints following SCI. (I–K) Confocal images of the minor dorso-lateral CST (BDA, yellow) and the adjacent gray
matter (Neurotrace, blue; border shown by dashed white line) in control mice (I) and in mice perfused 10 days (J) and 24 weeks (K, arrow indicates
CST collateral emerging from dorso-lateral CST) following SCI. (L) Quantification of the number of collaterals emerging from the minor dorso-lateral
CST component at different timepoints following SCI. (M–O) Confocal images of the minor ventral CST (BDA, yellow) and the adjacent gray matter
(Neurotrace, blue; border shown by dashed white line) in control mice (M, arrow indicates ventral CST fiber) and in mice perfused 10 days (N) and 24
weeks (O, arrow indicates collateral emerging from ventral CST) following SCI. (P) Quantification of the number of collaterals emerging from the
minor ventral CST component at different timepoints following SCI. Asterisks indicate significance compared to the unlesioned controls. Pound signs
indicate significance compared to the 10-day timepoint. Scale bar in A (also for B,C), 500 mm; in M (also for E–O), 100 mm.
doi:10.1371/journal.pone.0030461.g001
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CST collaterals refine their contacts on interneurons
between 3 and 12 weeks after lesion
To investigate how the projection pattern of CST collaterals
evolves over time, we analyzed the number of contacts that an
individual collateral formed with the cell bodies of spinal
interneurons (Fig. 5). We first determined the mature projection
pattern by evaluating contacts of hindlimb CST collaterals onto
interneurons in the lumbar spinal cord. Here, we found that in
most cases (85.564.7%, n = 2 animals and 59 collaterals) a CST
collateral forms 1 and in some cases (14.564.7%) 2 contacts on
spinal interneurons (Fig. 5 C). In contrast, the majority of newly
emerging CST collaterals in the cervical spinal cord displayed
multiple (up to 4) contacts on spinal interneurons at 10 days after
lesion (Fig. 5 C). This ‘‘multiple contact’’ pattern still persisted at
3 weeks after lesion (Fig. 5 A, C). The mature contact pattern was
only present at 12 weeks after lesion and at this time more than
80% (81.163.1%, n = 3 animals and 168 collaterals) of collaterals
only showed 1 contact per interneuron (Fig. 5 B, C). The mature
pattern then persisted over time and was still present at 24 weeks
after injury (Fig. 5C). The analysis of the individual CST
components showed that at 3, 8 and 12 weeks after lesion most of
the contacts on interneurons were formed by collaterals emerging
from the main CST tract (Fig. 5D).
Discussion
The plastic reorganization of axonal connections is an
important element of the recovery process after CNS damage.
This is exemplified by the remodeling of lesioned CST fibers after
spinal cord injury. Previous work has shown that the sprouting of
new CST collaterals above the level of the lesion is a key step in
the formation of intraspinal detour circuits that contribute to
functional recovery after traumatic and inflammatory lesions of
the spinal cord [6], [7], [14], [20]. Here, we can show that these
collaterals form and mature in distinct phases (Fig. 6). In the
growth initiation phase that encompasses the first 10 days after
lesion, CST collaterals emerge and, at least in the case of the main
and dorso-lateral CST, start to enter the cervical gray matter. In
the collateral formation phase that covers the ensuing weeks, these
collaterals elongate, branch and form synaptic contacts in the
cervical gray matter. The final maturation phase, 12 weeks after
injury, is then characterized by the small-scale refinements of the
projection pattern that includes the removal of excessive inputs
Figure 2. Strategies for labeling individual CST collaterals. (A, B) Confocal images of the cortex of a Thy1-Brainbow (A; YFP, yellow; CFP, blue)
and Thy1-Stp-YFP mouse (B; YFP, green; Neurotrace, red) after local injection of rAAV-Cre. Boxed areas are magnified 2 times in insets. (C,D) Confocal
images of CST collaterals in the cervical spinal cord of a Thy1-Brainbow (C; YFP, yellow; CFP, blue) and Thy1-Stp-YFP (D; YFP, green; Neurotrace, red)
mouse after injection of rAAV-Cre in the cortex. Boxed areas are magnified 2 times in insets. Arrows in inset in C indicate different collaterals
expressing either CFP (blue), YFP (yellow) or a combination of both (white). Dashed white line indicates the outline of the spinal gray matter. (E–G)
Confocal images of individual collaterals (white) emerging from the main CST (F), the dorso-lateral CST (E) and the ventral CST (G) following SCI.
Arrows indicate individual collaterals. Dashed white lines indicate the outline of the spinal gray matter. Scale bar in B (also for A),100 mm; Scale bar in
D (also for C),100 mm; Scale bar in G (also for E,F), 50 mm.
doi:10.1371/journal.pone.0030461.g002
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from interneurons. Another example of this refinement process is
provided by our previous analysis [6] of CST contacts onto two
distinct interneuronal populations, the long propriospinal neurons
which connect the cervical spinal cord to the lumbar spinal cord
[15–18] and the short propriospinal neurons that form intracervi-
cal connections [21], [22]. The cell bodies of these interneurons
are located side by side in the cervical gray matter. Indeed, at 3
weeks after lesion - at the end of the formation phase - similar
fractions of long and short propriospinal neurons are contacted by
CST collaterals. However at 12 weeks - at the end of the
maturation phase - many of the contacts on short propriospinal
neurons have been removed while contacts on long propriospinal
neurons persisted [6]. Taken together with the results of this study,
it seems that the main aim of the maturation phase is the removal
of excessive connections and the strengthening of pertinent
connections. The emergence and selection of CST collaterals
thus shows interesting parallels to the initial formation and
refinement of neuronal connections in development. In the
neuromuscular system it has been shown that initially exuberant
connections between motor neurons and muscle fibers are formed,
leading to the innervation of single neuromuscular junctions by
multiple axons [23]. Over time, most of these inputs are then
removed and only a single axon remains to innervate the junction
[24], [25].
Similarly, during the development of the CNS initially excessive
connections are formed that are later pruned. A classical example
for the removal of excessive connections is the pruning of early
corticospinal projections that originate from the occipital cortex
[26], [27]. The refinement of CST connections during develop-
ment however extends beyond this large scale pruning. For
example, it is known that in different species the initial termination
pattern of the CST encompasses the entire gray matter from
dorsal to ventral horn and becomes more restricted later on [28–
31]. In addition, while most corticospinal fibers in adults terminate
contralateral to their origin in the cortex, during development
CST axons also show extensive projections to the ipsilateral spinal
gray matter. This can be at least partially explained by the findings
that during development a larger proportion of axons appear to
descend ipsilaterally without decussating in the pyramid while
other projections cross not only in the decussation but again in the
Figure 3. Reconstruction of individual hindlimb CST collaterals at different timepoints after spinal cord injury. (A–C) Reconstruction of
individual collaterals (blue asterisks indicate the entry point of the collateral in the gray matter) emerging from the main dorsal (A) and the minor
ventral (B) and dorso-lateral (C) CST components at 10 days following SCI. (D–F) Reconstruction of individual collaterals (green) emerging from the
main dorsal (D) and the minor ventral (E) and dorso-lateral (F) CST components at 4 weeks following SCI. (G–I) Reconstruction of individual collaterals
(red) emerging from the main dorsal (G) and the minor ventral (H) and dorso-lateral (I) CST components at 12 weeks following SCI. (J–L)
Quantification of the total collateral length (J), the number of branchpoints/collateral (K) and the number of boutons/collateral (L) measured in
individually reconstructed collaterals at different timepoints after SCI. Blue bars, 10-day timepoint; green bars, 3-week timepoint; red bars, 12-week
timepoint. Asterisks indicate significant differences compared to the 10-day timepoint. Pound signs indicate significant differences between
collaterals emerging from different CST components at 3 weeks (green) and 12 weeks (red) after injury. Scale bar in A (also for B–I), 50 mm.
doi:10.1371/journal.pone.0030461.g003
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spinal cord [32]. At least some of these initial CST connections,
including many of the double-crossed or uncrossed collaterals
appear to be transient and are removed during the maturation of
the CST [32], [33]. Further work will be necessary to determine to
what extend these structural commonalities between developmen-
tal and post-injury remodeling also imply common regulatory
mechanisms. For example, it will be interesting to see if neuronal
activity patterns, that are important determinants of competition
at the neuromuscular junction [34–36] or during CST develop-
ment [37] also regulate the fate of newly formed CST collaterals.
Likewise it will be important to explore to what extend molecules
that affect pruning such as the semaphorins/plexins [38], [39],
ephrins [40] or components of the wlds pathway [41] also
influence the removal of CST collaterals.
The excessive formation and subsequent sorting of connec-
tions is one way how the specificity of new CST connections
Figure 4. Synaptic differentiation of newly formed CST boutons. (A–B) Confocal images of bassoon immmunostaining (green) in the cervical
spinal cord of mice with a traced hindlimb CST (BDA, red) perfused 10 days (A) and 3 weeks following SCI (B). Yellow arrows indicate boutons that
were immunoreactive for bassoon, white arrows indicate those that were not. (A9–A90) Single plane confocal image of the boutons boxed in A
showing the collateral (A9; BDA, white), bassoon immunostaining (A0; white) and the overlay (A90; BDA, red; bassoon, green) at 10 days after SCI. (B9–
B90) Single plane confocal image of the bouton boxed in B showing the collateral (B9; BDA, white), bassoon immunostaining (B0, white) and the
overlay (B90; BDA, red; bassoon, green) at 3 weeks after SCI. (C) Quantification of the number of boutons on hindlimb CST collaterals that were
immunopositive for bassoon at 10 days and 3 weeks following SCI in the cervical cord. The percentages were normalized to the expression pattern in
the lumbar cord (L) of control animals (which was set to 100%). (D–E) Confocal images of synapsin I immunostaining in the cervical spinal cord of
mice with a traced hindlimb CST (BDA, red) perfused 10 days following SCI (D) and at 3 weeks post-injury (E). Yellow arrows indicate boutons that
were immunoreactive for synapsin I, white arrows indicate those that were not. (D9–D90) Single plane confocal image of the bouton boxed in D
showing the collateral (D9, BDA, white), the synapsin I staining (D0; white) and the overlay (D90; BDA, red; synapsin I, green) at 10 days after SCI. (E9–
E90) Single plane confocal image of the bouton boxed in E showing the collateral (E9; BDA, white), the bassoon staining (E0; white) and the overlay
(D90; BDA, red; synapsin I, green) at 3 weeks after SCI. (F) Quantification of the number of boutons on hindlimb CST collaterals that were
immunnopositive for synapsin I at 10 days and 3 weeks following SCI in the cervical cord. The percentages were normalized to the expression pattern
in the lumbar cord (L) of control animals (which was set to 100%). (G) Quantification of the co-expression of bassoon and synapsin I in boutons of CST
collaterals of animals perfused at 3 weeks after injury (expressed as percentages of all immunoreactive boutons). Scale bar in A (also for B, D, E),
10 mm and in A9 (also for A0–E90), 3 mm.
doi:10.1371/journal.pone.0030461.g004
Figure 5. Analysis of CST contacts onto cervical interneurons after SCI. (A,B) Confocal images of contacts (arrows, defined as boutons in
apposition to neuronal cell bodies) between hindlimb CST collaterals (YFP, green) and the cell bodies of cervical interneurons (Neurotrace, red) at 4
weeks (A) and 12 weeks (B) following SCI. (C) Quantification of the number of contacts a given hindlimb CST collateral makes with the cell body of a
single interneuron at different timepoints after SCI as well as in the lumbar spinal cord of unlesioned animals. (D) Quantification of the percentage of
Neurotrace (NT)-stained interneurons contacted by collaterals emerging from the different CST components at multiple timepoints following the
lesion. Asterisks indicate significant difference compared to main CST collaterals. Scale bar in A (also for B), 15 mm.
doi:10.1371/journal.pone.0030461.g005
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can be established. Another measure to ensure specificity is the
targeting of axons to specific neurons or regions of the spinal
cord. In the case of the newly formed CST connections, the
refinement of initial connections during the maturation phase
suggests that initial targeting is not established by specific
recognition of single neurons. On the other hand, the
distribution of newly formed CST collaterals in the spinal
cord gray matter indicates that specific regions of the spinal
cord, in particular the intermediate layers V–VII are
preferentially targeted by CST collaterals (see Fig. 1C). Taken
together our findings thus suggest that a combination of
‘‘region-specific’’ targeting that guides collaterals to the
intermediate layers of the spinal cord and a subsequent
refinement process that removes excessive connections collab-
orate to ensure specific targeting of newly formed CST
connections to intraspinal relay neurons.
Figure 6. Schematic representation of hindlimb CST remodeling following SCI. Scheme illustrating the formation of cervical collaterals
derived from the main CST (upper row) and the minor dorsolateral (2nd row) and ventral (3rd row) CST components at 10 days (blue), 3–4 weeks
(green) and 12 weeks (red) after SCI. Bottom row illustrates the refinement over time of the contacts between CST collaterals and cervical
interneurons.
doi:10.1371/journal.pone.0030461.g006
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It should be noted however, that while most newly formed CST
collaterals end in the intermediate layers of the spinal cord, some
fibers reach the ventral horn and might form contacts with ventral
motoneurons [42]. These direct connections of hindlimb CST
axons to forelimb motoneurons could be one anatomical substrate
that underlies the shift of motor maps that occurs both in animal
and humans in response to spinal cord injury [43–45].
A second important finding of our study is that different CST
components contribute to the remodeling of the CST. Antero-
grade tracing revealed three distinct localizations of CST fibers in
the spinal cord, with the majority of fibers located in the main
CST component at the bottom of the dorsal funiculus and a
smaller proportion of fibers located in the dorso-lateral funiculus.
Only very few fibers were observed in the ventral funiculus,
contralateral to the main and dorso-lateral CST. These ventral
fibers together with the fibers in the dorso-lateral funiculus form
the minor CST components. This structure of the CST is in
accordance with previous reports in mice, where the ventral CST
component is relatively small [13], [46], [47], as well as in other
rodents [11], [12], [48–50]. We further observed that following
injury the number of fibers in the ventral component that is spared
by the lesion is increased. This is probably due to sprouting of
additional CST collaterals that can enter the ventral white matter
tract as previously described [51]. Our analysis of collateral
formation reveals both commonalities and differences between the
distinct CST components. For example, the overall timecourse of
collateral initiation, formation and maturation appears mostly
similar in major and minor CST components. The comparably
lower number of CST collaterals derived from the minor CST
tracts detected in the gray matter at 10 days after injury likely does
not reflect a different growth initiation but rather the longer
distance between the parental axons and the gray matter border. It
is interesting to note that while the overall timecourse of collateral
formation is similar, the number of collaterals an individual CST
axon sends to the gray matter differs substantially between the
CST components. A CST axon running in the ventral funiculus,
for example, extends more than 10-fold more collaterals into the
gray matter at 3 weeks after lesion than a main CST axon (Fig. 1
H, P). These findings suggest an important role for ventral CST
fibers in the CST remodeling process. As after a midthoracic
lesion, the ventral funiculus consists of both pre-existing ventral
fibers as well as newly sprouted collaterals likely derived from
other CST components, it is possible that both unlesioned fibers
and new collaterals emerging from lesioned CST fibers contribute
to this response. An important role of ventral fibers is in line with
previous experiments in rats that have demonstrated that ventral
CST fibers can play an important role for the recovery of CST
function [52]. However, it appears that not only the relative
number of collaterals emerging from a given CST component but
also their complexity differs between CST components. For
example, collaterals emerging from the dorso-lateral CST contain
several-fold more branch points and boutons at 4 weeks after
lesion than collaterals emerging from main or ventral CST. This
might suggest that dorso-laterals CST contact different target cell
populations. The idea that distinct CST components target distinct
cell populations is consistent with our previous observation that
dorso-lateral CST collaterals appear to be primarily responsible
for direct contacts on motoneurons in the lumbar spinal cord [13].
Taken together the characteristic differences between main and
minor CST components strongly suggest that individual compo-
nents might play distinct roles in the recovery process. The single
collateral tracing techniques established in this study can in the
future help to further define these distinct roles in different lesion
paradigms. This is of interest as the remodeling process after a
spinal lesion likely extends beyond the corticospinal tract to other
supra- and intraspinal tract systems. For example, the reticulosp-
inal tract has been shown to spontaneously sprout after SCI [53],
[54] and the spontaneous restoration of serotonergic activity, likely
mediated by the remodeling of serotonergic circuits, was found to
contribute to functional recovery [55], [56].
Finally our study demonstrates that once collaterals from all
CST components are formed they by and large persist long-term -
in our experiments at least up to the end of the observation period
(24 weeks after lesion for the population analysis and 12 weeks
after lesion for the analysis of individual collaterals). Our analysis
further shows that after early formation and refinement of the
collaterals, very little changes to the collateral number, structure
and contact pattern are observed beyond 12 weeks after lesion.
This suggests that an early critical period for CST remodeling
exists during which the formation or refinement of collaterals can
be influenced. However after this period, newly formed connec-
tions appear to remain stable. This defines a time-window for
therapeutic interventions that are likely most effective in the first
10 days after lesion if the aim is to improve collateral initiation,
between 10 days and 3–4 weeks if they aim to support collateral
formation and between 3–4 and 12 weeks if the aim to modulate
target connections. This is of interest as despite the spontaneous
remodeling of axonal connections substantial functional impair-
ments often remain following experimental and clinical spinal cord
injuries. It will therefore be important to develop therapeutic
strategies that can enhance the remodeling process. One
promising approach could be to foster the intrinsic neuronal
growth response of cortical projection neurons targeting, for
example, c-AMP and its downstream mediators [57], the growth
cone-associated proteins GAP43 and CAP23 [58], components of
the PTEN/mTOR pathway [59], [60] or the JAK-STAT pathway
[60], [61]. Another possible way to enhance axonal remodeling is
through rehabilitation. Several studies [43], [62–64] have already
demonstrated the positive effect of rehabilitation on axonal
sprouting following spinal cord injury. Care needs to be taken
however not to favor task-specific rewiring at the cost of other
tasks. Several studies have indeed shown that experimental
rehabilitation schemes in which one task is trained repetitively
will lead to improvement in this task to the detriment of other tasks
[43], [65–67]. To our mind, the analysis techniques introduced in
this study can in the future help to evaluate whether and how these
therapeutic approaches can improve axonal remodeling after
injury.
Materials and Methods
Ethics Statement
All animal experiments conformed to the institutional guidelines
and were approved by the Animal Study Committee of the
Regierung von Oberbayern. Approval ID: 55.2-1-54-2531-127-
05.
Animals
Adult C57BL/6 female mice 6–8 weeks old, Thy1-Stp-YFP and
Thy1-Brainbow mice (line TYC9, kindly provided by J. Livet,
INSERM) were used in this study. C57BL/6 mice were used for
all conventional CST tracing experiments. Thy1-Stp-YFP mice
express yellow fluorescent protein (YFP) in neurons after Cre-
mediated excision of a floxed STOP-sequence [13], [68]. Thy1-
Brainbow mice show a combinatorial expression of different
fluorescent proteins after Cre-mediated excision of Lox sites [19].
Briefly, in the brainbow-1.0 mice used in this study, lox P sites
alternate with incompatible lox variant (lox2272) sites. The Cre
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recombinase thus randomly chooses between different initial excision
events. As the initial excision between a pair of identical lox sites
removes one of the other pair, it prevents multiple recombination.
Before Cre action, only the gene following the promoter is
expressed (RFP). The recombination then switches expression to
either YFP or M-CFP depending on the site of the initial
recombination event. Further, the presence of multiple copies of
the brainbow construct that recombine independently can lead to
the co-expression of different fluorescent proteins [19]. Thy1-Stp-
YFP and Thy1-Brainbow mice were used for single collateral
analysis.
Spinal Cord Injury
Mice were anesthetized with a subcutaneous injection of
Ketamin/Xylazin (Ketamine 150 mg/kg, Xylazine 10 mg/kg).
A laminectomy was performed at thoracic level 8 (T8) and a dorsal
hemisection of the spinal cord was performed with fine iridectomy
scissors. This lesion interrupts the main dorsal and the minor
dorso-lateral CST components but not the minor ventral CST
component (Fig. 7). After surgery animals were heated,
rehydrated and treated with analgesics (which were also
administrated immediately before surgery).
rAAV-Cre
AAV1/2-CAG-HA-NLS-Cre-WPRE-BGH-polyA expression
vectors were used to generate viral particles in which the CAG
promoter consists of the chicken b-actin promoter hybridized with
the CMV immediate early enhancer sequence. The CAG
promoter drives the expression of the P1 Cre recombinase, the N-
terminus of which is fused to an HA-tag followed by a nuclear
localization signal (NLS). The woodchuck post-transcriptional
regulatory element (WPRE) and the presence of the bovine growth
hormone (BGH) polyadenylation sequence ensure high transcrip-
tion following transduction. AAV1/2 particles were generated by
GeneDetect.com Ltd.
Anatomical tracing of hindlimb corticospinal tract (CST)
Population analysis of CST collaterals. To study
reorganization of both the major and minor CST components
we traced the hindlimb CST in adult C57BL/6 mice by bilateral
pressure injections as previously described [14]. For this purpose,
1 ml of a 10% solution of biotinylated dextran amine (BDA
10 000, Molecular Probes) was slowly injected with a glass
capillary (tip diameter of about 20 mm) into lamina V of the
hindlimb motor cortex (coordinates: 21.3 mm posterior to
bregma, 1 mm lateral to bregma, 0.6 mm depth). The
micropipette remained in place for 2 minutes after completion
of the injection to minimize backflow and diffusion of the tracer.
Single CST collateral analysis. To study the projection
pattern of individual collaterals, we first determined the amount of
rAAV necessary to label single hindlimb CST collaterals by
varying the injected volume. We then performed bilateral pressure
injections of 0.3 ml of a rAAV-Cre (titer: 161012 genomic
particles/ml) into lamina V of the hindlimb motor cortices of
Thy1-Stp-YFP and Thy1-Brainbow mice. The micropipette remained
in place for 2 minutes after completion of the injection to
minimize backflow and diffusion of the virus.
Tissue preparation and immunohistochemistry
Animals were perfused transcardially with 4% paraformalde-
hyde (PFA). Brains and spinal cords were dissected, postfixed
overnight and cryoprotected in 30% sucrose for 3 days. For the
population analysis of CST collaterals we analyzed the cervical
spinal cord of C57BL/6 mice between the spinal level C3 and C5,
where the cell bodies of long propriospinal neurons are located.
For this purpose coronal sections (50 mm thickness) were cut on a
vibratome and processed as described previously [69]. The
hindlimb CST was revealed after BDA tracing using 0.4%
ammonium nickel sulfate (Sigma), 0.015% DAB (Sigma), 0.004%
H2O2 in 50 mM Tris buffer (pH 8) resulting in a black reaction
product. For the analysis of individual CST collaterals consecutive
coronal sections (100 mm thickness) of the cervical spinal cord of
Thy1-Stp-YFP and Thy1-Brainbow mice were cut on a vibratome
and mounted on gelatinized glass slides. Sections were then
incubated with a rabbit anti-GFP antibody (diluted 1:500,
Invitrogen) overnight at 4uC and on the next day with a goat-
anti-rabbit secondary antibody conjugated to Alexa Fluor 488
(Invitrogen). Finally, sections were counterstained with Neurotrace
435 (diluted 1:500, Invitrogen) to identify the cell bodies of spinal
interneurons.
For analysis of synaptic maturation 20 mm thick cryostat
sections derived from animals, in which the hindlimb CST was
Figure 7. Illustration of a dorsal hemisection of the thoracic spinal cord. (A) Confocal image of a cross-section of the thoracic (T8) spinal
cord of a mouse perfused 12 weeks after dorsal hemisection (counterstained with Neurotrace). Dashed line indicates lesion border. (B) Schematic
representation of the location of the different CST components (highlighted in different shades of green) in relation to this lesion (outlined by dashed
line from A). Scale bar in A, 200 mm.
doi:10.1371/journal.pone.0030461.g007
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labeled with BDA, were immunostained for synapsin I or bassoon
as follows. Sections were incubated with ABC (Vector Laborato-
ries) and primary polyclonal antibodies reactive against either
synapsin I (Millipore, 1:500) or bassoon (Synaptic System, 1:500)
in Tris buffer containing 0.3% Triton X-100 (Sigma) and 2.5%
goat serum serum (Invitrogen) overnight at 4uC. For double
immunostaining the polyclonal anti-synapsin I antibody (dilution
same as above) was combined with a mouse monoclonal anti-
bassoon antibody (dilution 1:100, Enzo Life Sciences). After a
20 min tyramide amplification (Biotin-XX, TSA Kit #21,
Invitrogen) to detect BDA, the sections were incubated overnight
with Streptavidin conjugated to Alexa Fluor 594 (1:500, Invitro-
gen) and a goat-anti-rabbit antibody conjugated to Alexa Fluor
488 (1:500, Invitrogen). Counterstaining was performed using
NeuroTrace 435 (1:500, Invitrogen) and sections were mounted in
Vectashield (Vector Laboratories).
Quantification of anatomical reorganization
Population analysis of CST collaterals. Fibers exiting
from main and minor CST components and entering the grey
matter were counted in 30 consecutive coronal sections of the
cervical spinal cord using a IX71 microscope (Olympus) with a
640 (NA 0.65) objective. To correct for inter-animal differences in
tracing efficiency, the number of CST collaterals was divided by
the number of traced fibers in the respective CST component and
expressed as a ratio of collaterals per CST fiber.
Single collateral analysis. Consecutive coronal sections of
the cervical spinal cord of Thy1-Stp-YFP and Thy1-Brainbow mice
were imaged on an Olympus FV1000 confocal microscope. Image
stacks were acquired with a620 oil objective and processed using
ImageJ (http://rsbweb.nih.gov/ij/) and Adobe Photoshop
software. Alignment and tracing of collaterals in consecutive
sections was performed in Adobe Photoshop. Collateral properties
(collateral length, number of branch points) were measured using
the NeuronJ plugin in ImageJ.
Contacts on interneuronal cell bodies. To quantify the
contacts onto interneuronal cell bodies 20 mm sections of the
cervical spinal were scanned with a620 (NA 0.85) oil immersion
objective. Single hindlimb CST collaterals (labelled with BDA)
were followed and the number of boutons in contact with the cell
body of an interneuron (labelled with Neurotrace) was counted.
Expression of synaptic markers. To determine the
percentage of boutons that express the synaptic markers
synapsin I and bassoon image stacks were acquired with an
Olympus FV1000 confocal microscope equipped with standard
filter sets and a 660 (NA 1.45) oil immersion objective. Tissue
from the population analysis was used for this analysis as the high
number of BDA-labelled collaterals in this tissue allowed us to
analyse sufficiently large numbers of CST boutons. The total
number of boutons as well as the number of these boutons that
expressed synapsin I or bassoon were counted. To analyze the co-
expression of synapsin I and bassoon, sections from the cervical
spinal cord of animals perfused 3 weeks after lesion (n = 3 mice)
were used. The number of CST boutons immunoreactive for
either bassoon, synapsin I or both was determined and expressed
as percentage of all immunoreactive boutons. All quantifications
were performed by a blinded observer.
Image processing
Image stacks obtained with confocal microscopy were processed
using ImageJ software to generate maximum intensity projections.
To obtain final images, these maximum intensity projections were
processed in Adobe Photoshop using gamma adjustments to
enhance visibility of intermediate gray values and median filtering
to suppress noise when necessary. For the representation of CST
collaterals (Fig. 1 A–C) 5 consecutive sections were reconstructed
and overlaid.
Statistical evaluation
Results are given as mean 6 SEM unless indicated otherwise.
For paired comparison data were analyzed by the Student’s t test.
For multiple comparisons a two-way ANOVA followed by a
Tukey’s or a Bonferroni post hoc was performed using Graphpad
Prism 5.01 for Windows (GraphPad Software). Significance levels
are indicated as follows: *p,0.05; **p,0.01; ***p,0.001.
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In the peripheral nervous system (PNS), damaged axons regenerate
successfully, whereas axons in the CNS fail to regrow. In neurons of
the dorsal root ganglia (DRG), which extend branches to both the
PNS and CNS, only a PNS lesion but not a CNS lesion induces axonal
growth. How this differential growth response is regulated in vivo
is only incompletely understood. Here, we combine in vivo time-
lapse ﬂuorescence microscopy with genetic manipulations in mice
to reveal how the transcription factor STAT3 regulates axonal
regeneration. We show that selective deletion of STAT3 in DRG
neurons of STAT3-ﬂoxed mice impairs regeneration of peripheral
DRG branches after a nerve cut. Further, overexpression of STAT3
induced by viral gene transfer increases outgrowth and collateral
sprouting of central DRG branches after a dorsal column lesion by
more than 400%. Notably, repetitive in vivo imaging of individual
ﬂuorescently labeled PNS and CNS axons reveals that STAT3
selectively regulates initiation but not later perpetuation of axonal
growth. With STAT3, we thus identify a phase-speciﬁc regulator of
axonal outgrowth. Activating STAT3might provide an opportunity
to “jumpstart” regeneration, and thus prime axons in the injured
spinal cord for application of complementary therapies that im-
prove axonal elongation.
in vivo microscopy | spinal cord injury | peripheral nerve lesion | intrinsic
growth program
Lesioned peripheral nervous system (PNS) axons regeneratesuccessfully, whereas lesioned CNS axons fail to regrow. This
differential behavior is exempliﬁed by neurons located in the
dorsal root ganglia (DRG), which extend one branch into the PNS
and another into the CNS. In these neurons, a cut in the PNS but
not in the CNS is followed by neuronal outgrowth (1). If, however,
the DRG neuron is “conditioned” by a transection of its periph-
eral branch, a subsequent central lesion can be followed by ex-
tensive outgrowth (2, 3). This suggests the existence of a common
intrinsic neuronal growth program that can, in principle, support
both PNS and CNS growth but is normally initiated only after
a PNS lesion. In recent years, several intracellular components
that might regulate this intrinsic growth program have been
identiﬁed (4, 5). They include a number of transcriptional regu-
lators such as the transcription factors cJun (6), SMAD1 (7),
ATF3 (8), AKRD1 (9), NFIL3 (10), and several KLF family
members (11). One particularly interesting transcriptional regu-
lator is STAT3, which is activated as part of the JAK–STAT sig-
naling pathway (12). The following ﬁndings make STAT3 a good
candidate for regulating axon growth: ﬁrst, increased levels of
STAT3 expression and phosphorylation are associated with axo-
nal regeneration (13–15) and axonal remodelling (16). Second,
molecules that can affect STAT3 signaling such as the neuro-
poietic cytokines IL-6, ciliary neurotrophic factor, and leukemia
inhibitory factor, as well as the intracellular regulator SOCS3,
have been shown to inﬂuence axonal regeneration (17–20). Third,
STAT3 expression promotes neuronal outgrowth in cultured CNS
neurons (21) and increased STAT3 expression is directly involved
in the conditioning response of DRG neurons (22).
The identiﬁcation of STAT3 and other transcription factors
indicates that multiple transcriptional programs exist that can, in
principle, inﬂuence the neuronal growth response to injury.
Whether they operate in concert or in succession, e.g., by affecting
speciﬁc phases of the growth response, such as growth initiation or
elongation, is not known. A direct way to elucidate how a given
factor affects different phases of axonal growth is to visualize
progress of regenerating axons in vivo (3, 23–25) in the presence
or absence of such a factor.
Here we use in vivo imaging in combination with selective ge-
netic manipulations to address whether and when the transcrip-
tion factor STAT3 inﬂuences the divergent growth pattern of
lesioned PNS and CNS axons. We show that deletion of STAT3 is
sufﬁcient to impair PNS axon regeneration. By comparing the in
vivo growth pattern of regrowing STAT3-competent and STAT3-
deﬁcient axons, we discovered that STAT3 regulates the timing of
growth induction but not subsequent axon elongation. In line with
this ﬁnding, viral gene delivery of either STAT3 or its constitu-
tively active version, STAT3c, to DRG neurons signiﬁcantly
improves terminal and collateral sprouting after a CNS lesion by
promoting growth induction but not elongation. Thus, STAT3
acts as a phase-speciﬁc regulator of axonal regeneration that se-
lectively controls the timing of growth induction after CNS and
PNS lesions.
Results
STAT3 Deletion Impairs the Regeneration of PNS Axons. To conﬁrm
that STAT3 is activated after a PNS lesion, we studied the ex-
pression of STAT3 and its active, phosphorylated form P-STAT3
in DRG neurons by immunohistochemistry at different time
points after creation of bilateral lesions of the saphenous nerves,
which contain the axons of the third lumbar (L3) DRGs (26).
Starting within a few hours and lasting for weeks after transection,
we observed a signiﬁcant increase in the number of P-STAT3–
positive nuclei in L3 DRG neurons (Fig. 1 A, B, and E). STAT3
expression in DRG neurons overall followed a similar time course
(Fig. S1). However, at early time points, hours after the lesion,
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STAT3 phosphorylation appears to precede increased STAT3
expression. Together these ﬁndings indicate that, after a PNS
lesion is created, STAT3 activity is regulated on both the phos-
phorylation and expression levels.
To assess the contribution of STAT3 activation to PNS re-
generation, we selectively deleted STAT3 expression in DRG
neurons. We constructed recombinant adeno-associated viral
vectors (rAAVs) expressing either a bicistronic combination of
Cre recombinase and GFP (rAAV-Cre-ires-GFP) or just GFP
(rAAV-ires-GFP; SI Materials and Methods). After injection of
rAAV-Cre-ires-GFP into the DRGs of STAT3-ﬂoxed (STAT3ﬂ/ﬂ)
mice (27), transduced DRG neurons become depleted of STAT3,
while at the same time their axons can be readily identiﬁed by
GFP expression. Injection of the control vector (rAAV-ires-GFP)
labels axons without affecting STAT3 expression. The efﬁciency
of STAT3 deletion was conﬁrmed by analysis of P-STAT3 im-
munohistochemistry 4 d after lesion creation (Fig. 1 C–E and
Fig. S2). We then performed bilateral saphenous nerve trans-
ections in STAT3ﬂ/ﬂ mice that had been injected 10 d earlier with
rAAV-Cre-ires-GFP in the right L3 DRG and rAAV-ires-GFP in
the left L3 DRG. We compared the growth response of STAT3-
deﬁcient and STAT3-competent GFP-positive axons over time
(Fig.1 F–M). At 4 d after lesion, STAT3-competent axons showed
substantial sprouting and regeneration along the nerve for as
much a several hundred micrometers (Fig. 1 F, J and K). In con-
trast, STAT3-deﬁcient axons showed only minimal sprouting
(Fig. 1 H and J), as well as fewer and shorter regenerating axons
(Fig. 1 H and K). Two weeks after lesion, long-distance axonal
regeneration in STAT3-deﬁcient axons was still impaired (Fig. 1 I
and M), while many STAT3-competent axons had grown several
millimeters to reenter the distal stump of the saphenous nerve
(Fig. 1 G and M). However, at this time, sprouting around the
lesion and axonal regeneration close to the lesion was comparable
between STAT3-deﬁcient and STAT3-competent axons (Fig. 1 L
andM). This suggests that STAT3-deﬁcient axons can still initiate
the regeneration process. Indeed, retrograde labeling from the
distal saphenous nerve performed at 28 d after lesion showed that
similar proportions of STAT3-competent and STAT3-deﬁcient
axons had reapproached their termination zone (Fig. 1N).
Fig. 1. Deletion of STAT3 impairs regeneration of peripheral DRG axons after a saphenous nerve cut (SNC; A and B). Confocal images of L3 DRGs immu-
nostained for P-STAT3 (red) and counterstained with ﬂuorescent Nissl-like stain (NeuroTrace, cyan) in a control (unlesioned) WT mouse (A) and 2 d following
an SNC (B). (C and D) L3 DRGs of STAT3ﬂ/ﬂ mice 4 d after SNC previously injected with rAAV-ires-GFP (C) or rAAV-Cre-ires-GFP (D; NeuroTrace, cyan; P-STAT3,
red; GFP, green). GFP-positive DRG neurons (Insets, C and D) are at a magniﬁcation of ×3. (E) Quantiﬁcation of the number of P-STAT3–positive DRG neurons
(identiﬁed by NeuroTrace counterstaining) at different time points following SNC in WT mice and in STAT3ﬂ/ﬂ mice previously injected with rAAV-ires-GFP
(gray column) or rAAV-Cre-ires-GFP (blue column) at 4 d following a SNC (n = 6 animals per group). (F–I) Confocal images taken at 4 d (F and H) and 14 d (G
and I) after SNC display the proximal stump of STAT3ﬂ/ﬂ saphenous nerves that receive ﬁbers from L3 DRGs injected with control rAAV-ires-GFP (F and G) or
rAAV-Cre-ires-GFP (H and I). (J–M) Quantiﬁcation of axonal sprouting at the site of lesion (J and L) and regeneration ratios (K and M) at different distances
from the cut site (lines, H) of axons derived from STAT3-competent DRG neurons (ires-GFP, gray columns) and STAT3-deﬁcient DRG neurons (Cre-ires-GFP,
blue columns) at 4 d (J and K) and 14 d (L and M) after SNC. (N) Quantiﬁcation of the percentage of L3 DRG neurons retrogradely labeled with the tracer
Miniruby from distal STAT3-competent (ires-GFP, gray columns; n = 21 sections, n = 6 DRGs) and STAT3-deﬁcient (Cre-ires-GFP, blue columns; n = 11 sections,
n = 4 DRGs) saphenous nerves 28 d following SNC (values were normalized to the percentage of Miniruby-positive DRG neurons traced from the same
anatomical localization in unlesioned mice). (Scale bars: A, 100 μm; F, 250 μm.)
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STAT3 Deletion Affects Initiation but Not Perpetuation of PNS Axon
Regeneration in Vivo. Impaired regeneration of STAT3-deﬁcient
PNS axons could be caused by delayed growth induction or re-
duced elongation of regenerating axons. To differentiate these
possibilities, we followed the outgrowth of ﬂuorescently labeled
STAT3-competent and STAT3-deﬁcient axons by repetitive in
vivo imaging. We ﬁrst imaged regrowing axons on consecutive
days when axonal regeneration is induced (day 2–4 after lesion).
Many STAT3-competent DRG axons initiate growth within 2 d
after lesion and progress with an average speed of 132 ± 23 μm/d
from day 2 to day 3 (Fig. 2 A and C). In contrast, the vast majority
of STAT3-deﬁcient axons fail to initiate growth during the ﬁrst 2 d
after lesion. Accordingly, the speed of regeneration is reduced
more than threefold in STAT3-deﬁcient axons in this initiation
phase (33 ± 6 μm/d; Fig. 2 B and C). Notably during the axon
elongation phase 7 to 8 d after lesion, when regeneration speed
has increased to approximately 400 μm/d, there is no difference
between axons derived from STAT3-competent and STAT3-
deﬁcient DRG neurons (411 ± 48 μm/d for axons from rAAV-
ires-GFP-injected DRGs vs. 341 ± 53 μm/d for axons from rAAV-
Cre-ires-GFP-injected DRGs; Fig. 2D). Taken together, these
results indicate that STAT3 is crucial for the timing of growth
initiation but not for subsequent elongation of PNS axons.
STAT3 and STAT3c Gene Therapy Can Initiate but Not Perpetuate CNS
Axon Outgrowth. The failure to initiate growth is a key impediment
to successful regeneration in the CNS. Therefore, we examined
whether STAT3 overexpression is sufﬁcient to induce outgrowth
of CNS axons in vivo. We ﬁrst evaluated the activation of en-
dogenous STAT3 after a CNS lesion by P-STAT3 and STAT3
immunostaining of cervical DRGs after a bilateral dorsal column
transection, which interrupts central projections from cervical
DRG neurons. In contrast to the sustained activation of STAT3
after a PNS lesion (cf. Fig. 1), a dorsal column lesion induces no
signiﬁcant changes in the P-STAT3 and STAT3 immunoreactivity
in DRG neurons (Fig. 3 A and D and Fig. S1). To exogenously
increase STAT3 expression, we produced rAAVs expressing ei-
ther a control protein (enhanced CFP or Cre recombinase; con-
trol rAAV), STAT3 (rAAV-STAT3), or a constitutively active
variant of STAT3 (rAAV-STAT3c) and conﬁrmed the efﬁciency
of viral gene transfer by immunoﬂuorescence (Fig. 3 B–D). We
then injected the respective rAAVs into the DRGs of Thy1-GFPs
mice, which express GFP in a subset of DRG neurons (28). Ten to
12 d later we surgically reexposed the spinal cord, lesioned in-
dividual GFP-positive axons emerging from the injected DRGs in
the dorsal funiculus using a hand-held small-diameter needle, and
imaged their growth response over time. As expected, 2 d after
lesion, only 9% of axons emerging from DRGs injected with
control rAAV had formed sprouts (Fig. 3 E, F, andK and Fig. S3).
In contrast, 53% of r-AAV-STAT3–transduced axons (Fig. 3G,H
and K and Fig. S3) and 46% of the rAAV-STAT3c–transduced
axons (Fig. 3 I, J, and K and Fig. S3) showed an early growth re-
sponse. Interestingly, STAT3 expression not only increased ter-
minal sprouting, but also collateral sprouting along the axon (Fig.
3 G, I, and L). The ﬁnding that a similar growth induction was
observed after injection of rAAV-STAT3 and rAAV-STAT3c
indicates that overexpression of STAT3 alone is sufﬁcient to in-
duce downstream effects on regeneration.
To determine how STAT3 overexpression affects different
phases of axonal outgrowth, we used repetitive multiphoton im-
aging to follow the growth pattern of individual GFP-labeled
DRG axons emerging from DRGs injected with control-rAAV,
rAAV-STAT3, or rAAV-STAT3c at 2, 4, and 10 d after lesion.
STAT3 and STAT3c overexpression increased the speed of axo-
nal growth in the early phase (2–4 d) of regeneration (Fig. 4 A-C).
However, this early growth cannot be sustained, and only very
limited axonal extension can be observed in all groups between 4
and 10 d after lesion (Fig. 4 A, B, and D). Thus, in the CNS, as in
the PNS, STAT3 regulates the initiation of axonal growth but not
the elongation of regenerating axons.
Discussion
The present study identiﬁes the transcription factor STAT3 as
a phase-speciﬁc regulator of neuronal outgrowth in both the PNS
and CNS. InDRGneurons, the endogenous expression of STAT3
parallels the regenerative response. By using conditional deletion
of STAT3 in combination with in vivo imaging, we now also show
that STAT3 expression is not only associated with axonal re-
generation, but is in fact crucial for the timing of axonal growth
initiation after a PNS lesion. It is interesting to note, however, that
axons from STAT3-deﬁcient neurons can still mount a growth
response, albeit with a prolonged “lag” phase compared with their
STAT3-competent counterparts. This suggests that in the PNS
compensatory mechanisms are in place that can induce neuronal
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growth in the absence of STAT3. Notably, additional over-
expression of STAT3 or STAT3c did not further improve PNS
regeneration (Fig. S4), indicating that a PNS lesion alone is suf-
ﬁcient to induce optimal levels of STAT3 activation for re-
generation. When regeneration has been initiated, STAT3-
deﬁcient axons grow with the same speed as STAT3-competent
axons. Thus, STAT3 is primarily needed to induce a neuronal
growth program. When the growth program has been initiated,
STAT3 is no longer required for perpetuation of axonal out-
growth. Given this role of STAT3 in PNS regeneration, it is
tempting to speculate that the failure of CNS lesions to up-regulate
STAT3 expression is directly linked to the failure of CNS axons to
initiate outgrowth. Indeed, we can show that overexpression of
STAT3 by viral vector gene transfer alone is sufﬁcient to initiate
axonal growth initiation in more than half the lesioned CNS axons.
However, as the baseline sprouting response of CNS neurons is not
affected by STAT3 deletion (12% of axons with sprouts are
emerging from STAT3-competent DRGs, compared with 15.4%
emerging from STAT3-depleted DRG axons; n= 28–30 axons per
group), it is likely that, as in the PNS, additional regulators can
induce CNS outgrowth independent of STAT3.
The observation that early stages of axon growth can be initiated
in many transected axons, even in the hostile CNS environment, by
expression of a single intracellular molecule highlights the impor-
tance of intrinsic mediators of axonal growth. During recent years,
a number of molecules that can inﬂuence the intrinsic neuronal
growth response have been identiﬁed. These include c-AMP and its
downstream mediators (29), the growth cone-associated proteins
GAP43 and CAP23 (30), components of the PTEN/mTOR path-
way (31), as well as a number of transcription factors (6–11). Fur-
ther, a number of recent studies in Caenorhabditis elegans have
demonstrated an essential role of the DLK-1MAP kinase pathway
for axon regeneration, and in particular growth cone formation
and migration (32–34). As more and more components of the in-
trinsic growth response are emerging, it becomes increasingly im-
portant to understand how they act in concert to regulate the
complex process of axonal outgrowth.
The present study provides evidence that, in vivo, this intrinsic
growth response can be divided into at least two distinct phases:
initiation and elongation. The concept of a multiphasic growth
response suggests a number of conclusions. One is that the distinct
phases of axonal growth are likely regulated by distinct molecular
mechanisms. STAT3, for example, controls the timely initiation of
Fig. 3. Viral vector gene transfer of STAT3 and STAT3c induces terminal and collateral sprouting of DRG branches after a central lesion. (A–C) Confocal
images of cervical DRGs immunostained for P-STAT3 (red) and counterstained with ﬂuorescent Nissl-like stain (NeuroTrace, cyan) in a WT mouse 2 d following
a dorsal column lesion (DCL, A) and in lesioned Thy1-GFPs mice (GFP, green) injected with control rAAV (B) or rAAV-STAT3 (C). Insets: Higher-magniﬁcation
(×3) of the GFP-positive neurons boxed in the images. (D) Quantiﬁcation of the number of P-STAT3–positive DRG neurons (identiﬁed by NeuroTrace
counterstaining) at different time points following DCL in WT mice and in mice previously injected with control rAAV (gray column), rAAV-STAT3 (red
column), or rAAV-STAT3c (orange column) at 2 d after a central lesion (n = 6 animals per group). (E–J) Confocal images of lesioned spinal axon endings derived
from DRGs injected with control rAAV (bulbs, E and F), rAAV-STAT3 (terminal sprout, G and H), or rAAV-STAT3c (terminal sprout, I and J). (F, H, and J) Higher-
magniﬁcation views of details boxed in E, G, and I. Additional insets (G and I) show a magniﬁcation ×2 of the boxed collateral sprouts. (K and L) Quantiﬁcation
of terminal (K) and collateral (L) sprouting of axons derived from DRGs injected with control rAAV, rAAV-STAT3, or rAAV-STAT3c and analyzed 2 d after
transection. (Scale bars: A and I, 100 μm; J, 25 μm.)
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axonal growth but does not affect axonal elongation. The molec-
ular mechanisms by which STAT3 initiates this axonal growth
program are currently not known. However, as STAT3 is a tran-
scription factor, it is likely that the downstream effects are medi-
ated by induction of gene expression. A large number of genes that
are affected by STAT3 have already been identiﬁed. Some of these
downstream targets like the cell cycle inhibitor P21/Cip1/Waf1 (35)
or the small proline rich protein 1a (SPRR1A) (36) can directly
affect neuronal outgrowth (37, 38). Notably, a recent transcrip-
tional proﬁling study has identiﬁed several additional genes that
are speciﬁcally regulated by STAT3 in DRG neurons. At least one
of these genes, the IFN regulatory factor 1 (IRF1), is sufﬁcient to
increase neuronal outgrowth in cultured cerebellar neurons (21).
Our results further suggest that it is likely that environmental
cues play key roles in shaping the distinct stages of axonal regrowth.
For example, in the PNS, it is conceivable, that the transition from
growth initiation to elongation is induced by the interaction of axons
with Schwann cells. Schwann cells align after injury to form tubes,
also called bands of Büngner, that guide the axons to their target
cells (39). Axons could require STAT3 to initiate growth in-
dependently of Schwann cell guidance; however, when a regrowing
axon has contacted the Schwann cell tube, it shifts to the elongation
mode and no longer requires STAT3. In line with this scenario, we
can show that PNS crush lesions that do not interrupt Schwann cell
guidance do not induce STAT3 expression in the corresponding
DRG neurons (Fig. S5). Although the reasons behind this lack of
STAT induction are not yet understood and might include the in-
duction of differential injury signals by crush and cut lesions (40),
the rapid outgrowth of crushed axons (41) indicates that axonal
growth along glial support structures does not require STAT3. Like
in the PNS, changes in the environmentmay also help to explain the
transition (or lack thereof) between different growth phases after
a CNS lesion. Although, in the PNS, the regrowing axon can reach
Schwann cell support at some point, CNS axons that initiate growth
in response to STAT3 continue to encounter a growth-inhibitory
CNS environment that becomes even more hostile with the de-
velopment of a glial scar. These changes in the lesion environment
might help to explain why STAT3-transduced axons can initiate
growth early but fail to support it later. In line with this assumption,
when we combined the induction of STAT3 (by viral vector gene
transfer of rAAV-STAT3) with the neutralization of inhibitory scar
components (by application of chondroitinase ABC) (42), the av-
erage axonal outgrowth over a period of 10 d after a CNS lesion was
increased more than twofold (141 ± 53 μm for axons treated with
rAAV-STAT3 and chondroitinase ABC vs. 42 ± 26 μm for axons
treated with rAAV-STAT3 alone and 64 ± 28 μm for axons treated
with chondroitinase alone; n = 14–20 axons per group). These
results underline the importance of developing combined thera-
peutic strategies that target the molecularly distinct phases of the
axonal growth response. In this concept, phase-speciﬁc regulators of
axonal growth initiation such as STAT3 would be used to “jump-
start” the regenerationprocess andprime axons in the injured spinal
cord for application of complementary therapies that can sustain
axonal elongation in the growth-inhibitory CNS environment (43).
Materials and Methods
Mice. Animals used in this study were adult female WT mice on a C57BL/6
background (weight 20–30 g, 6–12 wk of age) with the following exceptions:
STAT3 was deleted by using STAT3ﬂ/ﬂ mice, which are maintained on a BL6
background (27). Further, central axon regeneration was investigated in
Thy1-GFPs mice (28), which express GFP in a subset of neurons and are
maintained on a mixed background. All animal experiments were per-
formed in accordance with regulations of the animal welfare act and pro-
tocols approved by the Regierung von Oberbayern.
AAV Vector Construction, Production, and Puriﬁcation. The adeno-associated
viral vectors used in this study have been cloned into the pAAV-MCS vector
from Stratagene and were produced by the adenovirus-free AAV production
method as detailed in SI Materials and Methods.
Tissue Processing, Immunohistochemistry, and STAT Expression Analysis. Ani-
mals were deeply anesthetized with isoﬂurane and perfused transcardially
with saline followed by 4% paraformaldehyde in 0.01 M phosphate buffer.
DRGs were dissected out, immunostained for P-STAT3 and STAT3 and ana-
lyzed as detailed in SI Materials and Methods.
Gene Therapy with Recombinant Adeno-associated Viral Vectors. For analysis
of PNS regeneration, the left and right L3 DRGs of anesthetized STAT3ﬂ/ﬂ
mice were surgically exposed after a dorsal laminectomy. Then, 1 μL of
rAAV-ires-GFP was slowly injected into the left L3 DRG with a thinly drawn
glass capillary and the same amount of rAAV-Cre-ires-GFP was injected into
the right L3 DRG of the same animal. Ten days after the injection, the sa-
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phenous nerve was bilaterally transected at the midthigh level using ﬁne
iridectomy scissors as previously described (23).
For analysis of CNS regeneration, a cervical dorsal laminectomy was
performed in Thy1-GFPs mice anesthetized by an i.p. injection of ketamine/
xylazine (ketamine 87 mg/kg, xylazine 13 mg/kg) as previously described
(24). DRGs, from which suitably labeled axons emerged, were identiﬁed by
in vivo imaging (SI Materials and Methods) and surgically exposed. Then,
1 μL of rAAV-STAT3, rAAV-STAT3c, rAAV-eCFP, or rAAV-Cre (control rAAV)
was slowly injected into the DRG with a thinly drawn glass capillary. Ten to
12 d later, Thy1-GFPs mice were reanesthetized, the spinal cord laminectomy
site was reaccessed, and selected ﬂuorescently labeled axons were trans-
ected with a hand-held 32-gauge hypodermic needle.
Confocal Microscopy.Weobtained confocal images ofﬁxed tissue on a FV1000
confocal system mounted on an upright BX61 microscope (Olympus) and
equipped with 20×/0.85 and 60×/1.42 oil immersion objectives. We recorded
stacks of 12-bit images that were processed using MetaMorph software
(Universal Imaging) or the freeware ImageJ/Fiji (http://rsbweb.nih.gov/ij).
In Situ and in Vivo Analysis of Axon Regeneration. The regeneration of
transected peripheral and central DRG axons was evaluated as detailed in SI
Materials and Methods.
Statistical Analysis. Results are given as mean ± SEM unless indicated other-
wise. Statistical signiﬁcance was determined using GraphPad Prism software
(GraphPad). All data were analyzed by using a one-way ANOVA followed
by a Tukey post-hoc test for multiple comparisons or a t test for single com-
parisons. For the statistical evaluation of the proportion of terminal sprouts
following rAAV treatment after CNS lesion, a frequency analysis was made
using a χ2 test.
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SI Materials and Methods
AAV Vector Construction, Production, and Puriﬁcation. The adeno-
associated viral vectors used in this study have been cloned into the
pAAV-MCS vector from Stratagene as follows. Brieﬂy, for the
control pAAV-ires-GFP vector, a strong modiﬁed internal ribo-
some entry site (ires) of the encephalomyocarditis virus, which
permits the translation of two genes of interest from a single bi-
cistronic mRNA, was cut with BamHI and BstXI from the pires2-
DsRed2 plasmid (Clontech) and inserted at the HincII site of
pAAV-MCS. Then the DNA coding for GFP was inserted at the
XhoI site of pAAV-MCS to create the pAAV-ires-GFP construct.
The pAAV-Cre-ires-GFP construct was cloned by excising the
coding sequence for Cre recombinase from pBS185 (gift of
Thomas Hughes, Montana State University, MT) with XhoI and
MluI and inserting it into the EcoRI site of pAAV-ires-GFP. For
the pAAV-STAT3, the STAT3 gene was excised from pcDNA3
STAT3 (Addgene plasmid 8706) with BamHI and XhoI and
cloned in the pAAV-MCS at the HincII site. For cloning the
pAAV-STAT3c, the STAT3c gene was excised from pRc/CMV
STAT3c Flag (Addgene plasmid 8722) with NotI and SwaI and
inserted in the HincII site of pAAV-MCS. Control pAAV-eCFP
was engineered by excising the eCFP gene from the peCFP N1
plasmid at BamHI and NotI and cloning it in the pAAV-MCS at
the HincII site.
AAV serotype 2 particles were then produced in HEK293 cells
by the adenovirus-free AAV production method (1, 2). Brieﬂy,
HEK293 cells were seeded at 80% conﬂuence and cotransfected
using the calcium phosphate method with 7.5 μg of pRC (3), 7.5 μg
of transgene plasmid, and 22.5 μg of pXX6 (1, 2). After 48 h, cells
were harvested and pelleted by low-speed centrifugation. Cells
were resuspended in 150 mM NaCl/50 mM Tris-HCl (pH 8.5),
freeze/thawed three times, and treated with Benzonase (50 U/mL
lysate) for 30 min at 37 °C. To purify viral vector preparations, cell
debris was removed by centrifugation at 3,700 × g for 20 min at
4 °C, and the supernatant was loaded onto a discontinuous io-
dixanol gradient (3). Following harvesting of the 40% phase, a
heparin afﬁnity chromatography was conducted. Brieﬂy, a hepa-
rin afﬁnity column (HiTrap heparin HP; GE Healthcare) was
equilibrated with 1× PBS solution/MgCl2 (1 mM)/KCl (2.5 mM).
The vector solution was diluted 1:10 in the same buffer and ap-
plied to the column. After a washing step with 1× PBS solution/
MgCl2 (1 mM)/KCl (2.5 mM), the vector was eluted with 1× PBS/
MgCl2 (1 mM)/KCl (2.5 mM) plus 1 M NaCl in 500-μL steps.
To determine the genomic particle titer, vector genomes were
isolated by DNeasy Tissue Kit (Qiagen) and subjected to quan-
titative PCR analysis by using the LightCycler rapid thermal cycler
system (Roche Diagnostics) and the SYBR Green kit (Roche
Diagnostics). Genomic titers were as follows: rAAV-STAT3, 9 ×
1012 genome copies/mL; rAAV-STAT3c, 5.5 × 1012 genome
copies/mL; rAAV-eCFP, 9.2 × 1012 genome copies/mL; rAAV-
Cre, 9 × 1012 genome copies/mL; rAAV-Cre-ires-GFP, 5.7–7.1 ×
1011 genome copies/mL; and rAAV-ires-GFP, 1.4–3.8 × 1012
genome copies/mL.
Tissue Processing, Immunohistochemistry, and STAT Expression Analysis.
Animals were deeply anesthetized with isoﬂurane and perfused
transcardially with saline solution followed by 4% paraformal-
dehyde in 0.01 M phosphate buffer. Tissues were postﬁxed in 4%
paraformaldehyde at 4 °C for 24 h. For immunoﬂuorescence
analysis, DRGs were dissected out, transferred to 30% sucrose for
at least 24 h, and embedded in Tissue-Tek optimal cutting tem-
perature compound (Sakura Finetek). Then, 20-μm-thick coronal
sections were cut on a cryostat. Immunoﬂuorescence staining of
DRG sections was performed as described previously (4). Before
immunostaining, sections were heated in a microwave to improve
antigen retrieval. Antibodies were diluted in a working solution of
PBS containing 0.2% Triton X-100 (Sigma) and 10% normal horse
serum (Jackson Laboratory), and incubation was performed at
room temperature or at 4 °C overnight. Details of the primary
antibodies are as follows: STAT3 (dilution 1:500; Cell Signaling),
P-STAT3 (dilution 1:50; Cell Signaling), and cJun (dilution 1:500;
Santa Cruz Biotechnology). Secondary antibodies (goat anti-rabbit
594, goat anti-rabbit 488) were obtained from Jackson Laboratory
and used at a dilution of 1:500. Nuclei were counterstained using
NeuroTrace 435 (Invitrogen) and mounted in Vectashield (Vector
Laboratories).
P-STAT3 and STAT3 immunoreactivity was analyzed in L3
DRGs of animals perfused at 1 h, 6 h, 2 d, 1 wk, and 2 wk after
a bilateral saphenous nerve transection. P-STAT3 immunoreac-
tivity was also analyzed in L3 DRGs of mice perfused 1 h, 6 h, 2 d,
1 wk, and 2 wk after the saphenous nerve was double-crushed
with hand-held forceps. Immunoﬂuorescence analysis of cJun
induction in DRG neurons and confocal microscopy analysis of
Wallerian degeneration in distal nerve segments of Thy1-YFP16
mice were used to conﬁrm the success of the crush lesion (Fig. S5).
P-STAT3 and STAT3 immunoreactivity was further analyzed
in C6 DRGs of animals perfused at 1 h, 6 h, 2 d, 1 wk, and 2 wk
after a bilateral dorsal column lesion. For the dorsal column le-
sion, animals were anesthetized with isoﬂurane, and a dorsal
laminectomy was performed at the C4 to C6 spinal cord level as
previously described (4). A small incision was made in the dura,
and the dorsal column was then cut with ﬁne iridectomy scissors.
Unlesioned animals were used as controls. All DRG sections were
counterstained with NeuroTrace 435 (as described earlier) to
reveal the total number of neuronal nuclei in the DRG, and the
proportion of DRG neurons showing STAT3 or P-STAT3 im-
munoreactivity was determined.
In Situ Analysis of Peripheral Axon Regeneration. To evaluate the
regeneration of peripheral DRG branches, STAT3ﬂ/ﬂ mice (5)
injected with rAAV-Cre-ires-GFP or rAAV-ires-GFP were
transcardially perfused with 4% paraformaldehyde at 4 or 14 d
after saphenous nerve transection. Cross-sections of the saphe-
nous nerve were cut rostrally to the injury site to quantify the
number of GFP-labeled axons above the lesion. The distal part of
the nerve containing the lesion site was dissected with the sur-
rounding muscular tissue and ﬂat-mounted in Vectashield (Vec-
tor Laboratories). High-resolution image stacks of the axons were
taken on a FV 1000 confocal microscope system (Olympus). Then
lines were positioned on the confocal maximum intensity pro-
jections at 0.1 mm, 0.2 mm, 0.4 mm, 0.8 mm, 1.4 mm, 2 mm, and 5
mm distal from the lesion site (Fig. 1H). The number of axons
crossing these lines was counted. A ratio of regenerating axons
was calculated by dividing the number of regenerating axons at
a given distances from the lesion by the number of labeled axons
rostral to the lesion.
To determine the percentage of DRG neurons that reach the
proximity of their original target area, retrograde tracing
experiments were performed as follows: At 28 d following the
SNC, a gel foam impregnated with the tracer Miniruby (Invi-
trogen) was applied to the distal-most part of the saphenous nerve
(located approximately 10 mm distal to the cut nerve). Three days
later, mice were deeply anesthetized and transcardially perfused
with PFA. Then, L3 DRGs were dissected and 20-μm sections
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were cut on the cryostat as described earlier. Confocal images of
the sections were acquired on an Olympus FV 1000 confocal
microscope and the number of Miniruby-positive DRG neurons
and total DRGneurons (identiﬁed by costaining with NeuroTrace
435) were counted. The percentage of Miniruby-positive DRG
neurons was calculated and normalized to the percentage of
Miniruby-positive neurons that were retrogradely traced from the
same anatomical localization in unlesioned mice (45 ± 6% of
Miniruby-positive L3 DRG neurons; n= 14 sections, n= 2mice).
Mice traced from the same anatomical localization immediately
after the saphenous nerve was cut showed no labeling, indicating
that the labeling at 28 d is caused by long-distance regeneration.
To determinewhether the overexpression of STAT3or STAT3c
could increase peripheral axon regeneration, we injected 1 μL of
rAAV-STAT3, rAAV-STAT3c, or rAAV-Cre (control rAAV)
into the L3 DRG of Thy1-YFP16 mice (6), in which a large pro-
portion of DRG neurons are ﬂuorescently labeled with the YFP.
We then performed an SNC and evaluated axonal sprouting and
regeneration at 4 d after the lesion as described earlier.
In Vivo Analysis of Peripheral Axon Regeneration. For in vivo imaging
experiments, we used sparsely labeled animals, lesioned the sa-
phenous nerve as described earlier, and marked the position of the
axons proximally and distally from the lesion site with a suspension
of 1-μm-diameter orange FluoSpheres (Invitrogen). Before each
imaging session, animals were anesthetized and placed directly
under a ﬂuorescence dissection microscope (Olympus). An in-
cision was made on top of the lesion site and the axons in the sa-
phenous nerve were imaged with 20×magniﬁcation at day 2 and 3
or at day 7 and 8 after lesion. Images were captured with a cooled
Sensicam QE CCD camera (pco.imaging). To determine the
growth of the transected axon ends, we measured the distance
from the axon end to the FluoSpheres proximal to the lesion site at
2 and 3 d or 7 and 8 d after lesion and calculated the speed of
growth per day.
In Vivo and in Situ Analysis of Central Axon Outgrowth. To image
central branches of ﬂuorescently labeled DRG neurons, we
adapted our previously established spinal in vivo imaging ap-
proach (4). Brieﬂy, Thy1-GFPs mice were anesthetized by an i.p.
injection of ketamine/xylazine. To access the cervical spinal cord,
a laminectomy was performed and the dorsal surface of the
spinal cord was exposed. During the imaging session, the spinal
cord was superfused with mouse artiﬁcial cerebrospinal ﬂuid. To
follow the outgrowth of individual axons in vivo, we ﬁrst iden-
tiﬁed single ﬂuorescently labeled axons emerging from a DRG
using a wideﬁeld set-up based on an Olympus BX51 microscope
equipped with ×4/0.13 dry, ×10/0.3 dry, and ×20/0.5 dipping cone
water-immersion objectives. To document these axons in vivo,
image streams of 25 to 50 images were acquired with a cooled
Sensicam QE CCD camera controlled by MetaMorph software
as previously described (4). The DRG from which the selected
axon was emerging was then surgically prepared and 1 μL of one
of the rAAVs was injected by using a glass capillary as described
earlier. Then, 10 to 12 d after the DRG injection, the dorsal
surface of the spinal cord was surgically reexposed. The pre-
viously identiﬁed axon was transected by using a hand-held
small-diameter needle and documented in vivo. Two different
imaging protocols were used as follows.
To determine the frequency of axonal sprouting, the animal was
perfused transcardially with 4% PFA 2 d after the lesion and the
previously imaged spinal cord segment was dissected. The
transected axon was then documented by using high-resolution
confocal microscopy as described earlier, ﬁrst in the intact spinal
cord and then in 100- to 250-μm-thick vibratome sections.
Confocal stacks were processed as described earlier and the
transected axons were reconstructed from the DRG root to the
lesion site. Axons were then evaluated by two blinded observers
and terminal axon ends were classiﬁed as “sprouts” or “bulbs”
based on their characteristic morphological appearances. Fur-
ther, the number of collateral sprouts emerging from the trans-
ected axons was counted.
To determine the speed of axonal outgrowth we reimaged the
transected axon ends at 2 and 4 d after lesion in vivo using a
custom-built multiphoton imaging setup based on an Olympus
FV 300 scanner equipped with a femtosecond pulsed Ti:Sapphire
laser (Mai Tai HP; Newport/Spectra-Physics). We acquired image
stacks of 50 to 200 images per stack (spaced at 1–2 μm in z di-
mension) for each frame with a ×20/0.5 dipping cone water-
immersion objective. Animals were then perfused transcardially
with 4% PFA 10 d after the lesion. The imaged part of the spinal
cord was dissected out. The transected axons were reidentiﬁed in
the ﬁxed tissue and imaged in the intact spinal cord by using an
Olympus FV1000 MPE multiphoton microscope or an Olympus
FV1000 confocal microscope. Image stacks of 20 to 100 frames
were acquired with a ×25/1.05 water-immersion or a ×20/0.85
oil-immersion objective. Imaging stacks were processed by using
MetaMorph or ImageJ/Fiji software. Frames containing the axon
were selected, and the transected axons were reconstructed using
Photoshop. To determine the growth of the transected axon
ends, we measured the distance from the axon end to a charac-
teristic proximal structure (in most cases the Y-branch point in
the dorsal root; in some cases a crossing point with another
axon) at 2, 4, and 10 d after lesion. To compensate for tissue
changes caused by ﬁxation in the perfused samples, we measured
a “constant” distance e.g., between two branch points in the
same unlesioned axon both in vivo and in the corresponding
ﬁxed tissue to determine a sample-speciﬁc “correction factor.”
The length of the transected axon end measured in ﬁxed tissue
was then multiplied by this correction factor. Axons that showed
substantial die-back were excluded from the analysis.
To determine the inﬂuence of endogenous STAT3 expression
on axonal sprouting after a CNS lesion, we injected 1 μL of rAAV-
eCFP or a combination of rAAV-eCFP and rAAV-Cre into the
cervical DRGs of STAT3ﬂ/ﬂ mice. Ten days after the injection,
ﬂuorescently labeled spinal DRG axons were lesioned by a pin as
described earlier. Then, 2 d following the lesion, animals were
perfused and axonal sprouting was evaluated based on confocal
stacks of the ﬁxed intact spinal cord as described earlier.
To determine the effects of a combination therapy with STAT3
and chondroitinase ABC, we performed the following experi-
ment. We ﬁrst injected 1 μL of rAAV-STAT3 or rAAV-Cre into
the cervical DRGs of Thy1-GFPs mice as described earlier. Ten
days after this injection, we then lesioned individual GFP-posi-
tive spinal axons and administered a ﬁrst bolus of 6 μL of
chondroitinase ABC (10 U/mL in saline solution with 0,01%
BSA; Sigma-Aldrich) or vehicle only (saline solution with 0.01%
BSA) immediately following lesion creation. At the same time,
an osmotic minipump (1007B; Alzet), which was connected to
a brain infusion kit (Alzet) inserted into the lateral ventricle, was
installed and started to deliver 0.5 μL/h of chondroitinase ABC
(10 U/mL in saline solution with 0.01% BSA) or vehicle only for
7 d. At 10 d following the lesion, the animals were perfused with
PFA, the spinal cords were dissected, and the transected axons
were imaged in the intact ﬁxed spinal cord by confocal micros-
copy as described earlier. On confocal image stacks, we then
measured the length of axonal sprouts to determine the axonal
outgrowth (axonal terminals that ended in tips or bulbs were
considered to be nongrowing axons and their outgrowth was set
to 0 μm).
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Fig. S1. Induction of STAT3 expression by a peripheral nerve cut but not by a central lesion. (A) Quantiﬁcation of the number of STAT3-positive DRG neurons
(identiﬁed by NeuroTrace counterstaining) at different time points following SNC in WT mice. (B) Quantiﬁcation of the number of STAT3-positive DRG neurons
(identiﬁed by NeuroTrace counterstaining) at different time points following DCL in WT mice.
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Fig. S2. rAAV-Cre-ires-GFP is an efﬁcient tool to delete STAT3 and concomitantly express GFP in DRG neurons. (A and B) Quantiﬁcation of the percentage of P-
STAT3–positive (A, also shown in Fig. 1E) and GFP-positive (B) neurons 4 d following SNC in DRGs of STAT3ﬂ/ﬂmice previously injected with rAAV-ires-GFP (gray
columns) or rAAV-Cre-ires-GFP (blue columns; n = 6 animals per group). Although GFP expression is comparable in both groups of DRGs, only injection of the
rAAV-Cre-ires-GFP leads to a signiﬁcant reduction of P-STAT3 expression. P-STAT3 expression is reduced by approximately 80% in DRG neurons, whereas only
50% of the neurons express GFP. This is expected because of the lower expression rate of the second reading frame, which encodes GFP, and the low number
of Cre molecules needed to ensure efﬁcient excision of ﬂoxed sequences. (C) Analysis of P-STAT3 expression in GFP-positive DRG neurons conﬁrms that P-STAT3
expression is completely abolished in DRG neurons infected with rAAV-Cre-ires-GFP.
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Fig. S3. Gallery of central DRG axon endings after treatment with control rAAV, rAAV-STAT3, and r-AAV-STAT3c. (A–C) Representative images of axon
endings 2 d after a central lesion derived from DRG neurons treated with control rAAV (A), rAAV-STAT3 (B), or rAAV-STAT3c (C). Axonal sprouts (asterisks) are
rarely found in control axons (A) but are frequent in axons emerging from DRG neurons expressing STAT3 (B) or STAT3c (C). (Scale bar: A, 25 μm.)
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Fig. S4. Overexpression of STAT3 or STAT3c does not increase peripheral axon regeneration following a SNC. (A–C). Confocal images taken at 4 d after SNC
displaying the proximal stump of saphenous nerve that receives ﬁbers from L3 DRGs injected with rAAV-STAT3 (A), rAAV-STAT3c (B), or control rAAV (C).
Axons are ﬂuorescently labeled with YFP (white) in Thy1-YFP16 mice. (D and E) Quantiﬁcation of axonal sprouting at the site of the lesion (D) and regeneration
ratios (E) at different distances from the cut site (Fig. 1H) of axons derived from DRG neurons that express normal levels of STAT3 (gray columns) or overexpress
STAT3 (red columns) or STAT3c (orange columns) at 4 d after SNC. (Scale bar: A, 250 μm.)
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Fig. S5. A peripheral crush lesion leads to Wallerian degeneration and induces cJun expression but not STAT3 activation in DRG neurons (A–C) Wallerian
degeneration of axons (white) in the distal stump of a saphenous nerve 4 d following saphenous nerve crush in Thy1-YFP16 mice. Magniﬁcation of the areas
boxed in A shows intact axons rostral to the lesion (B) and axonal fragments distal to the lesion (C). (D) Quantiﬁcation of the loss of continuous axons distal to
the lesion at 4 d after injury. (E–G) Confocal images illustrating cJun immunoreactivity (red) in an unlesioned control DRG (E), and in DRGs following saphenous
nerve cut (F) or crush (G; YFP, green; NeuroTrace, cyan). (H) Quantiﬁcation of the number of cJun-positive L3 DRG neurons (identiﬁed by NeuroTrace coun-
terstaining) in unlesioned controls and 4 d following saphenous nerve cut or crush. (I–K) Confocal images illustrating P-STAT immunoreactivity (red) in an
unlesioned control DRG (I) and in DRGs following saphenous nerve cut (J) and crush (K; YFP, green; NeuroTrace, cyan). (L) Quantiﬁcation of the number of
P-STAT3–positive DRG neurons (identiﬁed by NeuroTrace counterstaining) at different time points following saphenous nerve crush in WT mice. (Scale bars: A,
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Abstract  
In contrast to peripheral neurons, neurons of the central nervous system (CNS) fail 
to grow after injury. As a result axonal regeneration and remodeling after CNS lesions 
remain limited and functional deficits persist. The transcription factor Signal Transducer 
and Activator of Transcription 3 (STAT3) has recently been identified as a key element of 
axonal growth induction and its sustained expression is required for timely growth 
initiation in the peripheral nervous system.  
Here we use the corticospinal tract (CST) to investigate the role of STAT3 during 
axon regeneration and remodeling in the CNS. We show that cortical projection neurons 
only transiently overexpress STAT3 after spinal cord injury. This transient STAT3 
expression is insufficient to initiate axonal outgrowth and its conditional deletion in CST 
projection neurons affects neither axon regeneration nor sprouting at or remote from the 
lesion. If however sustained expression and activation of STAT3 is induced in these 
neurons by viral gene transfer, their axons show increased terminal and collateral sprouting 
as well as regeneration after spinal cord injury. Furthermore, after a unilateral 
pyramidotomy, sustained STAT3 expression and activation initiates the de novo formation 
of collaterals from unlesioned CST fibers that cross the spinal midline and contact 
interneurons and motoneurons that control forelimb function. Behavioral and 
electrophysiological recordings indicate that these newly formed ‘midline crossing circuits’ 
establish ipsilateral forelimb activation and contribute to forelimb function recovery. These 
findings identify intrinsic growth induction by STAT3 as a promising approach to promote 
regeneration and remodeling and improve functional recovery after CNS injury.   
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Introduction  
Traumatic, inflammatory or ischemic lesions to the spinal cord lead to the 
transection of axonal tract systems and as a result are often followed by devastating motor 
and sensory deficits (1). If the lesion of the spinal cord is complete, i.e. if the entire spinal 
cord is transected, severe deficits persist. If the lesion is however incomplete, some 
functional recovery can occur in rodents (2-5) as well as in humans (6,7). Over recent years 
a number of studies have investigated the anatomical basis of this recovery process often 
using the corticospinal tract (CST), a major descending motor tract, as a model system (2,3, 
8-10). The results show that – while long-distance regeneration of transected CST fibers 
fails – lesioned CST connections spontaneously attempt to remodel after injury (2,3,11). 
We have previously identified sprouting of CST collaterals into the cervical cord and their 
contacts to long propriospinal neurons as key components of endogenous CST remodeling 
(2,12). Despite the formation of this detour circuit, however, spontaneous functional 
recovery in most cases remains incomplete. To further improve functional recovery we thus 
need to devise strategies that can not only enhance axonal regeneration but also improve 
endogenous remodeling.  
How the induction of axonal remodeling is regulated is however so far only 
incompletely understood. One of the reasons is that so far many studies have focused on 
the induction of axonal regeneration based on the neutralization of extrinsic growth-
inhibitory signals at the lesion site (13-16). These strategies are however less likely to 
affect axonal remodeling, which often requires the formation of new collaterals remote 
from the lesion site. Here, strategies that affect the intrinsic growth capability of the entire 
neuron are conceptually more suited (17). We have previously identified the sustained 
expression of the transcription factor STAT3 (Signal Transducer and Activator of 
Transcription 3) is a key requirement for the timely induction of the intrinsic growth 
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program in DRG neurons (18). A key role for STAT3 in the induction of the intrinsic 
growth program is supported by the following findings: (i) The expression and 
phosphorylation of STAT3 correlates with the regenerative response of the neuron after 
injury; neurons that express STAT3 start to regenerate while those that don´t generally fail 
to grow (18-21). (ii) Deletion of STAT3 impairs the timely initiation of PNS regeneration 
(18) and STAT3 inhibition blocks the growth-promoting effect of a conditioning lesion in 
the CNS (22). (iii) STAT3 over-expression or the deletion of its inhibitor, SOCS3, can 
improve sprouting of central DRG projections (18) and promote optic nerve regeneration in 
vivo (23,24). Whether and how STAT 3 can initiate the remodeling of central neurons and 
their projections is so far not known.  
Here, we investigate how growth initiation by STAT3 affects CST regeneration and 
remodeling as well as functional recovery in different spinal cord injury paradigms. We use 
conditional genetics to delete endogenous STAT3 expression and viral gene transfer to 
induce sustained STAT3 expression. Stereotactic tracing of hindlimb CST fibers then 
allowed us to reveal the effects of STAT3 deletion or over-expression on CST regeneration 
and remodeling, while behavioural testing and electrophysiological recordings were used to 
assess the resulting functional recovery.  
 
 
Results  
Cortical projection neurons only transiently express and activate STAT3 after spinal 
cord injury  
To examine whether STAT is expressed and activated in lesioned cortical projection 
neurons, we investigated the expression of STAT3 and its activated, phosphorylated form 
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(p-STAT3) immunohistochemically in the hindlimb motor cortices of mice perfused at 
different timepoints from 6 hrs to 3 weeks following a dorsal midthoracic hemisection. In 
unlesioned animals, only very few layer V pyramidal neurons in the motor cortex (that 
were identified based on their typical morphology after neurotrace labeling) expressed 
either p-STAT3 (Fig. 1 A, C) or STAT3 (Supplementary Fig. 1A, C). The number of 
STAT3 and p-STAT3-positive cortical projection neurons was then significantly increased 
at 24 hrs after lesion (Fig. 1 B, C and Supplementary Fig. 1 B, C). However, even at this 
time only a subset of cortical projection neurons expressed STAT3 (Supplementary Fig. 1 
C) or p-STAT (Fig. 1 C). Moreover, in these neurons STAT3 expression and 
phosphorylation is only transiently induced and has returned to baseline levels at 1 week 
after injury (Fig. 1 C and Supplementary Fig. 1 C).  
 
Transient expression of STAT3 does not contribute to endogenous axonal 
regeneration and remodeling after spinal cord injury 
To assess to what extend the transient STAT expression supports endogenous 
attempts of axonal regeneration and remodeling, we selectively deleted STAT3 expression 
in cortical projection neurons. For this purpose we crossed Emx-Cre mice, which express 
Cre recombinase in the forebrain (25) with STAT3fl/fl mice. As expected no STAT3 or p-
STAT3 expression is detected in cortical projection neurons of Cre-positive STAT3fl/fl mice 
(Fig. 1 D-F and Supplementary Fig. 1 D-F). We then performed midthoracic dorsal 
hemisections in STAT3 competent (Cre–) and conditional STAT3 deficient (Cre+) mice 
and examined the effects of STAT3 deletion on CST sprouting, regeneration, remodeling 
and functional recovery. Our analysis revealed no differences between STAT3 competent 
and conditional STAT3 deficient mice in all parameters analyzed: Axonal sprouting and 
regeneration at the lesion site was comparable between both groups both at 1 week 
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(Supplementary Fig. 1 G-K) as well as at 3 weeks after lesion (Fig. 1 G, H). Likewise, no 
differences in the formation of intraspinal detour circuits were detected as similar numbers 
of cervical collaterals form, which do not differ in length, complexity and number of 
boutons and contact similar proportions of long propriospinal neurons (Fig. 1 I, J 
Supplementary Fig. 1 L-O and data not shown). Consistent with these observations no 
differences in the recovery of hindlimb locomotion assessed by BMS and rotarod tests were 
detected between STAT3 competent and conditional STAT3 deficient mice 
(Supplementary Fig. 2 A-C). 
 
Sustained STAT3 expression induces corticospinal sprouting and regeneration 
As the transient induction of STAT3 expression after central lesions is thus 
insufficient to contribute to axonal regeneration and remodeling, we next investigated 
whether the exogenous induction of sustained STAT3 expression would be sufficient to 
promote axonal outgrowth. To induce sustained STAT3 expression in cortical neurons, we 
injected a recombinant adeno-associated viruses (rAAV) expressing STAT3 into the 
cortical hindlimb motor area (Fig. 2 A-C). Immunohistochemical analysis of STAT3 
expression and phosphorylation demonstrated that transfer of rAAV-STAT3 is sufficient to 
induce sustained expression and phosphorylation of STAT3 for at least 3 weeks after the 
injection of the virus.  
To assess the effect of sustained STAT3 expression on regeneration and remodeling 
of lesioned CST fibers, we injected rAAV-STAT3 or Control rAAV into the hindlimb 
motor cortex, lesioned the main dorsal and the minor dorso-lateral component of the CST 
by a midthoracic hemisection and performed the following analyses: First, to assess effects 
on CST regeneration we counted the number of sprouts at the lesion site as well as the 
number of regenerating CST fibers that extend for up to 500 µm beyond the lesion site 
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(Fig. 2 A, E). Our analysis showed that sustained STAT3 expression is sufficient to induce 
a significant increase in CST sprouting at the lesion site (Fig. 2 E-H, J). Moreover 
significantly more regenerated CST fibers were detected in mice injected with rAAV 
STAT3 at 200 – 400 µm from the lesion site (Fig. 2 E-I). Sustained expression of STAT3 is 
thus sufficient to induce CST sprouting at and regeneration beyond the lesion site. 
To assess to what extent sustained STAT3 expression can also support the 
remodeling of CST fibers distant from the lesion site, we quantified the formation of 
intraspinal detour circuits after midthoracic dorsal hemisections in mice injected with 
rAAV-STAT3 and Control rAAV (Fig. 3 A). Indeed mice injected with rAAV-STAT3 
showed an increased formation of cervical CST collaterals at 3 weeks after injury (Fig. 3 
B-D). However the intraspinal targeting of these collaterals is not affected and thus a 
similar proportion of long propriospinal neurons are contacted in mice injected with rAAV-
STAT3 and Control rAAV (Fig. 3 E, F). Notably, mice injected with rAAV-STAT3 
displayed the formation of cervical collaterals (Fig. 3 G-J) and contacts onto long 
propriospinal neurons (Fig. 3 K, L) even in the absence of a spinal lesion. This indicates 
that sustained STAT3 expression can also induce the remodeling of fibers that have not 
been primed to grow by their previous transection. 
 
Sustained expression of STAT3 induces the de novo formation of midline-crossing 
CST circuits after pyramidotomy 
To further investigate the capability of STAT3 to recruit unlesioned fibers to the 
remodeling process, we induced a unilateral lesion of the left CST at the level of the 
medulla oblongata (‘unilateral pyramidotomy’, Fig. 4 A). We then assessed whether and 
how unlesioned fibers from the contralateral, right forelimb portion of the CST remodel in 
response to the unilateral denervation. In animals injected with Control rAAV no 
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significant increase in the number of CST fibers that exit the right CST is detected at 1, 3 or 
12 weeks after pyramidotomy (Fig. 4 B, E). Further CST fibers that exit the CST rarely 
crossed the spinal midline (Fig. 4 B, F). In contrast in animals injected with rAAV-STAT3 
additional CST collaterals exit the CST at 3 weeks after injury (Fig. 4 C, E). These newly 
formed collaterals extend towards the denervated side of the spinal cord resulting in a 
significant increase in the number of midline-crossing fibers that is first detected at 3 weeks 
(Fig. 4 C, F) and persist for at least 12 weeks after lesion (Fig. 4 D, F). We next examined 
the projection pattern of these newly formed midline crossing CST collaterals and found 
that in animals injected with rAAV-STAT3, CST collaterals extended significantly further 
into the denervated spinal cord and often projected to the intermediate and ventral laminae 
VI-IX of the spinal cord (Fig. 4 G, H). As the cell bodies of short propriospinal neurons 
and spinal motoneurons that control forelimb movement are located in these laminae we 
next assessed to what extend these neurons are targeted by midline crossing CST collaterals 
at 12 weeks after pyramidotomy. Our results show that the proportions of short 
propriospinal neurons and spinal motoneurons that are contacted by CST collaterals are 
increased more than 4- and 20-fold, respectively, in animals injected with rAAV-STAT3 
(Fig. 4 I-L).  
 
De novo formation of midline crossing circuits improves behavioral and 
electrophysiological recovery after injury 
To investigate whether the newly formed midline crossing CST circuits induced by 
sustained STAT3 expression can foster functional recovery we performed the following 
analyses after unilateral pyramidotomy. First, we used the staircase test which measures the 
capability of mice to remove sugar pellets placed on different stairs of a staircase to 
evaluate skilled forelimb grasping as described in SI Materials and Methods (Fig. 5 A,). 
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While mice from both experimental groups showed similarly impaired forelimb grasping 
immediately after injury, mice injected with rAAV-STAT3 recovered quicker and 
performed significantly better in the staircase reaching task compared to mice injected with 
Control rAAV from 5 weeks after pyramidotomy onwards (Fig. 5 B). To study the 
contribution of midline-crossing circuits to this functional recovery, we recorded forelimb 
flexor electromyographs (EMGs) after intracortical stimulations (Fig. 5 C, D). Unlesioned 
animals elicited EMG responses in 100% of the cases (n=24 stimulations, Fig. 5 E). In the 
days following pyramidotomy, this response was basically abolished (Fig. 5 E). When we 
investigated the response to stimulation twelve weeks following pyramidotomy, we 
observed that animals treated with the Control rAAV exhibited 53±9% while animals 
treated with rAAV-STAT3 exhibited 94±4% of responsive sites in the ipsilateral cortex 
(Fig. 5 E). The finding that cortical stimulation in animals injected with rAAV-STAT3 
evoked an increased ipsilateral EMG response is consistent with the idea that newly formed 
midline crossing CST fibers mediate this recovery. To confirm the contribution of new 
CST connections below the level of the pyramids to the recovery we performed an 
additional pyramidotomy of the intact side in mice that had previously recovered 
responsiveness to stimulation at 12 weeks after lesion and injection with rAAV-STAT3. In 
these mice the second pyramidotomy completely abolishes the response to cortical 
stimulation (Fig. 5 E). Further analysis of the cortical stimulation parameters revealed 
lower stimulation thresholds and shorter latencies to an EMG response in mice 12 weeks 
after injection with rAAV-STAT3 compared with mice injected with Control rAAV (Fig. 5 
F, G). Taken together our electrophysiological and behavioral analysis strongly suggests 
that the midline crossing CST circuits induced by sustained expression of STAT3 are 
functional and contribute to improved recovery of forelimb function after injury.  
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Discussion  
  The sustained expression of p-STAT3 is required for the timely initiation of 
neuronal growth in the lesioned peripheral nervous system (18). Here, we show that in 
response to a central lesion STAT3 and p-STAT3 expression are only transiently 
upregulated in a subset of cortical projection neurons. This transient upregulation is 
consistent with previous reports that investigated STAT3 expression in layer V cortical 
projection neurons following transient cerebral ischemia in rats (26) and the expression of  
JAK-STAT family members (JAK1 and STAT3 in particular) in the injured spinal cord 
(19). The conditional deletion of STAT3 expression now shows that this transient 
expression of STAT3 does not contribute to the induction of endogenous attempts of 
axonal regeneration and remodeling. This suggests that at least in cortical projection 
neurons other pathways might be responsible for endogenous induction of axonal 
sprouting.  
While the transient STAT3 expression induced by central lesions can thus not 
influence axonal growth, we can now show that sustained expression of STAT3 induced by 
viral gene transfer is sufficient to substantially improve the neuronal growth induction of 
transduced cortical projection neuron and affect multiple aspects of the CST response to 
injury: First, sustained STAT3 expression improves axonal sprouting and regeneration at 
the lesion site. This pro-regenerative effect of STAT3 expression is consistent with 
previous reports that have shown that STAT3 over-expression can induce sprouting of 
central DRG projections (18) and that deletion of its negative regulator SOCS3 can 
improve optic nerve regeneration (23,24). The molecular mechanisms by which STAT3 
initiates this axonal growth are currently not fully understood. However, several genes that 
are induced by the transcription factor STAT3 have already been identified and include the 
cell cycle inhibitor P21/Cip1/Waf1 (27), the small proline rich protein 1a (SPRR1A, 28) 
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and the interferon regulatory factor 1 (IRF1; 21), all of which can directly affect neuronal 
outgrowth (21,29,30). When evaluating the effects of STAT3 in regeneration, it should be 
noted that axonal growth initiation by STAT3 appears to primarily increase the number of 
CST axons that attempt to regenerate after a lesion. As these axons still have to grow 
through the growth-inhibitory environment of the lesioned CNS (13-16,31) it is probably 
not surprising that even after STAT3 induction most regenerating fibers terminate within 
the first 500 µm from the lesion. By itself this pro-regenerative effect of STAT3 is thus 
unlikely to contribute to functional recovery, however improved growth induction by 
STAT3 can be an ideal therapeutic complement to strategies that counteract growth-
inhibitory signals in the glial scar and central myelin (13-16,31,32). In line with this 
concept we could previously show synergistic effects on axonal outgrowth of central 
sensory connections when we combined STAT3 induction with the neutralization of 
growth-inhibitory chondroitin sulfate proteoglycans (18).  
While the contribution of axonal regeneration to functional recovery is thus limited, at least 
in the untreated spinal cord, the remodeling of axonal connections can promote some 
recovery of function even in the absence of therapeutic support. We and others have 
previously shown that the formation of intraspinal detour circuits is a key component of the 
endogenous recovery process following spinal cord injury (2,3,12,33). For detour circuits 
to be formed lesioned CST fibers first extend new collaterals distant from the lesion site. 
These collaterals enter the intermediate layers of the cervical spinal cord and there contact 
different interneurons including long propriospinal neurons. Long propriospinal neurons 
act as relay neurons and increase their projections to the denervated target area of the 
transected hindlimb CST thereby completing the detour circuit. We can now show that 
sustained STAT3 expression can further increase the number of cervical CST collaterals 
that form after lesion. However increased collateral formation does not result in significant 
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changes to the CST connections to the long propriospinal relay neurons. This might 
indicate that the endogenous growth response of lesioned CST projection neurons is 
sufficient to promote the formation of detour circuits at an “optimal” rate that is not 
improved further by the presence of additional CST collaterals.  
While lesioned CST fibers thus spontaneously reorganize after injury, unlesioned fibers 
generally do not adapt in response to injury. Our results now indicate that the sustained 
expression of STAT3 is sufficient to recruit unlesioned fibers to the remodeling process.  
After a unilateral lesion of the CST at the level of the pyramids, sustained expression of 
STAT3 induces the formation of collaterals from the unlesioned CST. These collaterals 
enter the cervical gray matter, cross the spinal midline and form contacts to the previously 
denervated spinal interneurons and motoneurons that control forelimb function. The 
findings that neuronal growth initiation by STAT3 is sufficient to induce the de novo 
formation of these midline crossing circuits indicate that the guidance signals that attract 
newly formed collaterals are endogenously present in the denervated spinal cord. It is 
interesting to note in this context that the remodeling of unlesioned CST fibers can not only 
be induced by sustained STAT3 expression.  Indeed previous studies have, for example, 
shown that activation of the mTOR pathway through deletion of PTEN leads to sprouting 
of uninjured CST axons and regeneration of injured CST axons past the lesion site (10) and 
that the over-expression of the neuronal calcium sensor1 (NCS1), which acts via the 
PI3K/Akt pathway, induces sprouting and midline crossing of unlesioned CST fibers (9).  
The therapeutic potential of interventions that promote the remodeling of unlesioned 
connections is illustrated by our behavioral and electrophysiological analyses that 
demonstrate meaningful recovery of forelimb function in animals treated with rAAV-
STAT3 following pyramidotomy. One caveat of strategies that promote axonal remodeling 
is the induction of “unwanted” new connections that could in principle augment pain or 
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spasticity after spinal cord injury. Our results from this and previous studies however 
suggest that endogenous regulatory mechanisms might be in place that prevents the 
formation of functionally “unwanted” connections. For example, we could previously show 
that the formation of collaterals is followed by a phase of sprout sorting and refinement 
during which excessive connections e.g. to short propriospinal neurons that do offer a 
detour around the lesion are at least partially removed (2,33). Further, as discussed above 
our current experiments provide evidence for the existence of endogenous guidance cues 
that target sprouting collaterals to denervated areas of the spinal cord. Finally, the 
combination of strategies that promote axonal reorganization with neurorehabilitation 
approaches might further help to enhance desired and limit unwanted consequences of 
nervous system remodeling (34). Thus we believe that the support of endogenous axonal 
remodeling, for example by the induction of sustained expression of STAT3 or selective 
manipulation of its downstream targets, is a promising therapeutic avenue that can help to 
improve functional recovery in many neurological conditions in which trauma, 
inflammation or ischemia cause permanent axon damage.  
 
Materials and Methods 
Animals:  
To delete STAT3 expression in cortical projection neurons, we crossed STAT3fl/fl 
mice, in which deletion of the STAT3 gene depends on Cre-mediated excision of loxP 
sites, and EMX-Cre mice (25) in which regulatory elements of the Emx1 gene drive Cre 
expression in the forebrain. Adult female mice homozygous for the floxed STAT3 allele 
and either expressing Cre (STAT3-deficient group) or Cre-negative (control group) were 
used for experiments. For all other experiments we used adult female C57/Bl6 mice (6-8 
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weeks old).  All animal experiments were performed in accordance with regulations of the 
animal welfare act and protocols approved by the Regierung von Oberbayern. 
Generation and production of AAV vectors 
We cloned and produced rAAV-STAT3 and Control rAAV as previously described 
(25). Additional details can be found in SI Materials and Methods. Genomic titers were as 
follows: rAAV-STAT3, 9 ×1012 genome copies/ml; Control rAAV-eCFP, 9.2 × 1012 
genome copies/ml; Control rAAV-mbYFP, 8.6 x 1012 genome copies/ml. 
 Surgical procedures 
We performed midthoracic hemisections and pyramidotomies and labelled CST 
fibers and propriospinal neurons as described in detail in SI Materials and Methods.  
Tissue processing and histological analysis 
Animals were perfused transcardially with 4% paraformaldehyde (PFA). Brains and 
spinal cords were dissected and postfixed overnight in PFA. The tissue was then 
cryoprotected in 30% sucrose for 3 days. Coronal sections (50µm thick) were cut on a 
cryostat. To visualize CST collaterals, BDA detection was performed as described in SI 
Materials and Methods.  
Confocal microscopy and image processing 
  Stained sections were scanned using an Olympus FV1000 confocal microscope 
equipped with x20/0.85 and x60/1.42 oil immersion objectives. Image stacks were then 
later processed using the freeware ImageJ/Fiji (http://rsbweb.nih.gov/ij) to generate 
maximum intensity projections. To obtain final representations, these maximum intensity 
projections were further processed in Photoshop (Adobe) using gamma adjustments to 
enhance visibility of intermediate gray values.  
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Quantification of CST regeneration and remodelling 
The extent of CST regeneration and remodelling was quantified as detailed in SI 
Materials and Methods. 
Behavioral analysis and Electrophysiology  
To assess behavioural recovery we monitored the BMS score and performed Food 
pellet grasping and the Rotarod tests as described in SI Materials and Methods. We 
stimulated the forelimb motor cortex and performed electrophysiological recordings as 
described in SI Materials and Methods. 
Statistical evaluation 
Data were analyzed by the Student's t test in case of comparisons of two groups or 
two-way ANOVA with Tukey's post hoc test in case of multiple comparisons using 
Graphpad Prism 5.01 for Windows (GraphPad Software). 
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Figure Legends 
 
Figure 1. Transient upregulation of p-STAT3 expression in cortical neurons does not 
contribute to endogenous CST regeneration and remodeling after injury. 
(A,B) Confocal images of the expression of the activated form of STAT3, p-STAT3 in 
lamina V cortical neurons (green, NeuroTrace 435; red, p-STAT3) of an unlesioned mouse 
(A) and a mouse perfused 24hrs following a midthoracic hemisection (B). (C) 
Quantification of p-STAT3 expression in lamina V cortical neurons of unlesioned mice 
(white bar) and mice perfused at different timepoints following thoracic hemisection (grey 
bars). (D,E) Confocal images of p-STAT3 expression in lamina V cortical neurons (green, 
NeuroTrace 435; red, p-STAT3) of a STAT3 competent (D) and a conditional STAT3 
deficient mouse (E) perfused 3wks following a midthoracic hemisection. (F) Quantification 
of p-STAT3 expression in lamina V cortical neurons in STAT3 competent and conditional 
STAT3 deficient mice perfused 3wks following a midthoracic hemisection. (G,H) 
Quantification of axonal regeneration at different distances distal from the lesion site (G) 
and of axonal sprouting (H) at the site of the lesion in STAT3 competent (grey bars) and 
conditional STAT3 deficient (blue bars) mice perfused 3 wks following midthoracic 
hemisection. (I,J) Quantification of axonal sprouting in the cervical spinal cord (I) and of 
the percentage of long propriospinal neurons contacted by CST fibers (J) in STAT3 
competent (grey bars) and conditional STAT3 deficient (blue bars) mice perfused 3 wks 
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following thoracic hemisection. Scale bars equal 50μm B (also for A), 50μm in E (also for 
D). 
 
Figure 2. Sustained STAT3 expression promotes axonal sprouting and regeneration 
following spinal cord injury.  
(A) Schematic representation of the analysis of CST sprouting and regeneration following 
spinal cord injury. (B,C) Confocal images of p-STAT3 expression in lamina V cortical 
neurons (green, NeuroTrace 435; red, p-STAT3) of mice injected with Control rAAV (B) 
or rAAV-STAT3 (C) and perfused 3 wks following a midthoracic hemisection. (D) 
Quantification of p-STAT3 expression in lamina V cortical neurons of mice injected with 
Control rAAV (grey bars) or rAAV-STAT3 (red bars) and perfused 3wks following 
midthoracic hemisection. (E-H) Confocal image of a longitudinal section of the spinal cord 
(asterisk, indicates lesion site) illustrating sprouting and regeneration of the transected CST 
(BDA, white) in mice injected with rAAV-STAT3 (E-G) and in mice injected with Control 
rAAV (H).  The dotted lines in (H) represent the distances at which regenerating CST 
axons were counted. Boxed areas in (E) are magnified 2-times in (F) and (G). (I,J) 
Quantification of axonal regeneration at different distances distal from the lesion site (I) 
and of axonal sprouting (J) at the site of the lesion in control (grey bars) and STAT3 
overexpressing (red bars) mice perfused 3 wks following midthoracic hemisection. Scale 
bars equals 100μm in C (also for B). Scale bar in H (also for E) equals 60μm. 
 
Figure 3. Sustained STAT3 expression induces sprouting of lesioned and unlesioned 
fibers in the cervical spinal cord following injury.  
 (A) Schematic representation of the analysis of cervical CST sprouting and remodeling 
following a midthoracic spinal cord injury. (B,C) Confocal images of sprouting hindlimb 
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CST collaterals in lesioned mice injected with Control rAAV (B) or rAAV-STAT3 (C) and 
perfused 3 wks following injury. (D) Quantification of the number of collaterals exiting the 
hindlimb CST tract in the cervical spinal cord in mice injected with Control rAAV (grey 
bar) or rAAV-STAT3 (red bars) 3 wks following spinal cord injury. (E) Confocal image 
(single plane) of a contact between a hindlimb CST collateral (red) and a long 
propriospinal neuron (green) in a mouse injected with rAAV-STAT3 and perfused 3 wks 
following the lesion. (F) Quantification of the percentage of long propriospinal neurons 
contacted by hindlimb CST collaterals 3 wks following the lesion (grey bar: mice injected 
with Control rAAV, red bar: mice injected with rAAV-STAT3). (G) Schematic 
representation of the analysis of cervical CST sprouting and remodeling in unlesioned 
mice. (H,I) Confocal images of sprouting hindlimb CST collaterals in unlesioned mice 
injected with Control rAAV (H) or rAAV-STAT3 (I). (J) Quantification of the number of 
collaterals exiting the hindlimb CST in the cervical spinal cord of unlesioned mice injected 
with Control rAAV (grey bar) or rAAV-STAT3 (red bar). (K) Confocal image (single 
plane) of a contact between a hindlimb CST collateral (red) and a long propriospinal 
neuron (green) in an unlesioned mouse injected with rAAV-STAT3. (L) Quantification of 
the percentage of long propriospinal neurons contacted by hindlimb CST collaterals in 
unlesioned mice (grey bars: mice injected with Control rAAV, red bars: mice injected with 
rAAV-STAT3)., Scale bar equals 50μm in C (also for B, H, I) ,  25μm in E (K).  
 
Figure 4. Sustained STAT3 expression induces de novo formation of midline crossing 
circuits following pyramidotomy.  
(A) Schematic representation of the analysis of CST remodeling after unilateral 
pyramidotomy and injection of Control rAAV or a rAAV-STAT3. (B-D) Confocal images 
of midline crossing fibers in mice injected with Control rAAV (B) or rAAV-STAT3 (C, D) 
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and perfused 3 wks (B, C) or 12 wks (D) following pyramidotomy. (E, F) Quantification of 
the number of fibers exiting ipsilateral from the main CST (E) and crossing the spinal 
midline (F) in mice injected with Control rAAV (grey bars) or rAAV-STAT3 (red bars) 
and perfused 1, 3 or 12 wks following pyramidotomy. (G) Quantification of the percentage 
of midline crossing fibers that project to the contralateral (denervated) laminae VI to IX in 
mice injected with Control rAAV (grey bars) or rAAV-STAT3 (red bars) and perfused 3 
and 12 weeks following pyramidotomy. (H) Quantification of the density of midline 
crossing fibers in the contralateral (denervated) side of the spinal cord at different distances 
from the midline in mice injected with Control rAAV (grey line) or rAAV-STAT3 (red 
line) and perfused 12 weeks following pyramidotomy. (I, K) Confocal images (single 
planes) of contacts between midline crossing forelimb CST collaterals (red) and a short 
propriospinal neuron (I, green) or a motoneurons (K, green) in mice injected with rAAV-
STAT3 and perfused 12 wks following the pyramidotomy. (J, L) Quantification of the 
percentage of short propriospinal neurons (J) and motoneurons (L) contacted by mideline 
crossing forelimb CST collaterals in mice injected with Control rAAV (grey bars) or 
rAAV-STAT3 (red bars) and perfused 12wks following injury. Scale bars equal 200 μm in 
D (also for B, C), 50 μm in K (also for I). 
 
Figure 5. Sustained STAT3 expression promotes functional recovery following 
pyramidotomy.  
(A) Picture of a mouse in a “staircase test” which we used to evaluate forelimb reaching 
and grasping abilities in mice. (B) Quantification of the number of pellets eaten by mice 
injected with Control rAAV (grey line) or rAAV-STAT3 (red line) at different test 
intervals up to 10 weeks following pyramidotomy. (C) Schematic representation of the 
cortical electrostimulation and EMG recording that we used to quantify circuit 
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reconnection after pyramidotomy. (D) Trace of a forelimb EMG recording after cortical 
stimulation. (E) Quantification of the percentage of responsive sites contralateral to the 
lesion in unlesioned mice (black bar) and ipsilateral to the lesion acutely following 
pyramidotomy (white bar) and 12 wks following pyramidotomy in mice injected with 
Control rAAV (grey bar) or rAAV-STAT3 (red bar). A second pyramidotomy 12 weeks 
following pyramidotomy and injection of rAAV-STAT3n abolishes the ipsilateral 
responses (red bar, re-lesion). (F, G) Quantification of the stimulation thresholds (F) and 
latencies (G) of the forelimb responses in unlesioned mice (black bars, contralateral to 
lesion) in mice injected with Control rAAV (grey bar, ipsilateral to the lesion) or rAAV-
STAT3 (red barm ipsilateral to the lesion) at 12 weeks following pyramidotomy.  
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4.1. Structural remodeling of corticospinal tract collaterals 
4.1.1 Summary of key findings 
Following a dorsal hemisection, the corticospinal tract (CST) sprouts newly formed 
collaterals and remodels its axons rostral from the lesion site. The ability of the CST tract to 
remodel its connections to form new intraspinal detour circuits is a key feature in enabling 
spontaneous functional recovery following injury (Bareyre et al., 2004; Courtine et al., 2008).  
 
The reconstruction of single CST collaterals at different time points after injury allowed us to 
reveal that axonal remodeling occurs through three orchestrated phases (Figure 7; Lang et 
al., 2012):   
(1) A growth initiation phase, where there is growth of newly formed 
collaterals that are simple in structure (10 days following injury),  
(2) A collateral formation phase, where collaterals develop a complex 
structure (occurs between 10 days-4 weeks after injury),  
(3) A maturation phase where there is refinement and maturation of synaptic 
connections onto spinal interneurons (occurs 3-12 weeks after injury).  
 
 
Throughout these phases, newly formed collaterals undergo structural and synaptic 
changes before reaching a mature projection pattern. Once they reach a mature pattern, 
newly formed CST collaterals persist long-term for at least up to 6 months after injury. The 
reconstruction of single collaterals originating from different CST components further 
revealed that although the timing of the remodeling phases is similar between the main and 
minor CST components, their structural complexity differed depending on their tract of origin.   
 
In this study we were able to provide a detailed anatomical analysis and the time 
course of CST remodeling following injury. This improved understanding of the 
characteristics of the different phases will aid in the design and timing of therapeutic 
interventions that specifically target the individual phases of the remodeling process.  
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Figure 7. Schematic representation of hindlimb CST remodeling following SCI. Scheme illustrating 
the formation of cervical collaterals derived from the main CST (upper row) and the minor dorsolateral (2nd 
row) and ventral (3rd row) CST components at 10 days (blue), 3–4 weeks (green) and 12 weeks (red) after 
SCI. Bottom row illustrates the refinement over time of the contacts between CST collaterals and cervical 
interneurons (Taken from Lang et al., 2012; doi:10.1371/journal.pone.0030461.g006) 
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4.1.2 Stages of collateral remodeling  
A key feature of CST remodeling that emerged from our analysis is that initially 
extensive collaterals and contacts are established. However over time only some of these 
contacts and collaterals are maintained while others are eliminated. This maturation and 
refinement of the circuit following injury is reminiscent of similar mechanisms that occur 
during development. For example, during development, in systems such as the visual 
system (Sretavan and Shatz 1986), auditory system (Leake et al., 2002) and the neocortex 
(Portera-Cailliau et al., 2005), there is an excess of immature axonal projections. This is then 
followed by a refinement phase which eventually leads to a mature adult topographical 
pattern. In the developing CST, aberrant sprouts are also formed though these are then later 
pruned during maturation (Stanfield et al., 1982; Stanfield and O'Leary 1985; Chakrabarty 
and Martin 2000; Li and Martin 2002), indicating that this process is a common feature 
necessary for circuit formation. Molecules such as semphorins/plexins (Bagri et al., 2003; 
Low et al., 2008) and ephrins (O'Leary and Wilkinson 1999) have been implicated to be 
players in this refinement process. In our study we found that the injured CST undergoes a 
similar process of sprouting followed by pruning, which raises the possibility that similar 
molecular mechanisms may also regulate the refinement of neuronal circuits after injury.   
 
Our work further shows that during CST remodeling that not only the number of CST 
collaterals but also the CST contact pattern on interneurons evolves over time. Collaterals 
formed 10 days post injury emerging from all tracts were short in length and had very few 
boutons and branch points. These collaterals were immature in both structure and the 
synaptic machinery present in their boutons (Lang et al., 2012). Comparative observations 
from our population study revealed that at 10 days post injury, approximately 10% of newly 
formed collaterals formed more than 3 contacts onto one interneuronal cell body, with 
around 38% observed to form only one contact. At a late time point when a mature circuit is 
established, 12 weeks post injury, 80% of collaterals were found to make one contact onto a 
single neuronal cell body (Figure 7), while the remaining 20% were observed to form a 
maximum of 2 contacts. A majority of the CST collaterals boutons at this time point 
expressed the mature synaptic marker synapsin I (Lang et al., 2012). We considered this a 
“mature” contact pattern as a comparable synaptic marker expression was observed in the 
lumbar cord of unlesioned mice. Monosynaptic input appears to be the typical form of 
innervation as this is reminiscent of the innervation pattern at the neuromuscular junction. 
Here in this system, initially multiple axons innervate one junction.  Competition between the 
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axons then occurs and in the end only a single input remains (Balice-Gordon and Lichtman 
1993; Balice-Gordon et al., 1993).  
 
The mechanisms that determine which inputs are maintained and which are removed 
during CST remodeling after injury are currently only partly understood. In the developing 
nervous systems, where initial connections made by invading axons are often inaccurate, 
neural activity has emerged as the deciding factor in the formation of a precise neural circuit 
(Shatz 1996; Chakrabarty and Martin 2010; Kerschensteiner et al., 2009; Morgan et al., 
2011). In the case of the CST, it has been shown that inhibition of activity with an 
intramuscular injection of botulinum toxin A, which causes muscle paralysis, results in the 
development of immature CST axons (Martin et al., 2004). At maturity, CST axons are 
known to be morphologically complex when compared to the immature CST axons seen in 
development (Chakrabarty and Martin 2000; Li and Martin 2002). The complex structure of 
the mature CST axons, mainly due to an increase in the number of branches, has been 
noted to coincide with the establishment of the cortical motor map (Li and Martin 2002). To 
produce the mature projection pattern that is required for skilled movements, incorrect CST 
connections are eliminated and essential functional connections are maintained. In the CST 
system, motor experiences are known to be important for the development of CST 
terminations and function (Martin et al., 2004; Chakrabarty et al., 2009; Chakrabarty and 
Martin 2010).  
 
In general, synapse formation and elimination appears to be a recurrent occurrence 
throughout the lifetime of an animal as even the adult system, in response to injury can 
undergo cell type-specific plasticity and rearrangements. The observed parallels between 
post-injury remodeling and developmental circuit formation suggest that a combination of 
guidance cues and activity-dependent mechanisms governs the formation and refinement of 
specific connections during corticospinal remodeling (Martin et al., 1999; Martin et al., 2000; 
Li and Martin 2002). Collectively, the combination influences the permanency of a collateral, 
its structure, a synapse, and synaptic strength (Colicos et al., 2001; Nikonenko et al., 2003; 
De Paola et al., 2003; De Paola et al., 2006). 
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4.1.3 Contribution of main and minor CST components  
At maturation, the newly formed collaterals emerging from the different components 
of the CST, the main dorsal and the minor dorsolateral and ventral components, have 
distinct structures (Lang et al., 2012). Collaterals sprouting from different white matter 
locations displayed differences in branching and bouton number, suggesting that their 
contacts and their role in the de novo neural circuit may differ (Lang et al., 2012). Although 
the signals that govern the distinct structure of CST collaterals are unknown, one 
explanation is that structure is related to function. Newly sprouted collaterals emerging from 
different anatomical locations would have access to distinct interneuronal pools. Dorsolateral 
and main CST collaterals with their complex branching patterns are able to project into a 
larger area of the spinal grey matter, mainly into the intermediate and ventral horn near the 
vicinity of propriospinal interneurons and motorneurons (Steward et al., 2004). In contrast, 
the projection field of the simple-in-structure ventral CST collaterals is more confined to the 
region where the motorneurons are located.  Given their extensive projection pattern, newly 
formed main and dorsolateral CST collaterals after lesion are likely to have a more 
prominent role in the formation of the detour circuit. In particular, the contribution from the 
main component is more significant as this component sprouts the majority of fibers, 
followed by the dorsolateral component. As a result we found that collaterals emerging from 
the main and to a lesser extent from the dorsolateral CST, were responsible for the majority 
of contacts onto spinal interneurons. The complex structure of dorsolateral and main CST 
collaterals could be a requirement for creating strong functional connections and for the 
integration of different interneuronal pools to create an operational communicative neural 
circuit to enable the CST to regain control of skilled limb movement.  
 
This raises questions about the simple ventral CST collaterals and their role in the 
new neural circuit. While their simple structure might suggest an insignificant role, the 
following findings suggest that ventral CST collaterals also play an important role during the 
remodeling process. First, despite the fact that the ventral CST fibers are unlesioned in our 
model system they sprout, relative to the tract size, a high number of new collaterals. 
Second, previous work in rats has shown that the collaterals that sprout from this tract are 
important for functional recovery. Weidner et al., (2001) found that when the ventral CST 
component was lesioned there was no sprouting or functional recovery. Furthermore, lesion 
of the ventral component (at cervical level C2) 5 weeks after a dorsal column transection (at 
cervical level C3), eliminated the functional recovery that was previously observed with only 
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a dorsal lesion. In addition it was reported that the proportion of fibers remaining in the 
ventral or lateral funiculus after a T8 lesion in rats was proportional to the open field 
locomotor score (Schucht et al., 2002).  
 
 
4.1.4 Axonal remodeling following SCI and the implications for 
functional recovery and therapy  
The ability of newly formed CST collaterals for spontaneous axonal remodeling is a 
key mechanism that mediates functional recovery after spinal cord injury. Exploiting the 
natural tendency for collaterals to form compensatory detour circuits is an attractive strategy 
in terms of enhancing recovery following CNS lesions. Bareyre et al., (2004), illustrated that 
following a dorsal thoracic lesion, CST collaterals remodel their connections rostral from the 
lesion site. Contacts onto interneuronal pools that are not beneficial were lost while 
functional contacts were strengthened. Comprehensive behavioral and electrophysiological 
assessments validated that the CST remodeling, observed in this study, is a crucial step for 
the recovery of CST function (Bareyre et al., 2004).   
 
The CST is not the only tract that is known to spontaneously remodel following injury. 
Studies have observed that other tract systems such as the rubrospinal and reticulospinal 
tract and the serotonergic circuit respond to injury. For example, the rubrospinal tract that 
cooperates with the corticospinal tract in controlling fine skilled motor movements (Whishaw 
et al,. 1998) has been observed to sprout in the spinal cord following a CST transection at 
the brainstem (Raineteau et al., 2001). The reorganization of reticulospinal axons and the re-
establishment of serotonergic activity can also contribute to functional recovery after injury. 
The reticulospinal tract (RST) has its axons running in the lateral and ventral white matter 
and is often spared in a contusion lesion (Hill et al., 2001). The RST tract, which is involved 
in the initiation of walking, has been observed to sprout below the injury site (Ballermann and 
Fouad 2006). Spinal motor neurons require neuromodulators such as serotonin (5-HT) for 
the generation of rhythmic movement (Jordan et al., 2008; Fouad et al., 2010). Constitutive 
serotonergic activity following SCI can be beneficial in terms of enabling motorneuron 
recovery and hence walking. However there are detrimental effects should there be no 
cortical regulation as constant expression of serotonergic activity can lead to spasms 
(Murray et al., 2010).  
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Remodeling processes are likely not limited to descending tract systems as circuit 
refinement can also happen at the level of the spinal interneurons. Propriospinal 
interneurons are part of the central pattern generator (CPG). The CPG is a self-sustained 
spinal motor pattern able to produce neural activity that is modulated by sensory afferent and 
supraspinal commands (Grillner and Wallen 1985).  Courtine et al., (2008) found that 
elimination of propriospinal neurons causes a loss of functional recovery after injury. Using a 
staggered hemisection model they could show that when the propriospinal circuit was 
destroyed all recovered movement was abolished. Additional studies show that the CPG as 
a whole can spontaneously adapt and reorganize its connections following injury (Lovely et 
al., 1989; Rossignol et al., 1999; de Leon et al., 1999; Edgerton et al., 2004).  For example in 
cats, when the supraspinal input is cut and the muscles are paralyzed, thereby depriving the 
cord of sensory cues, the animals can still be trained to walk on a treadmill.  Continuous 
locomotor training further improves the stepping pattern. Cats with extensive treadmill 
training for 12 weeks are capable of full weight support and efficient stepping (Hodgson et 
al., 1994), demonstrating that the CPG circuits responds to task related plasticity (Raineteau 
and Schwab 2001).  However without constant training the cats have poor locomotor 
performance, though with retraining the stepping ability could be relearned (Hodgson et al., 
1994). In relation to humans, functional MRI studies have revealed that the supraspinal 
locomotor control between humans and quadruped animals is similar (Jahn et al., 2008; Filli 
et al., 2011). CPG circuits are also known to exist in humans, and can be therapeutically 
targeted to improve the recovery of SCI injured patients (Dietz et al., 1994; Barrière et al., 
2008; van Hedel and Dietz 2010).  
 
Extensive reorganization following SCI not only occurs in the spinal cord, it 
additionally transpires in the cortex. Intact areas of the cortex have been found to expand 
into de-afferented regions with various methods including intracortical microstimulation 
(Fouad et al., 2001; Emerick et al., 2003; Martinez et al., 2009), electrophysiology (Aguilar et 
al., 2010), trans-synaptic tracing (Bareyre et al., 2004), functional magnetic resonance 
imaging (fMRI) (Endo et al., 2007; Ghosh et al., 2009; Nishimura and Isa 2009; Ghosh et al., 
2010), voltage-sensitive dye imaging (VSD) (Ghosh et al., 2009; Ghosh et al., 2010) and 
retrograde tracing (Ghosh et al., 2010). For example, Ghosh et al., (2010) found through 
VSD and BOLDMRI imaging techniques that following a thoracic lesion there is expansion of 
the forelimb sensory representation into the affected hindlimb sensorimotor area. Input from 
the forelimb region could be a form of compensation or due to extensive reliance on the 
forelimb after injury. Even the human brain has been reported to undergo such 
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reorganization, utilizing these newly formed connections to regain functional recovery 
(Freund et al., 2011; Lu et al., 2011).  
 
Taken together, extensive axonal remodeling processes can be observed on multiple 
anatomical levels and likely form the basis for the spontaneous improvement in motor, 
sensory or other neurological function that can be observed in approximately 40% of SCI 
patients (Bracken et al., 1992; Frankel 1998; Weidner et al., 2001; Freund et al., 2011). 
Despite the fact that there is some spontaneous remodeling, in most cases functional 
impairments still persist following CNS injures. The further support of axonal remodeling 
processes is thus an attractive target for therapeutic strategies. The improved understanding 
of the remodeling process can now help to guide the development of new therapeutic 
strategies. Our investigations revealed that remodeling occurs in timely phases and these 
phases offer windows of opportunities to influence the remodeling process.  For example, to 
improve growth, one would target treatment within the first 10 days following lesion. 
Alternatively interventions that aim to modulate connectivity would be effective 3 weeks 
following injury.  
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4.2. Enhancing and modulating axonal outgrowth and 
remodeling 
4.2.1 Summary of key findings 
In the first study we investigated the role of STAT3 during the regeneration of 
lesioned peripheral and central DRG branches (Bareyre et al., 2011). The main findings of 
this study were: 
• Sustained STAT3 expression is induced by a peripheral but not a central 
lesion. Selective deletion of STAT3 impairs the regeneration of the peripheral 
branch following injury. While viral gene transfer of STAT3 promoted axonal 
outgrowth and sprouting of the DRG central branch. 
•  In vivo time-lapse imaging revealed that STAT3 is a phase-specific regulator 
of the intrinsic growth program and that it is essential for the initiation of 
axonal regeneration but does not affect axonal elongation. 
 
In a second study we then examined whether and how the induction of STAT3 
expression can be used to improve axonal regeneration, remodeling and functional recovery 
after spinal cord injury (Lang et al., Chapter 3 submitted). The main findings of this study 
were: 
• Following spinal cord injury, STAT3 expression in cortical projection neurons 
is only transiently induced and the conditional deletion of this expression 
affects neither spontaneous regeneration nor remodeling of CST axons. 
• Sustained expression and activation of STAT3 in cortical projection neurons 
can be induced by viral gene transfer leading to improved regeneration and 
remodeling of lesioned CST axons.  
• The forced upregulation of STAT3 can recruit unlesioned CST fibers to the 
remodeling process. In a unilateral CST lesion (pyramidotomy) paradigm, 
sustained STAT3 expression triggers the formation of new collaterals that 
emerge from the unlesioned tract. These collaterals were observed to cross 
the spinal midline and contact interneurons and motorneurons on the 
denervated side of the spinal cord (Figure 8). Moreover, behavioral and 
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electrophysiological assessments validated that a new intraspinal circuit is 
formed that contributes to the improved recovery of the impaired forelimb.  
 
In summary, the results from these studies identify STAT3 as a key regulator of axonal 
growth initiation and demonstrate that the induction of sustained STAT3 expression, for 
example through viral gene transfer, is a promising strategy to enhance axonal regeneration, 
remodeling and functional recovery after spinal cord injury.  
 
 
Figure 8. Schematic representation of the pyramidotomy paradigm used in this experiment in 
conjunction with treatment using a control rAAV or a rAAV-STAT3. STAT3 overexpression induces 
compensatory midline sprouting of fibers from the unlesioned tract following a pyramidotomy lesion. 
(adapted from Lang et al., Chapter Three, manuscript submitted) 
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4.2.2 STAT3 as an initiator of the intrinsic neuronal growth program 
Peripheral and central injuries can trigger differential changes in gene expression, 
hence explaining the difference in regenerative responses (Broude et al., 1997, Herdegen et 
al., 1997, Herdegen and Leah 1998, Schwaiger et al., 2000, Sheu et al., 2000, Snider et al., 
2002, Kruse et al., 2011, Mason et al., 2011). Regenerative associated genes (RAGs) and 
transcription factors are found to be upregulated in regenerating PNS neurons after a 
peripheral nerve injury (Richardson and Verge 1987, Mason et al., 2002). STAT3 is a 
regenerative associated transcription factor part of the intrinsic growth program present in a 
neuron. Injury to the peripheral branch of the DRG sensory neuron results in the increased 
expression of activated STAT3, even at two weeks post injury, and the activation of the 
regeneration program (Neumann and Woolf 1999; Qiu et al., 2005; Bareyre et al., 2011). 
The conditional deletion of STAT3 in the peripheral branch was found to only delay the 
regenerative response, thereby verifying the role of this transcription factor in the intrinsic 
neuronal growth program as an initiator (Bareyre et al., 2011). STAT3 was revealed to have 
a significant regulatory role in the PNS following injury, as the endogenous expression and 
activation of the transcription factor can influence the initiation of axonal growth. 
 
In the CNS, the intrinsic growth machinery has been shown to be activated in CNS 
neurons after axotomy (Richardson and Verge 1987; Benowitz and Routtenberg 1997; Smith 
et al., 2011), and in CNS neurons that have axons regenerating through a peripheral nerve 
graft (Benfey et al., 1985). However due to inhibitory factors and feedback pathways, the 
effect is only transient (Sun and He 2010; Kruse et al., 2011). In upper cortical neurons, 
following lesion, there is only a transient upregulation of activated STAT3 with return to 
baseline levels one week following injury (Lang et al., Chapter Three submitted). This is due 
to the fact that STAT3 activation is tightly regulated and controlled by SOCS3, which itself is 
also upregulated after injury (Croker et al., 2008; Smith etc al., 2009). The lack of sustained 
activation of factors in this program in injured mature CNS neurons is one of the main 
reasons why regeneration in the PNS is successful, while in the CNS there is failure.  This is 
in accordance with not only our studies but with others who have found impaired growth and 
regeneration when STAT3 levels were indirectly negatively affected via pharmacological 
means. Inhibition of the pathway with a Janus kinase 2 (JAK2) inhibitor AG490 (Qiu et al., 
2005) or by blockade of IL6 signaling, in essence inhibiting activation of the Jak/STAT3 
pathway (Zhong et al., 1999; Caffetry et al., 2001) resulted in regeneration failure of 
‘conditioned’ dorsal column axons, which usually have regenerative capabilities. 
Alternatively, a number of studies, ours included, have found that sustained activation of 
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STAT3 either by genetic deletion of its inhibitor SOCS3 (Smith et al., 2009; Sun et al., 2011) 
or through an rAAV-STAT3 (Bareyre et al., 2011; Lang et al., Chapter Three submitted) can 
promote axonal growth and regeneration after a CNS lesion.  
 
The upregulation of STAT3 following injury indicates that it is required for inducing 
axonal growth, but its deletion will not affect the spontaneous recovery system that the 
injured CST has in place in the form of spontaneous axonal remodeling and the formation of 
de novo detour circuits. The presence of axonal growth in both the PNS and CNS when 
STAT3 is deleted (Bareyre et al., 2011; Lang et al., Chapter Three submitted) indicates that 
there are other systems able to compensate for its deletion. Therefore there are likely to be 
substitute candidate factors that are able to initiate the growth response in the absence of 
STAT3. Members of the PTEN/mTOR pathway (Park et al., 2010; Liu et al., 2010) are 
potential candidates as they have been reported to influence the intrinsic growth response.  
Another such potential candidate is the cAMP signaling pathway, which is important for 
neuronal growth (McQuarrie et al., 1977; Qiu et al., 2000; Cai et al., 2001; Qiu et al., 2002). 
cAMP levels have been found to be up-regulated after sciatic nerve transection and 
administration of cAMP into the DRG can promote the regeneration of dorsal column axons 
(Neumann et al., 2002; Qiu et al., 2002).  
 
Additionally, the identification of STAT3 as a phase-specific regulator that only affects 
growth initiation implies that there are distinct phases of axonal growth modulated by 
different factors. What are the possible regulators that will switch the axon from a growing 
state to an elongation state?  Axonal elongation, for example, could be modulated by the 
interaction with Schwann cells, which following injury align to form tubes and are able to 
guide axons to their target cells (Höke 2006). Potentially, the Schwann cells are responsible 
for the shift from the growth phase to the elongation phase. In a crush injury, which leaves 
Schwann cell guidance intact, the absence of STAT3 has no effect on the elongation of 
injured PNS axons. This suggests that once axons enter the axonal elongation phase, 
STAT3 is no longer required. Nevertheless, sustained activation of pathways that enhance 
and promote growth, such as STAT3, in selective neuronal populations is a promising 
strategy that can further promote functional recovery. Indeed our studies (Bareyre et al., 
2011, Lang et al., Chapter Three manuscript submitted) found that direct overexpression of 
STAT3 through gene therapy is a strong therapeutic strategy that can trigger further growth, 
remodeling, regeneration compensatory sprouting and functional recovery following CNS 
lesions.   
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4.2.3 Integration of STAT3 into the signaling pathways that regulate 
neuronal growth 
How STAT3 initiates the neuronal growth program is an interesting question that is so 
far still only incompletely understood. However, as STAT3 is a transcription factor it is likely 
that the downstream effects are mediated by induction of gene expression. A large number 
of genes that are affected by STAT3 have already been identified. The small proline rich 
protein 1a (SPRR1A), the cell cycle inhibitor P21/Cip1/ and the regulatory factor 1 (IRF1) are 
known to be downstream targets of STAT3 (Coqueret and Gascan 200; Pradervand et al., 
2004; Smith et al., 2011). All of these molecules have also been implicated as regulators of 
axonal regeneration (Bonilla et al., 2002; Tanaka et al., 2004; Smith et al., 2011). For 
example, in cultured cerebellar neurons, IRF1 was found to increase neuronal outgrowth 
(Smith et al., 2011). In addition to these downstream targets, STAT3 also increases the 
expression of immediate early gene c-Jun. C-Jun expression has been previously identified 
as a key step in the induction of axonal regeneration and mice that lack c-Jun expression in 
the nervous system have impaired regeneration of motorneurons after injury (Raivich et al., 
2004). 
 
Another important question is which factors are responsible for the activation of 
STAT3 after injury. Referring to the Jak/STAT pathway, we know that the pathway is 
activated by cytokines that include CNTF (Rajan et al., 1996), IL-6 (Zhong et al., 1994) and 
LIF (Kunisada et al., 1996). Following injury the expression of these neuropoetic cytokines 
factors are increased at the lesion site and can influence STAT3 signaling (Bourde et al., 
1996; Kurek et al., 1996). At the lesion site, the secretion of cytokines would lead to the 
activation of STAT3, which is then transported retrogradely along the axon (Curtis et al., 
1994; Lee et al, 2004; Ben-Yaakov et al., 2012). Preventing expression of these classical 
inducers of the Jak/STAT pathway, results in impaired axonal regeneration and functional 
recovery (Zhong et al., 1994; Cafferty et al., 2001; Cafferty et al., 2004). Overall these 
studies indicate that the activation of STAT3 by cytokines is a key step in activating the 
intrinsic growth program and thus facilitating axonal regeneration.    
 
Furthermore it appears that STAT3 expression can also be affected by classical 
neurotrophin signaling. In particular the interaction between STAT3 and BDNF has been 
reported (McAllister et al., 1999; Bramham and Messaoudi 2005; Ng et al., 2006). Knockout 
of STAT3 by siRNA in hippocampal cells decreases the neurite outgrowth effect that BDNF 
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can elicit (Bramham and Messaoudi 2005). In PC12 cells, crosstalk between the BDNF and 
STAT3 signaling pathways was observed with STAT3 acting as a signal transducer for 
tyrosine kinase A (TrkA). STAT3 activation is downstream from TrkA activation, with TrkA 
able to phosphorylate STAT3 at Ser-727 thereby enhancing transcription (Ng et al., 2006).  
 
In addition it is likely that other intracellular signaling pathways of the intrinsic 
neuronal growth program can interact with STAT3.  As mentioned previously, Liu et al., 
(2010) and Yip, et al., (2010) illustrated that through genetic manipulation that leads to the 
inactivation of PTEN (Liu et al., 2010) or the overexpression of NCS1 (Yip et al., 2010), it is 
possible to induce axonal growth and regeneration. These experiments identified PTEN and 
NCS1 as key components of the intrinsic neuronal growth response. Inactivation of PTEN is 
known to activate Akt and mTOR signaling and inhibit signaling molecules such as GSK-3 
(Zhou et al., 2004; Ma and Blenis 2009; Park et al., 2010; Liu et al., 2010) and PIP3 (Zhao et 
al., 2006). The Akt pathway provides a link between PTEN signaling and NCS1 as it has 
been shown that overexpression of NCS1 increases the levels of phosphorylated Akt, 
thereby activating the pathway (Yip et al., 2010; Figure 8). The activation of the PI3K/Akt 
pathway is associated with enhanced neurite outgrowth in the DRG, perinatal cortical 
neurons (Markus et al., 2002; Ozdinler and Macklis 2006) and embryonic cortical neurons 
(Nakamura et al., 2006). Notably, STAT3 has also been reported to interact with the Akt 
pathway via PI3K (Figure 8; Park et al., 2006; Lu et al., 2008; Blando et al., 2011). In cell 
culture experiments, when STAT3 is deleted there is reduced expression of Akt (Park et al., 
2006; Lu et al., 2008). Further, in cancer cells interaction between the Jak/STAT3 and PTEN 
signaling pathways has been observed (Sun and Steinberg 2002; Yang et al., 2003; Saxena 
et al., 2007; Zhou et al., 2007; Blando et al., 2011). The Jak/STAT3 pathway was found to 
be positively regulated by PI3K/mTOR signaling, whereas PTEN served as a negative 
regulator of both Jak/STAT3 and mTOR signaling (Zhou et al., 2007). Sun et al., (2011) 
found that PTEN and SOCS3 independently regulate two different pathways that can act 
synergistically to promote axonal regeneration. Double deletion of the STAT3 inhibitor 
pathway, SOCS3, and PTEN resulted in enhanced and sustained axonal regeneration in the 
optic nerve, compared to a single deletion of either factor (Figure 8).  
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Figure 9. Simplified scheme of selected pathways that have been identified to be important for 
enhancing axonal growth following injury. Overexpression of neuronal calcium sensor 1 (NCS1) 
increases the levels of phosphorylated Akt, a serine/threonine protein kinase. Activation of the Akt signaling 
pathway is known to increase neurite outgrowth.  Inhibition of PTEN, which functions both as a dual 
specificity protein phosphatase and an inositol phospholipid, activates the Akt, and mTOR signaling 
pathway. PTEN is also known to negatively regulate the Jak/STAT3 signaling pathway. Deletion of both 
SOCS3 (an inhibitor of the Jak/STAT3 pathway) and PTEN was found to enhance axonal regeneration and 
growth in the optic nerve. While a single knockout of either will still result in axonal growth and regeneration 
following injury, the effect is not as great. Insert is of a layer 5 pyramidal cortical neuron.  
 
 
4.2.4 STAT3 as a therapeutic target 
Our results identify STAT3 as an attractive target for therapeutic strategies that aim 
at improving functional recovery after spinal cord injury. One resulting action of sustained 
STAT3 expression is that there is the induction of sprouting of lesioned CST axons at the 
lesion site, as well as regeneration up to 400µm into the lesion site (Lang et al., Chapter 
Three submitted). The finding that STAT3 can induce regeneration of corticospinal fibers is 
important as the CST projection has a reputation of being one of the difficult axonal systems 
to experimentally elicit regeneration (Blesch and Tuszynski 2009). Factors and proteins that 
elicit regeneration in other tracts may not have an effect on the CST.  For example, insulin-
like growth factor-1 (IGF-1) or BDNF are able to promote regeneration of raphespinal axons 
or rubrospinal axons respectively but not of corticospinal axons (Kobayashi et al., 1997; Lu 
et al., 2001; Jin et al., 2002; Liu et al., 2002; Kwon et al., 2002; Hollis et al., 2009). However 
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it should be noted that although the treatment of STAT3 resulted in the regeneration of CST 
fibers up to 400µm from the site of the lesion, long-distance regeneration that extends 
substantially past the lesion site was not observed. This indicates that even though the 
stimulation of growth can push CST neurons into a regenerative state, alone it is still not 
enough to enable successful regeneration across the lesion site. The failure of successful 
long-distance regeneration is due in part to the inhibitory environment formed after injury. It 
is difficult to override the inhibitory environment with the presence of growth inhibitory 
molecules that include chondroitin sulphate proteoglycans (CSPGs) (Fawcett and Asher 
1999; Silver and Miller 2004) and myelin-associated neurite growth inhibitors (McGee and 
Strittmatter 2003; Filbin 2003). In combination with the down-regulation of the CNS 
regenerative response (Schwab and Bartholdi 1996; Neumann and Woolf 1999), and the 
lack of trophic factor support (Widenfalk et al., 2001; Jones et al., 2001) it is not a surprise 
that it is difficult for axons to fully extend past the lesion site without additional assistance. 
For long-distance regeneration to be successful it is thus important to combine the induction 
of the intrinsic growth program with strategies that target extrinsic growth inhibition. Such 
strategies that target extrinsic inhibitors in the glial scar and myelin have been developed in 
the recent years. For example, the removal or neutralization of myelin can improve axonal 
regeneration. When an antibody aimed against neutralizing inhibitory factors like Nogo-A 
(IN-1 antigen) is used, regenerative sprouts and long distance elongation is seen (Schnell 
and Schwab 1990; Brosamle et al., 2000), as well as growth and sprouting of damaged and 
intact fibers (Schnell and Schwab 1990; Liebscher et al., 2005; Freund et al., 2007; Müllner 
et al., 2008; Maier et al., 2009; Gonzenbach et al., 2010). Chondroitinase ABC is a bacterial 
enzyme that is often used in SCI research due to its property to digest extracellular 
chondroitin sulfate proteoglycans (CSPGs) and the perineuronal nets (Carulli et al., 2010). 
Following injury it has been found to enhance axonal regeneration (Zuo et al., 1998; Yick et 
al., 2000; Bradbury et al., 2002) and reactivate plasticity in adult CNS by promoting sprouting 
and an increase in bouton number (Pizzorusso et al., 2002; Wang et al., 2011). In theory, the 
selective initiation of neuronal growth by sustained STAT3 expression is an ideal therapeutic 
complement to strategies that then counteract the growth-inhibitory signals in the inhibitory 
lesion environment that the regenerating axons encounters. In line with this concept we 
could show synergistic effects on axonal outgrowth of central sensory connections when we 
combined STAT3 induction with the neutralization of growth-inhibitory CSPGs (Bareyre et 
al., 2011). Combined treatments that include STAT3 induction may thus be promising 
strategies that might eventually enable successful regeneration of CST axons.
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At least equally important as the initiation of axon regeneration, are the effects of 
sustained STAT3 expression on the remodeling of CST fibers. Our laboratory and other 
groups have previously shown that lesioned CST fibers can spontaneously remodel after 
injury and that the formation of detour circuits using intraspinal relay neurons is a key 
mechanism that mediates recovery of CST function (Bareyre et al., 2004; Courtine et al., 
2008). We can show that sustained STAT3 expression can further increase the number of 
cervical CST collaterals that form after lesion. However increased collateral formation does 
not result in a significant increase of the CST connections to the long propriospinal relay 
neurons. This might indicate that the endogenous growth response of lesioned CST 
projection neurons is sufficient to promote the formation of detour circuits at an “optimal” rate 
and that is not improved further by the presence of additional CST collaterals. In line with 
this assumption, it was previously shown that the application of antibodies directed against 
the growth inhibitor NogoA does not further enhance detour circuit formation (Bareyre et al., 
2004). 
 
 In contrast to lesioned fibers, unlesioned fibers mostly do not remodel after injury. 
Our results now indicate that sustained STAT3 expression can also recruit unlesioned fibers 
to the remodeling process. Through the use of the pyramidotomy model, we were able to 
investigate the effects of STAT3 on unlesioned fibers.  This model is advantageous as it 
allows for a specific unilateral lesion of the CST, interrupting the direct cortical input 
(Thallmair et al., 1998). Pyramidotomy is known to affect voluntary movement of the 
forepaws (Steward et al., 2004; Lacroix et al., 2004), locomotion (Metz et al., 1998; 
Fanardjian et al., 2001), somatosensory sensation (Thallmair et al., 1998), fine-skilled paw 
reaching (Whishaw et al., 1998; Thallmair et al., 1998; Z’Graggen et al., 1998; Weidner et 
al., 2001), and cause asymmetrical limb use (Thallmair et al., 1998; Z’Graggen et al., 1998; 
Starkey et al., 2005). When STAT3 is overexpressed in cortical projection neurons, we found 
that the unlesioned tract sprouted more collaterals and sends these collaterals across the 
midline to the denervated side of the spinal cord, where they were found to contact both 
SPSNs and motorneurons responsible for forelimb movement. Our results thus show that 
after STAT3 overexpression the unlesioned tract can be recruited to the remodeling process 
and compensate for the loss of innervation by forming a new intraspinal circuit (Figure 10) 
that leads to functional recovery assessed electrophysiologically and behaviorally.  
 
It should be noted that sustained STAT3 expression is not the only way to improve 
recovery in the pyramidotomy model. For example, sprouting across the midline from the 
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intact CST can be induced by neurotrophic factors (Zhou and Shine 2003), inhibition of the 
neurite outgrowth inhibitor NOGO (Thallmair et al., 1998; Bareyre et al., 2002; Wiessner et 
al., 2003), and even electrical stimulation (Brus-Ramer et al., 2007). There are also other 
factors that if manipulated can also induce midline sprouting in the pyramidotomy model. Yip 
et al., (2010) demonstrated that overexpression of the protein neuronal calcium sensor1 
(NCS1) promotes midline sprouting and supports functional recovery. Thus, over the recent 
years a number of therapeutic targets and tools have been identified that can, in principle, 
improve axonal remodeling and functional recovery after spinal cord injury. STAT3 is a 
particularly attractive target as it can induce axonal regeneration and remodeling of spared 
fibers and due to its phase specific action it can selectively induce the initiation of axonal 
outgrowth.  
 
Figure 10. The effect of overexpression of STAT3 in layer 5 cortical neurons. (A) Overexpression of 
STAT3 promotes growth and regeneration of lesioned hindlimb corticospinal tract (hCST) fibers 3 weeks 
following a thoracic dorsal hemisection. (B) In the pyramidotomy paradigm, the overexpression of STAT3 
induces compensatory sprouting and remodeling of forelimb CST (fCST) fibers from the unlesioned tract. 
Fibers from the intact fCST tract cross the midline into the denervated side of the cord, where they are 
found to contact both SPSNs and motorneurons responsible for forelimb movement. A new intraspinal 
circuit is formed enabling substantial functional recovery of the forelimb.  (C) Image of pyramidotomy lesion 
performed at the level of the medulla and (D) of a mouse performing the pellet grasping test which 
assesses fine forelimb grasping ability.  Scale bar equals 0.5mm in (C) and 5mm (D).  
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The use of pharmacological inhibitors to manipulate STAT3 expression is not ideal as 
STAT3 signaling is not limited to selective neuronal populations, thereby presenting a risk of 
activating STAT3 action in other cell types. STAT3 signaling plays an essential part in many 
biological processes such as regulating the immune response (Shuai and Liu 2003) and 
astrogliosis (Okada et al., 2006; Herrmann et al., 2008). Additionally, sustained STAT3 
expression can cause uncontrolled cell growth and is linked to diseases such as cancer 
(Turkson and Jove 2000; Silver and Montell 2001; Sano et al., 2005). Therefore the use of 
viral gene therapy to specifically target STAT3 to particular neuronal cell population is a 
more suitable strategy. However with persistent expression the risk of tumor induction 
remains, hence in the long run it will be important to develop strategies to limit the duration 
of STAT3 overexpression. From our investigations, we have seen that through efficient 
genetic delivery of STAT3 to specific neuronal populations it is possible to manipulate axonal 
remodeling and regeneration. In terms of clinical implications, success with gene therapy 
has been seen in leukemia where T-cells were genetically engineered with lentiviruses to 
recognize and destroy leukemia tumor cells (Porter et al., 2011; Kalos et al., 2011). 
Recombinant adeno-associated viral vectors (rAAV) are well characterized in terms of safety 
profiles and are also used for gene therapy and clinical trials for neurodegenerative diseases 
such as Alzheimer's disease and Parkinson (Kaspar et al., 2002; Kaplitt et al., 2007; Lim et 
al., 2010). The vectors ability to infect CNS neurons and provide long term expression of the 
gene of interest without causing an immune response makes them attractive tools (Papale et 
al., 2009; Hutson et al., 2011; McCown 20011). 
 
 
4.3. Outlook and future directions  
The crucial step in the establishment of detour circuits is the formation of contacts 
between cortical projection neurons and intraspinal relay neurons (Bareyre et al., 2005, Lang 
et al., 2012). Newly formed dlCST and mCST collaterals display a complexity suggesting 
they are capable of contacting different population of spinal relay neurons. The spinal cord is 
full of excitatory and inhibitory interneuronal populations that could in principle be targeted by 
the newly formed CST collaterals. From our study (Lang et al., 2012), we observed contacts 
onto PSNs, an excitatory population of interneurons, and then wondered whether the 
targeting of newly sprouted CST collaterals was equal on all interneuronal populations. To 
address this question, we examined whether CST collaterals also formed contacts onto 
glycinergic neurons. To selectively label glycinergic neurons we used the GlyT2-GFP mouse 
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line that expresses enhanced green fluorescent protein (eGFP) in neurons under the Glycine 
Transporter 2 promoter (Zeilhofer et al., 2005). Surprisingly, we found that compared to 
excitatory interneurons such as long and short propriospinal neurons, only a very small 
percentage of GlyT2 interneurons were contacted by newly formed CST collaterals. This 
indicates that not all interneuronal populations are equally targeted by CST collaterals 
(Figure 11).  
 
This raises the question in what are the factors that determine which interneuronal 
populations are contacted by growing CST collaterals. This is an important question as the 
formation of functionally “meaningful” connections is key for functional recovery (Bareyre et 
al., 2004) and the formation of “incorrect” connections can lead to undesired symptoms that 
include neuropathic or phantom pain (Kaufmann and Moser 2000). The fact that 
propriospinal interneurons are preferentially contacted following injury suggests that this 
population of neurons express factors that attract the collaterals. Adhesive and repulsive 
interactions have been shown to guide cell-target recognition (Tessier-Lavigne and 
Goodman 1996; Sanes and Yamagata 1999; Matsuoka et al., 2011).  Understanding the 
molecules at play in guiding these new CST sprouts onto their target will be an important 
future challenge that will help us to better understand and therapeutically enhancing post-
injury circuit formation.  
 
 
Figure 11. Differential targeting of newly formed hCST collaterals following a dorsal thoracic 
hemisection. Newly formed hCST preferentially contact target short and long propriospinal interneurons 
(SPSN and LPSN), while only a small percentage of glycinergic (GlyT2) neurons were found to be 
contacted (insert). 
  Discussion 
 
    98 
 
The pyramidotomy model in combination with sustained STAT3 expression can now 
provide an experimental approach to address the identity of the molecules that guide newly 
sprouted CST collaterals to their targets. Here, we could show that STAT3 expression 
induces the emergence of CST collaterals from the unlesioned tract both with and without a 
lesion of the contralateral tract. However these newly emerging collaterals crossed the spinal 
midline only if the contralateral side was previously denervated. This indicates that 
denervation induces the expression of molecules that attract the CST collaterals across the 
midline. In order to identify these molecular cues that might be responsible for attracting the 
collaterals across the midline, we plan to perform quantitative gene expression profiling. 
Previous gene chip studies have provided evidence that the molecular composition of the 
denervated spinal cord changes in response to injury (Bareyre et al., 2002; Maier et al., 
2008). The denervated side was found to upregulate factors important for growth, adhesion, 
and synapse formation (Bareyre et al., 2002; Maier et al., 2008). In our current analysis we 
will focus the expression of guidance molecules that are differentially expressed following 
different treatment paradigms. The denervated and innervated sides of the spinal cord of 
mice lesioned at different timepoints and in which CST sprouting was induced by injection of 
rAAV-STAT3 will be analyzed and compared with untreated mice (Figure 12). From the data 
that will be collected we wish to identify candidate guidance molecules that attract fibers 
across the spinal midline. Then the manipulation of genes of interest could be envisaged 
using RNAi and viral gene transfer techniques to respectively knock out or overexpress 
candidate molecules and examine the effects on midline crossing of CST fibers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Scheme of proposed microarray gene expression protocol to analyze the innervated 
(green) and denervated (red) side of the cord following a pyramidotomy lesion.  rAAV-STAT3-treated 
and untreated mice lesioned at different timepoints will be evaluated. 
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4.4. Conclusions 
Spontaneous remodeling after injury has been illustrated to be an important feature 
that contributes to functional recovery after CNS injuries (Fouad et al., 2001; Bareyre et al., 
2004; Courtine et al., 2008). Incomplete spinal cord injuries are susceptible to such 
remodeling because the cortical, subcortical and some of the local spinal cord circuitry 
remains largely intact and still partially interconnected by unlesioned fibers. In SCI, 
remodeling is characterized by three phases that consists of a growth initiation phase, which 
is then followed by a collateral formation phase, and finally there is a refinement period. In 
the process of anatomical remodeling, new circuits are established through the sprouting of 
axonal branches and dendrites, and reorganization of connections. A better understanding 
of this temporal sequence can help to guide future studies targeting the molecular regulation 
and therapeutic support of axonal remodeling.  
 
Despite the fact that there is spontaneous remodeling, functional impairments still 
persist following CNS injures. Studies have indicated that supporting growth in the CNS is an 
attractive strategy to enhance axonal remodeling (Zhou et al., 2003; Liu et al., 2010; Yip et 
al., 2010). Therefore targeting the initial growth phase is an attractive and direct approach. In 
our studies we have identified that the regenerative-associated transcription factor STAT3 is 
a key phase-specific regulator of the initial phase and is necessary for the initiation of 
regeneration in the PNS (Bareyre et al., 2011). Further investigations revealed that 
sustained activation of STAT3 after CNS injuries not only enhances axonal regeneration, it 
improves axonal growth and remodeling of both lesioned and unlesioned fibers, and 
functional recovery. This approach to enhance axonal remodeling by stimulating growth 
through the direct manipulation of the intrinsic growth program is a promising strategy for the 
future.  Nevertheless, from the published research it can be inferred that a successful 
strategy would be expected to utilize a combination of therapies to overcome both the 
intrinsic and extrinsic barriers. In particular, intrinsic growth induction can be ideally 
combined with already established strategies to neutralize the extrinsic growth-inhibitory 
environment of the lesioned CNS. 
 
 In the future, it is hoped that studies such as ours will lead to better understandings 
of the mechanisms that underlie axonal remodeling after injury and help to devise effective 
therapies to prevent the devastating consequences of spinal injuries. Recent groundbreaking 
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work showed that improving functional recovery after spinal cord injury might not be an 
unrealistic therapeutic goal. In 2011, Harkema et al. (2011) revealed that it is possible for a 
human after spinal cord injury to achieve full weight-bearing standing, take steps on a 
treadmill and regain other key functions. The human subject was a 23 year old man with 
paraplegia from a C7–T1. A 16-electrode device was implanted in his lower back and in 
combination with intensive training the patient was able to walk on a treadmill as long as his 
cord was stimulated. The field of SCI research is continually evolving and over the last few 
years encouraging results have been published and with them bringing hopes to long 
suffering patients.  The range of techniques available that include in vivo imaging, transgenic 
mice, RNAi, electrophysiology, and optogenetics are further advancing the field, making it an 
exciting time for scientific research and enabling us to further investigate, manipulate and 
understand the complicated vast intriguing system that is the CNS network. 
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